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Chapter 1 
General introduction 

General introduction 
The genetic information of all living organisms is stored in DNA, a long 
macromolecule composed of four different nucleotides. Preservation of the sequence of 
nucleotides, defining the genetic code, is a prerequisite for a faithful transmission of the 
genetic information to subsequent generations and for accurate expression of this coded 
information. Although DNA is a relatively stable molecule, it is vulnerable to changes 
by metabolic activity or environmental DNA·damaging agents (128). Spontaneous DNA 
modifications are mainly due to an intrinsic instability of the glycosyl bond between the 
base and the sugar moiety of a nucleotide or are induced by chemical cellular processes 
such as oxidation, hydrolytic deamination or alkylation of nucleotides. Furthermore, 
chemical as well as physical agents in the cellular environment threaten the integrity and 
stability of DNA. A variety of chemical agents interact with or modify DNA, resulting in 
inter- and intra·strand crosslinks, single strand- and double strand breaks, oxidized 
nucleotides, alkylated bases and sugars, bulky adducts on nucleotides, protein-DNA 
crosslinks and products intercalated into the double-helix. The most prominent physical 
DNA-damaging agents are v-rays, X-rays and UV-light. 
DNA damage can disturb vital cellular processes, whichdirectly depend on the 
integrity of DNA, such as transcription and replication. Blockage of the transcription of 
important housekeeping genes causes malfunctioning of the cell, which may result in cell 
death. 
Replicative DNA synthesis is inhibited by lesions on the DNA. This hindrance can 
be circumvented by an error-prone replication mechanism. The resulting sequence 
alterations can influence expression of genes or affect the function of coded gene 
products. For example, such mutations can activate (proto)oncogenes andlor inactivate 
tumour suppressor genes, both resulting in a disturbance of either cell-cycle regulation 
or life-span controlling activities, and provoke uncontrolled cellular growth. 
Consequently, induction and accumulation of DNA lesions can be considered an early 
event in the multi-step process of oncogenesis. 
Disturbances of normal replication and transcription due to xenobiotic exposure 
are not only a result of DNA lesions, but also a consequence of the radiation-induced 
"signal transduction pathway". It has been shown that activities which regulate 
transcription, replication and cell-cycle progression are also influenced by mutagenic 
radiation (83). Modifying growth factor receptors by xenobiotics induces a cascade of 
reactions via the mitogen-activated kinase-pathway, resulting in phosphorylation and 
dephosphorylation of key transcriptional activators (204). Post-translational modifications 
affect transcription of responsive genes positively or negatively. Furthermore, DNA 
damage stabilizes the tumour suppressor gene product, p53 (40). Accumulated p53 
induces transcription of genes encoding cell-cycle controlling proteins, resulting in a G 1 
arrest (40, 206). Postponement of replication allows the cell to repair its DNA, thereby 
preventing the generation of mutations. 
Together with the shortening of telomeres (76) persisting DNA damage can be an 
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additional factor in the process of cellular aging of somatic tissues. 
During evolution several DNA repair pathways have emerged (61) in order to 
cope with the above mentioned deleterious effects of DNA lesions. Most of the repair 
mechanisms have been strongly conserved during evolution, with evident parallels 
between human and yeast and even Eschericia coli. In only a few cases have species-
specific repair systems evolved. The most relevant repair mechanisms are: 1) direct 
reversal of damage, 2) base excision repair, 3) nucleotide excision repair, 4) mismatch 
repair, 5) recombination repair, and 6) post replication repair. For a comprehensive 
review on DNA repair mechanisms see reference (60). 
The first evidence that DNA repair plays an important role in tumour prevention 
was reported more than 25 years ago, by Cleaver (34). He showed that the cancer-prone 
hereditary disorder xeroderma pigmentosum (XP), has as its bases on a defective 
nucleotide gxcision repair (NER) pathway. This rare, autosomal recessive disorder is 
characterized by extreme sensitivity of affected individuals to UV-light (resulting in DNA 
damage), in addition to a predisposition to the development of skin-cancer (35). In 
addition to this prototype repair disorder, other cancer-prone syndromes based on a 
defect in one of the repair processes, other than NER, are known. Examples are: 
Fanconi's anaemia (FA) and Bloom syndrome (BS). 
Two other excision repair-deficient hereditary syndromes have been recognized: 
Cockayne syndrome (CS) (167) and trichothiodystrophy (TTD) (235). However, no 
predisposition to skin-cancer is present among CS and TTD patients. Individuals suffering 
from these repair-deficient conditions display a broad spectrum of clinical traits, 
sometimes with overlapping features of two different syndromes. Most of these disorders 
are also heterogeneous at the genetic level, and generally multiple genes are involved 
in a given syndrome (chapter 3). 
The aim of the experimental work described in this thesis is to further characterize 
and dissect the genetic complexity of NER-deficient syndromes. Genetic analysis of 
patients with complex (and combined) clinical features resulted in the assignment of their 
inherited defect to a selected group of NER genes (appendices I, II, III and V). Additional 
studies provide a molecular basis for some of the previously unexplained clinical features 
of such individuals (appendices IV and V). For this reason, a more detailed introduction 
to NER, NER-syndromes and NER-factors is presented in chapters 2, 3 and 4. 
Biochemical studies revealed that another basic cellular process, transcription, is tightly 
connected to N ER. Basic information on this process is also provided in this thesis 
(chapter 5). 
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Chapter 2 
Nucleotide excision repair 

Nucleotide Excision Repair (NER) 
The major UV-induced lesions are cyclobutane pyrimidine dimers (CPD) and 6-4 
pyrimidine-pyrimidone (6-4PP) photoproducts(between two adjacent pyrimidines). These 
lesions, bulky chemical DNA adducts and intra-strand crosslinks are targets for the NER 
pathway. 
NER research has acquired more attention recently, because of the importance of 
this repair mechanism in relation to the expected increase of environmental UV-light 
exposure. Our environment is polluted with an increasing amount of chemical agents 
due to human industrial activities. The accumulation of CFCs in the atmosphere, which 
are thought to degrade the stratospheric ozone (64), is a significant potential threat. 
Reduction of the ozone layer results in an increased penetration of the mutagenic UV-
light on the earth's surface. A prediction can be made that as a consequence of the 
elevated Uv exposure an increase in the frequency of solar-induced skin cancer will arise 
(136, 300), since it is well-established that the incidence of cutaneous malignancies can 
be correlated with the amount of solar exposure. 
As with many other DNA repair processes, NER is evolutionary conserved (86, 
87). Although the different factors involved in N ER have diverged extensively between 
prokaryotes and eukaryotes (86), the overall basic pathway appears to be similar. The 
molecular reaction mechanism involves the following steps: 
1. Damage recognition factors scan the DNA for lesions. Recognition factors bound 
to lesions and mediate the assembly of excision factors. 
2. Local remodelling or opening of the dense chromatin structure to give access to 
the N ER components. 
3. The triggered or activated excision machinery makes a dual incision 
(excinuclease) on either site (5' and 3') at some distance from the lesion. 
4. Strand displacement of the excised, damage-containing fragment and turnover of 
the excinuclease complex. 
5. Filling in of the resulting gap by DNA polymerase and auxiliary factors. 
6. Rejoining of the newly synthesized DNA to the existing DNA by a ligase. 
The exact order of steps 1 and 2 is not known, it is possible that these occur 
simultaneously. This also holds for steps 4 and 5. 
2.1. Nucleotide excision repair in E. coli. 
Genetic analysis of a panel of UV-sensitive, NER-deficient E.coli mutants, gene 
cloning and biochemical studies on NER-gene products have resulted in a fairly well 
understood mechanism of this process (70). Two UvrA and one UvrB molecule form a 
hetero-trimer (Uvr A,B) (step 1) that scans the DNA-hel ix for lesions. The A,B complex 
hooks onto a lesion, UvrA dissociates and the lesion-bound UvrB bends the DNA and 
attracts a UvrC molecule (step 1, 2). This BC-complex possesses a dual endonuclease 
activity (excinuclease), cutting eight bases 5' (probably catalyzed by UvrC) of the lesion, 
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Table 1 Properties S.cereyisiae NER genes and mutants 
Affected NER Protein Homologous gene in: Remarks 
Gene UV' TCR" GGR" size (aa)3) human S.pombe 
RAD1 ++ 1100 ERCC4 ? rad16+ complex with Radl0, 5'-incision 5) 
RAD2 ++ 1031 XPC/ERCC5 rad13+ 3' incision 
RAD3" ++ 778 XPD/ERCC2 rad15+ TFIIH subunit, 5'_3' helicase, vital 
RAD4 ++ 754 XPC? single-strand DNA binding? 
RAD7 + + 565 ? SIR3 interaction 
RAD10 ++ 210 ERCCl swil0 complex with Radl, 5' incision S) 
RAD14 ++ 247 XPA damage recognition, Zn2 + -finger 
RAD16 + + 790 Zn2+-finger, SNF2-like helicase domains 
RAD23 + -? -? 398 HHR23A, B ubiquitin fusion, complex with Rad4? 
RAD25" ++ 843 XPB/ERCGJ rhpY TFIIH subunit, 3'-5' helicase, vital 
RAD26 + 1085 CSB/ERCC6 SNF2-like helicase domains 
SSL1" -/+ 461 p44/HHSSL1 ? TFIlH subunit, 2 Zn2 +-fingers 
TFB 1" -/+ 642 p62 TFIIH subunit 
RFA1 -/+ 622 RPA1 Single-strand DNA binding 
RFA2 -/+ 273 RPA2 single-strand DNA binding 
RFA3 -/+ 121 RPA3 single-strand DNA binding 
1) transcription coupled repair. 2) global genome repair. 3) predicted number of amino acids, based on sequence (ORF) of cloned gene. 
4) probably also other TFI1H subunits have an additional NER function. 5) additional role in recombination. 
A number of other mutants/genes; MMS, RAD24, SNM1, may playa role in NER as well. 
and 5 phosphodiester bonds 3' of it (likely performed by UvrB) (step 3). Displacement 
of the excised strand is performed by the collaborative action of UvrD (or helicase II) and 
DNA polymerase I (step 4), followed by DNA synthesis, filling the resulting gap (step 5). 
Steps 4 and 5 are probably performed simultaneously. The reaction is completed by a 
ligase (step 6). . 
Lesions can 'block the transcription process by stalling the elongating RNA 
polymerase II complex at the injured site (49). It is important for normal functioning of 
the cell to rapidly eliminate these serious impairments. For this reason, a specialized NER 
sub-pathway is thought to have arisen in E. coli: "transcription coupled repair", or 
"preferential repair" (150). This pathway is limited to the transcribed strand of active 
genes. Preferential repair is faster than its counterpart: "genome overall repair" (or repair 
of non-transcribed DNA). This subdivision of NER was first described for mammalian 
N ER (17). Preferential repair of the transcribed strand in E. coli has been shown in vivo 
as well as in vitro (217). Selective strand-specific repair is facilitated by the TRCF protein 
(transcription-repair coupling factor), which is encoded by the mid gene (221). mid 
mutants appear to be slightly UV-sensitive but have a 5x elevated frequency of UV-
induced mutagenesis in comparison to wild-type strains. TRCF functions in dissociating 
a stalled RNA polymerase from DNA at the site of a lesion and attracting the NER 
machinery by binding to the UvrA component (219), thereby providing a fast and 
efficient repair of DNA damage in more critical regions of the genome. 
2.2 Eukaryotic NER 
In contrast to the situation in E. coli, understanding of the eukaryotic N ER 
mechanism is less complete, although insight into this process is rapidly increasing. A 
number of genes and proteins involved in yeast (Saccharomyces cerevisiae) NER have 
been isolated and characterized, again with the aid of a set of NER-deficient mutants, or 
by using sequence conservation (190). Recently, some repair genes of the distantly 
related fission yeast Schizosaccharomyces pombe have been cloned (118). Several of 
these genes show homology with the S.cerevisiae genes (146). 
Properties of the yeast excision repair proteins are summarized in Table 1. Since 
in this thesis the emphasis is on genetic and biochemical defects in (human) repair 
syndromes, the overview of NER presented in the next chapters is limited to that 
occuring in mammals. Important parallels on structure and function between yeast and 
man N ER are discussed when relevant. 
2.3 Mammalian NER mutants. 
Identification and characterization of mammalian NER-deficient mutants is 
important to the study of mammalian DNA repair (as with E.coli and S.cerevisiae). The 
mammalian group of NER mutants is divided into two classes: 
1- laboratory-induced, rodent, UV-sensitive cell lines 
2- naturally existing human syndromes 
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Table 2 Features of rodent NER-deficient complementation groups. 
Complementation sensitivity" human cloned, 
group UV MMC" equivalent correcting gene 
++ +++ none ERCCI 
2 ++ + XP-D XPDIERCC2 
3 ++ + XP-B XPBIERCC3 
4 ++ +++ XP-F/ ERCC4 
5 +(+) ± XP-G XPGIERCC6 
6 + + CS-B CSBIERCC6 
7 + ± ? 
8 + + 
9 + + 
10 + + 
11 +(+) + ? 
1) +, 2-5x wt; + +, 5-IOx wt; + + + > lOx wt. 2) mitomycin-C, a cross/inking agent. 
2.3.1 Rodent mutants. 
UV-sensitive N ER-deficient rodent mutant cell lines have been isolated after 
mutagen ic treatment of established rodent cell strains and appropriate selection protocols. 
Most mutants were generated from chinese hamster ovary cells (CHO) (25, 80, 234). The 
partial hemi-zygocity, frequently occurring in CHO cultures, has been of great help in 
isolating mutants with a recessive repair phenotype (human NER syndromes are all 
recessively inherited). Cell hybridization experiments have resulted in the identification 
of 11 excision repair deficient complementation groups (Table 2) (25). 
A significant difference is observed between rodent and human NER. The overall 
genome repair of pyrimidine dimers is much less efficient in rodents (10-20% within 24 
h) than in man (60-70% within 24 h). However, the toxic effect of a given UV-dose is 
almost identical in cells derived from both species (271). This apparent discrepancy 
between these two species (the so-called: human-rodent repair paradox) has not yet been 
explained, but it should be taken into account whenever experimental data is 
extrapolated from one species to the other. 
Despite these observed differences a considerable similarity between rodent and 
human N ER is apparent (86, 87). Characteristics of the CHO cells, including the 
immortalized status and suitable transfection properties due to a relatively high capacity 
to integrate transferred DNA (88), made this group of mutants a valuable tool for the 
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isolation of mammalian NER genes via transfer of genomic DNA (Table 2). 
2.3.2 Human NER-deficiencies 
Three rare, autosomal recessive disorders are known to be based on a NER-
deficiency: the prototype NER-disease, xeroderma pigmentosum (XP)(34), Cockayne 
Syndrome (CS)(167), and the photosensitive form of trichothiodystrophy (TTD)(95, 236). 
In total ten NER-deficient complementation groups are recognized within these three 
disorders: seven for XP (XP-A to -G), two for CS (CS-A and CS-B) and TTD-A. Clinical and 
genetical characteristics of these syndromes are described in chapter 3. A significant 
overlap between the two groups of mammalian NER mutants has become apparent. 
Both groups of NER-deficient mutants were of much help for the identification and 
cloning of the mammalian NER genes. 
2.4 Cloning of mammalian NER genes 
In order to study the molecular mechanism of mammalian NER, it is necessary to 
isolate and characterize its components. Cloning of NER genes is a key step for further 
biochemical analysis. tn addition, sequence information is a prerequisite for performing 
gene targeting experiments which is used for the generation of animal models, mimicking 
human repair-deficient syndromes. 
Using genomic DNA transfection the first human NER gene (ERCCl) was cloned 
a decade ago (293). This gene corrected the NER defect in a Chinese hamster ovary 
(CHO) cell line from complementation group 1. Subsequent genomic DNA transfections 
to representatives of the different UV' CHO groups has resulted in the isolation of a set 
of human repair genes: ERCC21XPD (289), ERCC31XPB (291), ERCCSIXPG (160), and 
ERCC61CSB (262). The XPA gene was cloned by genomic DNA transfer to XP-A cells 
(254). Using an episomally replicating cDNA library, successful cloning of the XPC gene 
(116) and CSA gene (82) were reported. HHR23B and its homologue; HHR23A, were 
isolated by virtue of their evolutionary conserved nature. These genes were isolated after 
database searches, comparing the yeast protein (Rad23) with cloned mammalian 
sequences of unknown function (EST). Degenerative nucleotide primers, deduced from 
the micro-sequenced damage-specific DNA-binding (DDB) protein (32) which is altered 
in XP-E, were used to clone the gene encoding the 127 kDa protein (ODB)(250). Also 
with this approach, both genes encoding the XPC/HHR23B complex (see 4.4.3) were 
cloned (140). Recently the ERCC4 gene was cloned after transfection of a chromosome 
16 cosmid library (258), since this gene is localized to this chromosome (129). 
2.5 NER-assays. 
For monitoring N ER, several parameters can be used: cellular survival after UV, 
UV-induced mutagenesis, chromosomal aberrations, reactivation of UV-irradiated viruses 
or reporter genes, and removal of specific lesions. These assays, however, monitor the 
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biological consequence of NER. A direct NER assay is the measurement of the DNA 
synthesis step of the process, either in vivo (at the single cell level, with UDS) or in vitro 
in cell-free systems. To control or manipulate NER at the cellular level, it is necessary to 
introduce repair factors and inhibitors into the cells. Several methods for introducing 
components into cells have been used in the past, including transiently permeabilized 
cells, vesicle-mediated transfer or fusion with enveloped carriers, and microneedle 
injection with glass capillaries. This last method is the best controlled and has proven 
to be the most successful tool in studying cellular NER. More recently, a cell-free in vitro 
repair system has been developed. The use of the microneedle injection technique and 
more importantly the in vitro NER assay have both contributed to an increasing 
knowledge of mammalian NER. Since both assays were important tools for the research 
presented in this thesis, they will be briefly discussed below. 
Protein Fractions 
Antibodies 
(Mutant) genes 
UV 7 
~ 
3 H Uridine 3 H Thymidine 
t Autoradiography + 
Transcription UDS 
Figure 1. Scheme of microneedle injection DNA repair assay. 
2.5.1 Microneedle injection in DNA repair 
With the microneedle injection technique, the living cell is used as a test tube. 
The usage of microinjection in NER has been extensively reviewed by Hoeijmakers (85). 
With the aid of a glass microcapillary, substances [such as crude cell-extracts, 
(partly) purified proteins, antibodies, peptides, and nucleic acids (mRNA, DNA)], can be 
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directly targeted to the cytoplasm or the nuclei (Figure 1), of living repair-proficient or -
deficient (XP, CS or TTD) fibroblasts. After microinjection (and a desired incubation 
time), cells are exposed to UV-light (inducing DNA damage), followed by incubation in 
culture medium containing tritiated thymidine. During the course of repair replication, 
labelled nucleotides will be incorporated into DNA and can be visualized after 
autoradiography (UDS-assay). In a comparable manner, the recovery of RNA synthesis 
(RRS) after UV can be measured. In this procedure, some time after irradiation 
(dependent on the UV-dose), cells are labelled with tritiated uridine (added to the culture 
medium), fixed and exposed for autoradiography. The repair capacity of the injected cells 
can be quantified by counting the grains above the nuclei (both after UDS and RRS) and 
are compared to the number of grains above the uninjected surrounding cells. 
The advantage of this technique is that it is direct, efficient, not toxic to the cells, 
and that it consumes only small quantities of compounds. Moreover, NER is examined 
in its native setting (nuclear chromatin), and neigbouring non-injected cells serve as 
optimal (negative) controls. However, the method also has limitations: it is time-
consuming and laborious, and injection solutions are required to be free of particles and 
of toxic agents (detergents). Moreover, the NER reaction cannot be controlled or 
dissected into its several steps, and defined or specific lesions cannot be examined. 
Despite these limitations, microinjection studies have provided a better understanding 
of mammalian NER. 
O NER components and / or o ~ / crude ceillysates 
0 0 ~O Incision at dimer and gap filled with [32PJ-dNTP ! Mixture of damaged 
and non-damaged 
DNA plasm ids 
Fluorescence 
-<)---- Plasmid isolation 
and linearization 
non-damaged DNA 
damaged DNA 
Figure 2. Scheme of cell-free (in vitro) DNA repair assay. 
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2.5.2 Cel/-free mammalian NER 
To perform controlled biochemical studies on NER and to further dissect the 
different stages of the reaction, considerable effort has been invested in the development 
of an in vitro mammalian repair assay, similar to the repair system which has been used 
to elucidate the NER in E. coli (70). Almost simultaneously, two labs succeeded in the 
development of such a cell-free repair system (230, 295). Crude cell-Iysates were 
incubated, in the presence of an energy regenerating system, with different damaged and 
un-damaged plasmids, together with labelled nucleotides. After recovery and 
linearization of the plasmid DNAs, incorporation of nucleotides (into the repair patches) 
was monitored by autoradiography (Figure 2). Radio-active nucleotides are preferentially 
incorporated into the damaged plasmid in an ATP-dependent manner. ATP consumption 
is in agreement with previous reports using permeable cells (106). Based on this 
principle, Hanaoka and coworkers developed an in vitro repair assay, using isolated 
SV40 mini-chromosomes, in which the DNA is in a somewhat more natural configuration 
(16, 139, 140). These repair systems were capable of performing in vitro 
complementation after mixing extracts of different XP, and UVs rodent complementation 
groups (295, 240, 270). Using this cell-free NER system, several repair proteins were 
purified (140, 177, 200), the repair-patch size was determined (92) and activities 
required for the repair synthesis were identified (39, 227). Similar cell-free NER assays 
were established for the fission yeast Schizosaccharomyces pombe (231) and the bakers 
yeast Saccharomyces cerevisiae (287). Very recently, a successful in vitro reconstitution 
of the mammalian NER reaction with (partly) purified components has been reported (1, 
159). 
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Chapter 3 
Human NER-deficient syndromes 

Human NER-deficienl Syndromes 
3.1 Xeroderma pigmentosum 
XP patients are extremely sensitive to solar exposure due to the DNA damaging 
effect of the UV component of sunlight (35). Individuals predominantly express 
cutaneous and ocular abnormalities on sun-exposed areas, including acute sun-sensitivity 
(erythema and bullae), marked hyper- and hypopigmented spots, a dry aged-like and 
scaling skin, keratosis and telangiectasia. A large group of XP patients exhibit a high risk 
(more than 1 OOOx elevated) towards the development of cutaneous malignancies (basal 
cell carcinomas, squamous cell carcinomas and melanomas). 
A complex of different symptoms was found to be associated with a subgroup of 
patients originally designated; De Sanctis-Cacchione syndrome (DSC)(46). DSC describes 
mainly neurologic and developmental abnormalities of individuals with a freckling 
(pigmentosum) and parchment (xeroderma) -like skin. It later transpired that all DSC 
patients belong to XP, and the DSC designation has gone out of use. The (progressive) 
neurological symptoms in XP are: intellectual deterioration, loss of the ability to talk and 
increasing spasticity, which are all thought to be due to primary neuronal degeneration 
(198). Developmental problems are: microcephaly, dwarfism and immature sexual 
development. 
Also at the cellular level (XP-derived cell cultures), an abnormal UV-sensitivity 
is also observed. DNA repair synthesis after UV-irradiation, as measured by tritiated 
thymidine incorporation (autoradiographically), is severely reduced in XP (34)(Figure 3). 
Moreover, a series of mutagenesis studies on these cells revealed that XP cells are hyper-
mutable after a UV challenge. The spectrum of UV-induced mutations in XP cells is also 
different from that in NER-proficient cells (35). The elevated mutation frequency in XP 
after exposure to DNA damaging agents, and the high risk of skin tumour development, 
are in agreement with the idea that inappropriate processing of DNA lesions is an early 
step in oncogenesis. Persisting lesions can induce mutations after replication which may 
alter the function or expression of genes involved in cellular growth, replication fidelity, 
cell-cycle control or apoptosis. 
A broad clinical heterogeneity is observed among XP individuals. This varies from 
patients with severe neurological implications and a high number of skin tumours to 
individuals with mild pigmentary abnormalities without signs of neurological 
abnormalities. This variation can either be due to differences in genetic background of 
affected persons or to allelic variation. Cell fusion studies revealed in the early seventies 
that XP is a multi genic disorder (44). Cells of different patients were fused with the aid 
of inactivated Sendai-virus, and assayed for repair replication or UDS (ynscheduled QNA 
,ynthesis) after UV exposure. In some combinations of these somatic XP hybrids 
complementation of the defective repair replication can be observed (Figure 3). At the 
present time seVen different NER-deficient XP complementation groups (XP-A to XP-G) 
have been identified (Table 3)(278). This implies that at least seven genes are responsible 
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for a functional NER and that a defect in one of these results in a XP phenotype. 
Approximately 20% of XP patients do not have deficient NER and have been are 
designated XP-variant (XP-V)(35). The clinical spectrum of this group is also variable, 
ranging from severe cutaneous alterations (including skin malignancies) to very mildly 
affected individuals. In general neurological abnormalities have been observed in only 
a few patients within this group (35). Although cell survival of XP-variants after UV-
irradiation is in the near-normal range, UV-induced mutagenesis is enhanced. The 
spectrum of mutations is also different from that in normal cells (284). The primary defect 
in XP-V is thought to reside in a process called post replication repair (PRR)(119). In XP-V 
cells, DNA synthesis is more inhibited, and newly synthesized DNA is of a smaller size 
than in normal cells after UV-irradiation. The apparent mechanism is that DNA synthesis 
is blocked at a lesion, and replication had to re-start after the lesion. After a certain 
delay, the rate of daughter strand synthesis becomes identical to the normal situation. 
PRR is in fact a mechanism to avoid termination of replicative synthesis after DNA 
damage. Two PRR pathways are known, an error-free and an error-prone one (114a). 
Because of the elevated mutation frequency in XP-V, it is likely that the error-free 
pathway is disturbed in XP-V. 
homodikaryon 
UDS-
f 
uvf 
j'H-TdR 
autoradiography 
heterodikaryon 
UDS+ 
XP-B ..... ~ O'1lf' 
fu 
homodikaryon 
UDS-
Figure 3. Complementation analysis by cell-hybridisation. Prior to (Sendai-virus induced) 
fusion, cells were labelled with micro-spheres of different sizes. The different fusion 
products can be distinguished by their differential bead content. NER capacity is 
visualised as auto-radiographic grains above the nuclei, which is reduced or absent by 
XP cells. In case of complementation, the number of grains above the nuclei in the 
hybrid cell is identical as above repair-proficient cells. 
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3.2 Cockayne syndrome 
CS patients display mainly neurologic and developmental abnormalities (121, 
167). Individuals have a sun·sensitive skin (erythema after minimal exposure). However, 
in contrast to XP, there are no pigmentation abnormalities or predisposition to skin 
cancer. In some cases, thin and dry hair and skin are present. Ocular features are 
frequently found, these include pigmented retina, cataracts, optic disk atrophy, meiotic 
pupils and photophobia. Neurological signs are mental retardation (intelligence decline 
and behaviour problems), loss of gait and speech capacity, hyper-reflexia, occasionally 
seizures and sensorineuronal hearing loss. These neurological features might be 
explained by calcification of basal ganglia and perhaps more likely, by dysmyelination 
of the central- and peripheral nervous system. This neuropathology is of another kind 
than in XP, where abnormalities are due to primary neuronal degeneration (198). 
Developmental (as well as neurological) problems have a postnatal onset in almost all 
cases. These include cachectic dwarfism (in which weight is relatively more affected than 
height), microcephaly, decreased subcutaneous fat, peculiar (birdlike) facies or "wizened 
appearance" (preceding chin, beaked nose, protruding ears and deep sunken eyes), and 
immature sexual development (hypogonadism, undescended small testes). 
The NER defect in CS has only recently been established. Cells derived from CS 
patients are only moderately UV-sensitive and the repair synthesis (or UDS) is in the near 
normal (NER-proficient) range (3). The repair defect in CS-cells is manifest as a retarded 
or absent recovery of DNA (120) or RNA synthesis (144) after an UVchalienge which· 
normally recoveres within a few hours. The repair defect in CS was shown to be based 
on an impaired preferential repair of the transcribed strand, called transcription-coupled 
repair (TCR) (267, 273)(see chapter 4.4). This also explains the observed defect in 
recovery of RNA synthesis (RRS) after UV. The selective removal of ionizing-radiation-
induced lesions from the transcribed-strand also seems impaired in CS (115) suggesting 
that CS patients have mutations in genes that code for (a) general factor(s) which 
couple(s) transcription to repair. 
Complementation analysis has disclosed three groups in CS (Table 3)(117, 252): 
A, Band C. Groups A and B harbour the "classical" CS patients. Group C comprises only 
one patient (XP11 BE), who exhibits also the typical XP symptoms (belonging also to XP 
group B). This combined phenotype, or XP/CS-complex, will be discussed in more detail 
in the following paragraphs and in appendices I-V. 
The group of CS patients is clinically rather heterogeneous. A clinical 
differentiation among CS individuals can be made on the basis of the age of onset and 
severity of the disease: the classical type or CS I, and the severe early onset type, CS II 
(167). Clinical variation is also apparent from the notion that other syndromes like 
CAMFAK (cataracts, microcephaly, failure to thrive, kyphoscoliosis) and COFS (Cerebro-
oculo-facial syndrome) display a phenotype which resembles many of the traits 
commonly observed in CS. Both CAMFAK and COFS express the hallmarks of early onset 
CS with some additional features. However no DNA-repair characteristics nor UV-
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Table 3 Properties of XP, CS and PIBIDS complementation groups 
Complementation UV residual Affected N ER relative skin neurologic 
group sens. UDS" TCR~ GGR" frequency cancer abnormalities remarks 
XP-A +++ <5% high + ++ 
XP-B ++ 10-40% 3 families +/- ++1+ XP/CS and TID 
XP-C + 15-30% + high + 
XP-D ++ 15-50% intermediate +/- + +I± XP,XP/CS and TID 
XP-E ± ~50% rare +/-
XP-F + 15-30% rare +/- -/± 
XP-G ++ <5-25% rare +/- ++1+ XP and XP/CS 
TID-A + 10% 1 family + 
CS-A + normal range + intermediate ++ 
CS--B + normal range + high ++ 
XP_V4) +/± normal range + + high +/- ± 
1) Unscheduled DNA Synthesis/ expressed as percentage of repair synthesis in normal cells. 2) transcription coupled repair. 
3) global genome repair. 4) XP-variant, defect in post replication repair, proficient NER. 
sensitivity within these syndromes have been described (167). Recently, Itoh (97) 
described two siblings without clear CS signs, but with CS-like biochemical DNA-repair 
properties (UV-sensitivity, normal UDS but a reduced post-UV RRS). Genetic analysis 
revealed that these two siblings can be assigned to a new N ER-deficient 
complementation group (designated UV' syndrome), since they complement all known 
XP and CS groups (96). Two other patients (69) with a CS-type of repair defect also 
exhibit only XP symptoms. No complementation analysis has as yet been performed with 
these patients. At the other side of the spectrum, there are individuals with clear CS 
hallmarks (dwarfism, mental retardation, deafness and peculiar facies) but without a 
reduced post-UV RRS (121) and photosensitivity. 
3.3 Combined XP/CS 
A few patients have been described with the rare combination of XP and Cs 
features. The combined XP/CS patients are divided over three groups: XP-B, -D, and -G 
(21,277) (Table 3). Patient XP11 BE (199), who was for a long time the only known case 
of XP group B, expressed severe symptoms of both XP and Cs including numerous skin 
tumours, severe mental retardation, and poor physical development. Two siblings 
(XPCS 1 BA, and -2BA) with mild features of XP and Cs were recently assigned to XP-B 
(277). Developmental abnormalities are hardly present in these individuals and 
neurologic symptoms became evident only after the second decade of life (216). 
CS(A-B) 
(TCW) 
CS 
(TCR') 
Figure 4. Clinical and genetic continuum of NER-deficient land related) syndromes. The 
type of repair defect is indicated. The hatched group represents individuals expressing 
XP features, the light-gray box CS patients and the dark-gray group patients with TTO features. 
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A remarkable clinical variation is observed between the two XP-B families. The two 
siblings do not display any cutaneous malignancies despite a for XP relatively advanced 
age of more than 40 years, whereas patient XP11 BE had skin tumours at a very young 
age (18 years). Nevertheless, the level of UOS, representing the repair defect, is similar 
in both families (5-10% of NER-proficient cells). 
Patient XPCS2 exhibited clear signs of both XP and CS (114, 157) and was 
assigned to XP group 0 (278). Cells of this patient have a relatively high residual DNA 
repair capacity (~40% UOS). The mean residual UOS level in XP-O is around 20-25% 
of control. Patient XP8BR, with a clear XP-skin and severe CS features (died at age 2Y2 
years) and a residual UOS of 30-40%, was assigned to XP-O (21). Two very severe early 
onset CS patients (99) were assigned to XP group G (appendix I). Notably, these patients 
do not have any XP signs, despite a XP-like repair defect. Previously, it was suggested 
(197) that the combined XP/CS cases represent a distinct clinical entity. It is, however, 
tempting to assume that the characteristic features of XP, XP/CS and CS are part of a 
clinical continuum based on a defective NER (Figure 4), which can be designated as 
"NER-syndromes". Two reports (69, 97) describing patients with a confusing phenotype 
support this concept (see 3.2.2) 
3.4 Trichothiodystrophy 
The most prominent TTO features are sulphur-deficient brittle hair (also dry and 
sparse) and nails (95). With polarizing light microscopy a typical, "tiger tail" pattern of 
the hair is visible. Cutaneous signs include photosensitivity, ichthyosis, keratosis, 
erythema and 'collodion baby'. In many cases the brittle hair is associated with a 
heterogeneous complex of neuro-ectodermal abnormalities. Neurologic and 
developmental impairments within TTO are reminiscent to those found in CS (see 3.2.2). 
TTO cases have not been extensively examined for the origin of the neurologic 
abnormalities. In a few cases, calcification of the basal ganglia and dysmyelination (30, 
187,260) have been reported, which could be the cause of the clinical features, like in 
CS. Clinical manifestations and their severity vary extensively between TTO individuals. 
This broad spectrum of symptoms partly explains the confusing nomenclature in the 
literature for probably the same disease (95, 147). Different names have been used to 
describe cases in which some of the above features are present in combination with 
brittle hair. These are Pollitt syndrome (s.), Tay s., Amish brittle hair s., ONMR 
(onychotrichodysplasia, neutropenia, mental retardation), Sabinas s., Marinesco-Sj6gren 
s., BIDS (brittle hair, intellectual impairment, decreased fertility, short stature), IBIOS 
(ichthyosis and BIDS), PIBIOS (photosensitivity and IBIOS), SIBIOS (osteosclerosis and 
IBIOS). 
The association of TTO with deficient NER was discovered by Yong (296). 
Photosensitive TTO patients have a deficient NER (reduced UOS) and complementation 
studies have revealed that the majority of these TTO patients belong to XP group 0 (235, 
236). However, genetic heterogeneity within NER-deficient TTO is present (Table 3)(235). 
A single patient (TT01 BR), expressing the TTO features with severe sun-sensitivity, 
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represents a new NER-deficient complementation group, and was designated TTD-A 
(237). Very recently, the genetic heterogeneity was extended to a third group by the 
finding that the repair defect of a single TTD-family is based on a mutated XPB gene 
(279). The genetic overlap of TTD (identical to CS), with different XP groups, strengthens 
the suggestion above that in addition to XP, XP/CS and CS, UV'-TTD also belong to the 
phenotypical extremes of "NER-syndromes" (Figure 4). 
3.5 Genetic basis of clinical heterogeneity 
Clinical variation could be explained by locus heterogeneity (different genes), 
allelic heterogeneity (variable mutations of the same gene) and by a contribution from 
genetic background. To date, several allelic variations of distinct XP loci have been 
identified, since most of the XP genes have been cloned and mutational analysis has 
been performed on some patients. 
The assignment of two siblings with TTD features to XP-B, extends the already 
reported clinical heterogeneity within this complementation group (279). This 
heterogeneity is even more remarkable when the very low incidence of XP-B patients is 
taken into account (three different phenotypes among three families). In patient XP11 BE 
a splice acceptor mutation of the last intron of ERCC31XPB leads to a 4 bp insertion in 
the last exon, resulting in a frameshift of the last 40 amino acids (292)(Figure 5). A 
missense mutation in the same gene at the N-terminus, converting amino acid 99, a 
phenylalanine into a serine (Figure 5), leads to a similar low cellular repair level, but 
with a much milder phenotype (277). The mutation of the TTD/XPB family is located at 
the same N-terminal region of XPB: tyrosine 119 is substituted into a proline (G.Weeda, 
unpublished observations), resulting in a mild TTD and intermediate NER deficiency. 
This demonstrates that at least allelic heterogeneity (probably in combination with 
differences in genetic background) contributes to the different phenotypes within XP-B. 
Mutation 99 119 742 
F-+S T-+P Is 
Phenotype XP/CS TID XP/CS 
Residual UDS 10% 40% 10% 
Patient XPCS1,2BA TTD4VI,6VI XP11BE 
Figure 5. Schematic representation of the XPB protein. The N-, and C-terminal parts, as 
well as the conserved helicase domains (0 - VI), are indicated. The three mutations 
identified in XP-B patients, and the dominant negative mutation are also pointed. 
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A similar broad spectrum of symptoms is seen within XP-D (101). The majority 
of XP-D patients exhibit features of classical XP, most UV-sensitive TTD patients belong 
to XP-D and two patients show the XP/CS features. However, mutational analysis of XP-D 
patients does not uncover a clear genotype/phenotype correlation (20, 21, 60), although 
until now, causative mutations for XP and TTD phenotypes do not overlap. 
Twelve different mutations have been identified (174) in the XPA gene (253). A 
high frequency of splice mutations (at the 3' part of the third intron) creating an unstable 
mRNA has been observed in the Japanese population (homozygous and compound 
heterozygous), providing evidence for a founder effect of this mutation (208). This 
mutation gives rise to a homogeneous group of patients with a severe phenotype and a 
virtually absent NER (208). Some nonsense mutations at the C-terminal part of XPA 
generate a truncated protein, with residual repair capacity resulting in patients with a less 
severe phenotype (209, 21,0). The observed mutations in XP-A are in concordance with 
the phenotype. 
Different mutations of the XPC gene also seem to correlate with different cellular 
sensitivities and severity of symptoms (122). Since only one XP-G patient has been 
analyzed for mutations in the XPG gene (175), no conclusions can be drawn on a 
correlation between different mutations and the severity of the disease, within this 
extremely heterogeneous XP-G group (276). 
Some of the observed clinical symptoms (for example, photo-sensitivity, 
pigmentation, premature aging of the skin and cutaneous malignancies) within the above 
syndromes can be rationalized on the basis of defective NER. However additional 
manifestations, present mainly in CS and TTD (for example neurodysmyelination, growth 
retardation, impaired sexual development, cataracts, dental caries, ichthyosis and brittle 
hair) are difficult to explain by a DNA repair defect. Clues to the nature of these clinical 
features have been derived from recent observations that some N ER-factors play 
additional roles in fundamental cellular processes like basal transcription (see appendices 
IV and V and next chapter). 
The absence of predisposition to skin cancer in CS and TTD patients is notable, 
in view of the defective NER, and is as yet unexplained. The absence of cutaneous 
malignancies does not seem to correspond with the level of NER, since some TTD/XP-D 
patients with no increased cancer risk have a severe repair defect (20) (comparable to 
"classical" XP-D patients, which are cancer-prone). The postulated transcription defect 
in CS and TTD might suppress the initiation andlor progression of the carcinogenic 
process. 
The generation of mouse models mimicking mutations of both classical XP-D and 
TTD/XP-D in mice, may provide answers to the obscure relationship between NER-defect 
and susceptibility to malignancy and the contribution of allelic variation and systemic 
(genetic) influences to carcinogenicity and expression of phenotype. Moreover, mice 
mimicking the mutations of different patients (of various XP loci), could teach us more 
about the relevance of specific alleles and the genetic background to phenotypical 
expression. 
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Chapter 4 
Mammalian NER mechanism 

Mammalian NER Mechanism 
The available data on the identification, characterization, cloning and biochemical 
analysis of N ER factors can be combined into a model of the mechanism for mammalian 
NER (Figure 6). The different steps, as presented in this model, together with the 
experimental evidence for them are discussed in the following paragraphs. 
4.1 Damage recognition 
The first step in NER is expected to be the binding of a damage recognition factor to the 
lesion, which enables the association of further repair components. Both XPA and XPE 
(or DDB) are candidate "recognition-factors", since both proteins have a high affinity for 
UV-damaged DNA and are involved in NER. 
4.7.7 The XPA-correcting protein. 
XPA protein was purified from calf thymus and HeLa cells, either using the cell 
free system (200) or with the microinjection assay (52, 239). XPA has a high affinity for 
DNA (52, 200), with a preference for UV-damaged DNA (200). The enhanced binding 
of XPA to damaged DNA is specific for lesions which are targets for NER (4, 102). The 
strong bias (200-300 times) for UV-photoproducts is mainly due to 6-4PPs, since removal 
of CPOs (by photolyase) hardly affected the preferential binding (1 02). The lesion-specific 
affinity of XPA probably also accounts for the higher rate (5-10 times) of 6-4PP repair in 
comparison to CPOs (152, 249). Nevertheless, XPA should still be able to recognize 
CPOs in vivo, since XP-A cells lack the ability to repair these lesions. The absence of a 
detectable preference of XPA for CPO lesions probably reflects the limitations of these 
in vitro studies, since in these assays the configuration of DNA is different from DNA 
packed into nuclear chromatin. 
The deduced amino acid sequence of the cloned XPA gene (253), suggested the 
presence of a zinc-finger motif (4C-type), which might contribute to the DNA-binding 
properties of this protein. Atomic absorbtion analysis, confirmed the binding of zinc to 
XPA (4). Mutation studies demonstrates that an intact Zn-finger is indispensable for 
proper function of the protein (4, 154, 155). The S.cerevisiae homolog of XPA is RAO 7 4 
(9), having 27% identical and 54% similar residues. Rad14 also binds preferentially to 
6-4PPs and chelates zinc (75). 
4.7.2 DNA-damage binding protein (OOB). 
The other potential damage recognition factor, DDB (DNA damage binding), was 
first identified in human cell-Iysates, by specific retention with UV-damaged oligo-
nucleotides in a gel-mobility-shift assay (32). This DDB activity is possibly implicated in 
XP-E (32), since it is absent in extracts derived from some, but not all, XP-E patients (103, 
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107). Microinjection of purified DDB transiently corrects the partial NER-defect, only in 
XP-E cells which lack the DDB-activity (105). 
A controversy on the nature of the DDB activity has appeared in the literature. 
DDB is either purified as a hetero-dimer of 41- and 125 kDa (104, 250), or as a single 
125 kDa polypeptide (2, 94). With the aid of amino acid sequence information of the 
125 kDa protein (tryptic digests are micro-sequenced), the gene encoding this 
polypeptide was cloned from a cDNA library (250). The deduced primary structure of 
this protein does not reveal any consensus sequence for known DNA binding domains. 
Structural homo logs (in D.discoideum, and O.sativa) were found in a data base search 
and a DDB-like polypeptide in human and C.e/egans (250) (van der Spek, personal 
communication). These gene products probably represent a novel class of DNA-binding 
proteins. 
DDB (or XPE), specifically binds to UV-induced lesions, with a preference for 6-
4PPs (lOX higher affinity than to CPDs)(104, 192). Despite the very high affinity for 
damaged DNA, a specific role for DDB in NER is still in debate because of the partial 
NER defect in XP-E (slightly UV-sensitive, 50-80% UDS, normal in in vitro repair). 
Moreover, XPE is not involved in the core NER reaction in vitro, and is thought to act 
as an accessory factor (1). 
4.2 Lesion demarcation (melting of the double helix) 
It is likely that somewhere in the N ER reaction a DNA-unwinding activity (or 
helicase) is required, either before and/or after the incision. Two helicase activities have 
been recognized in E.coli NER: UvrA,B, which scans the DNA for lesions in an ATP-
dependent reaction and UvrD or Helicase II, which removes the excised damaged stretch 
of DNA and assists in the turnover of the UvrBC endonucleases. 
XPB(ERCC3) (292) and XPD(ERCC2) (290) both contain the seven conserved 
(consensus) domains of the superfamily of DNA and RNA helicases (67). In addition, 
both proteins have been shown to possess DNA unwinding activity (202, 241). 
4.2.1 XPD/ERCC2 and Rad3 helicase 
XPD is highly conserved during evolution, as was revealed after amino acid 
sequence comparison between human (XPD/ERCC2), Chinese hamster (CXPD), S.pombe 
(rad15/rhp3+) and S.cerevisiae (Rad3) (110, 162, 168, 194, 195, 290). Purified Rad3 
displays a DNA-dependent ATPase and 5'~3' DNA-helicase activity (243). The enzyme 
requires a single-strand stretch of DNA to bind to and initiate unwinding (77). Recently, 
it was shown that the human counterpart of Rad3, XPD, exhibits similar activities (241). 
Rad3 helicase- and ATPase-activities are inhibited after UV-irradiation of the 
substrate. Only lesions in the DNA-strand on which the enzyme translocates are 
inhibitory. Moreover, the protein seems to be sequestered to the lesion (164). These 
findings suggest a model in which Rad3 scans the DNA and binds to a lesion (analogous 
to UvrA,B). However, a specific mutant (K48~R)(242), which is ATPase-, helicase-, and 
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NER-deficient, still binds to UV-Iesions. This makes the damage recognition function of 
Rad3 after scanning rather unlikely (245). Lysine 48 (K48) is an invariable amino acid in 
the Walker A-type nucleotide binding box, required for ATP binding and hydrolysis. 
Furthermore, translocation of most helieases is inhibited by a distortion of the DNA 
structure. 
Different mutations in RAD3 resulted into a pleiotropic phenotype. Mutants vary 
from virtually complete NER-deficiency to a moderate UV-sensitivity and to a Rem' 
(recombination-mutagenesis) phenotype (156, 233). Deletion mutants are even lethal in 
haploid yeast cells (84, 169). Mutations in XPD also resulted into a heterogeneous 
phenotype (1 01). These data together suggest an additional (essential) role for Rad3 (and 
XPD). The nature of this other function has recently been uncovered by the finding that 
these proteins are components of the basal transcription initiation complex TFIIH (factor 
b) (54, 211 )(see appendix V and next paragraph). 
4.2.2 XPBIERCC3 and Rad251Ss12 helicase 
Like XPD, XPB is an evolutionarily conserved protein. With the aid of the 
mammalian sequence (using low-stringency hybridization on a S.cerevisiae genomic-
library) the S.cerevisiae homolog, RAD25 was isolated and characterized (185). 
Independently, the same gene, designated SSL2, was isolated as a suppressor mutant of 
an artificial stem-loop structure in the 5' UTR region of HIS4 (71). This genetic screening 
was designed to piek up genes involved in translation initiation. The helicase function 
might be necessary for unwinding the stem-loop in the mRNA. 
Some mutant alleles of ssl2lrad25 give rise to a UV-sensitive phenotype (71, 185). 
In addition, a C-terminal deletion mutant which mimicks the XPll BE mutation (292) 
caused a deficiency in CPD removal of both genome overall and transcription-coupled 
repair (248). Deletion mutants of RAD3, SSL2IRAD25 are not viable in haploid yeast 
cells (71, 185). Substitution of the highly conserved lysine'" (in the Walker A-type ATP 
binding box) into an arginine, is not vital (185). This suggests that the ATPase activity 
(and by implication also the heliease activity, whieh depends on ATP-hydrolysis) is 
indispensable for viability, which is in contrast to a similar mutation in RAD3 (242). 
Notably, micro-injection of human XPB cDNA, containing the same mutation induces 
a dominant negative effect on NER and transcription (appendix V). 
A Drosophila homolog of XPB was cloned (111, 158). A XPll BE-mimicking 
mutation gives rise to UV-sensitive flies (158). The Drosophila XPB is implicated in 
mutants expressing the pleiotropic haywire phenotype (158). One of the peculiar features 
of haywire is male sterility, probably due to a decreased expression of the testis-specific 
I>2-tubulin, which plays a role in meiotic spindle formation. Spermatogenesis is sensitive 
to the level of I>2-tubulin expression. This suggests that XPB plays a role in the 
expression of this testis-specific tubulin, either at the transcriptional or the translational 
level. These data together suggest that XPB (as XPD) plays an additional role in a (other 
than DNA-repair) vital cellular processes. This might also explain the extreme rarity and 
clinical heterogeneity of XPB patients (see chapter 3 and appendix V). 
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4.2.3 TFIIH involvement in NER 
Unexpectedly, XPB was identified as the 89 kDa subunit of the basal transcription 
initiation factor TFIIH/BTF2 (hereafter designated TFIIH). This multi-subunit protein 
complex possesses a helicase activity which is possibly derived from XPB (212). Also, 
the yeast homolog of XPB is associated with transcription factor b (yeast counterpart of 
TFIIH, recently designated (y)TFIIH)(54, 74, 191). Later, XPD was also found to reside 
both in human and yeast TFIIH (50, 54, 211). Even a third NER factor, TTDA, is present 
in TFIIH (appendix V). The heterogeneous and peculiar phenotypes found in XP-B, XP-D 
and TTD-A, are probably explained by the dual involvement of their respective factors 
in NER and the basal transcription machinery (appendix V). 
TFIIH is a multi-subunit protein complex containing at least 9 different 
polypeptides (chapter 5) and the entire complex is probably functional in NER and in 
transcription (appendix V). In both processes it may act as a functional helicase unit. In 
transcription initiation this helicase unit catalyses promoter clearance or opens the DNA 
prior to transcriptional start (chapter 5). A similar function can be envisaged for TFIIH in 
NER: after damage recognition and subsequent complex formation (Figure 6) (analogous 
to the preinitiation complex), unwinding activity is required to give access to the other 
NER factors. Or the excision machinery is directed to the "demarcated lesion" after 
unwinding. Alternatively, or in addition, the helicase function might also be required for 
further processing or turnover of reaction intermediates. In a stage after the dual incision, 
the damage-containing oligo nucleotide has to be removed before the gap-filling can start 
(analogous to the E.coli UvrD). A third possibility is that TFIIH acts as a lesion scanning 
activity, comparable to the UvrA,B complex: when a lesion is encountered, translocation 
of the complex stops and bound proteins attract incision activities. The exact place and 
role of TFIIH in NER will hopefully soon be uncovered with the aid of the recently 
developed in vitro reconstituted NER system (1, 159). 
4.3 Excision of the damaged patch 
After damage demarcation, either before or after unwinding, the next step in N ER 
is the removal of the damaged nucleotides. Removal can be performed either by 
endonucleolytic cleavage followed by exonuclease activity, or by an excision nuclease 
activity (dual incision on either site of the lesion). Repair patch size analysis revealed that 
during NER a gap of 20-30 bases around the CPD (or 6-4PP) is produced as a reaction 
intermediate (257). The identification of a released oligo-nucleotide of 27-29 nt., after 
treatment of damaged plasmids with cell-free extracts (CFE), confirmed the estimated NER 
patch size and confirmed the dual incision model (92). 
30 
4.3.1 The 3' endonuclease (XPC) 
Recently, it was shown that the XPG protein is one of the mammalian 
endonucleases involved in NER (176). XPG cuts structure-specifically, 3' of a single-
stranded bubble (unpaired) region, in duplex DNA. A similar structure can be envisaged 
as a reaction intermediate in the course of NER, after lesion demarcation and/or 
unwinding (Figure 6). XP-G extracts were not able to make this 3' incision on a substrate 
containing a single cisplatin adduct at a defined position, whereas this activity was 
present in extracts from repair-proficient cells (176). The XPC gene is identical to the 
previously cloned human ERCCS gene (135, 178,213, 224), which corrects the rodent 
complementation group 5 (160). 
The primary amino acid sequence encoded by XPCIERCCS revealed that this gene 
is the mammalian counterpart of S.cerevisiae RAD2 (137, 172) and S.pombe Rad13 (26). 
Mutants in each of these yeast genes give rise to an UV-sensitive phenotype. Moreover, 
this group of genes (XPC, RAD2 and Rad13) belongs to a new gene-family encoding 
proteins which are structurally (and possibly also a functionally) related. This gene-family 
is divided into two sub-groups, first, the XPClRAD21Rad13 group, and second, murine 
FEN-1 (79), S.cerevisiae YKLS10 (98) and S.pombe Rad2 (163). The former group acts 
in NER, while the latter is thought to be involved in Okazaki-fragment rejoining during 
lagging-strand DNA synthesis or double-strand break DNA-repair (78). FEN-1 (flap 
gndonuclease-1) only cuts flap structures with 5' termini. Both groups are sequence-
independent, unidirectional and structure-specific endonucleases, however each group 
acts on different substrates. Homology between the two sub-groups is restricted to three 
conserved domains ("N It , "I n and "e" regions), with asyet unidentifjed functions. A 
structural distinction between the two sub-groups is made on the bases of a differential 
spacer size ("S") between the domains N and I, which is extended in the RAD2 group 
in comparison with the FEN-1 group (79). This S-region probably defines the substrate 
specificity. 
Although RAD2 mutants are moderately UV-sensitive, epistasis analysis excluded 
this gene from the NER-deficient epistatic group (163). Although over-expression of 
YKLS10 does not complement the UV-sensitivity of RAD2 mutants, a (partial) redundancy 
for, an as yet unknown, RAD2 function can not be excluded. 
The structure-specific cleavage (176), suggested that XPG acts after (partial) 
unwinding around the lesion (Figure 6). 
4.3.2 The 5' endonuclease (complex) 
Since it has been shown that during NER a fragment of about 30 nt. is removed, 
another endonuclease with opposite directionality (incision 5' of the lesion) compared 
to XPG, can be envisaged. In yeast this activity is probably executed by the NER factors 
RAD1 and RAD10 (12). 
RAD1 and RADlO (61) form a stable complex both in vitro (13) and in vivo (6, 
11). Previously, it was demonstrated that this complex possesses an endonucleolytic 
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activity, both on single-stranded and double-stranded DNA (244, 261). Very recently, 
using V-shaped substrates, a specific 5' endonuclease activity on duplex DNA at single-
strand/double-strand junctions was established for this RAD1-RAD10 complex (12). 
Incision is performed at the second or third nt. at a branchpoint of duplex-DNA with 3' 
single-strand extensions (opposite direction as XPG/RAD2). 
Mutants in both RADI and RADIO have, besides deficient NER, a defect in one 
of the mitotic recombination pathways (214, 215). Moreover, damage-induced reciprocal 
recombination is dependent on a functional RAD1 and RAD10 (205). A similar 
endonucleolytic function (as in NER) displayed by this complex can be envisaged during 
recombination events. 
The mammalian homolog of RADIO is ERCCI (265). Complementation studies 
with cell-free Iysates revealed that extracts derived from ERCCI- deficient cells were not 
able to correct the repair defect of cells from CHO-groups 4 and 11 and XP-F, 
respectively (16, 193,270). Cell-extracts of these groups were still able to complement 
the NER defect of other groups. Genetic studies, however, clearly demonstrated that the 
CHO groups 1, 4 and 11 are defined by distinct genetic loci (24, 196). Immuno-
depletion and sedimentation experiments (270) together with partial purification of 
ERCC1 (269) provided evidence that ERCC1, ERCC4, ERCC11 and XPF reside in a 
complex of tightly associated proteins. The absence (or altered form) of one of the 
components influences the stability of the other, as was shown in XP-F extracts on 
immuno-blot analysis, where ERCC1 is strongly reduced (16, 269). 
Although not formally proven, it is generally believed that this ERCC1-ERCC4-
ERCC11 complex is the functional mammalian counterpart of RAD1-RAD10. Mutants of 
CHO-groups 1 and 4 are, besides UV, also extremely sensitive to DNA crosslinking 
agents, whereas group 11 is slightly sensitive to these agents (a phenomenon not 
observed in XP-F). These lesions are normally targets for the recombination repair 
process. This indicates that in addition to its function in NER, the ERCC1-ERCC4-
ERCC11-XPF complex is probably also involved in a recombination mechanism, 
analogous to its potential yeast counterpart. Furthermore, the recently cloned ERCC4 
gene (258) shows a significant homology with RAD I (Thompson, personal 
communication). The ERCC4 gene also induces a partial correction of the XP-F repair 
defect (Thompson, personal communication), suggesting that ERCC4 may be involved 
in XP-F. The total number of components in this complex is now reduced to three 
proteins, at least two of which have a yeast equivalent. It is, however, not formally 
excluded that the yeast incision complex contains additional components (6, 13). 
Although the candidate endonucleases in NER are probably identified, the. order 
of cleavage action is not yet known. It is even likely that a complete assembly of incision 
factors is required for the dual incisions which may act simultaneously. In addition to 
lesion recognition, helix unwinding and endonucleases the in vitro assay revealed that 
additional factors, like RPA and IF7, are required for an efficient excison of damaged 
DNA. IF7 is as yet poorly characterised and it is not known where it acts in the excision 
process (1). 
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4.3.3 Single stranded binding protein (RPA) 
The human single stranded binding protein (HSSB), or RPA (RF-A), plays a role 
in semi-conservative DNA replication (238). RPA is a tightly associated complex 
composed of three polypeptides: 70-, 34-, and 11- kDa (resp. RPA1, RPA2 and RPA3) 
(238). The function of each subunit has not been entirely resolved, although the 70 kDa 
polypeptide has been identified as the DNA binding subunit and the 34 kDa subunit is 
a target for phosphorylation during the cell-cycle (48,51). RPA2 is phosphorylated, only 
during S- and G2-phase (48), by the combined action of cyclin A-CDC2/CDK2 complexes 
and DNA-PK (51, 181). Hyper-phosphorylation of RPA2 occurs after genomic stress, 
including UV-irradiation (27, 130). 
In addition to its function in replication (and recombination), RPA also acts in 
NER. Addition of antibodies directed against either the RPA 1 or the RPA2 subunits 
inhibit repair synthesis, both after microinjection (Vermeulen, unpublished observations) 
and in cell-free extracts (39). Purified RPA enhances NER in extracts from repair-
proficient cells, but not in extracts of XP groups A to G. When, in XP extracts incision 
is bypassed by the E.coli UvrABC, RPA does not stimulate NER, suggesting that RPA acts 
in a similar stage as UvrABC (38). Further dissection of in vitro repair revealed that RPA 
is an important factor in the incision step of NER, rather than in the expected repair-
synthesis (1, 227). 
A speculative role for RPA in NER is the stabilisation of the single-stranded nature 
of DNA around a lesion, generated by the cooperative action of damage recognition 
proteins and helicases (resp. XPA and TFIIH). One single RPA unit protects a region of 
± 30 nt. (108) and matches well with the size of an excision repair patch (92), supporting 
the suggested role of RPA in N ER. 
A second (or additional) possible function for RPA is that it serves as a bridging 
factor between the different NER factors. RPA2 was shown to interact with XPA in the 
yeast two-hybrid system (141). This interaction is confirmed by GST-XPA pull-down, co-
immuno-precipitation and XPA affinity column binding (81, 141). RPA-XPA complex 
formation synergistically enhanced the DNA-binding properties of each activity: either 
RPA assists damage recognition of XPA, or stabilizes XPA-DNA complex formation. In 
addition, interactions between RPAl and XPA, and RPA2 and XPG were shown (81). 
These interactions suggest a bridging function for RPA in NER 
A functional homolog of RPA, 'RF-A', has been identified in S.cerevisiae. This 
activity also contains three subunits (69-, 36-, and 13- kDa), which are encoded by 
essential genes (resp. RFA 1, RFA2 and RFA3)(19). Some mutant alleles of RFA 1 give rise 
to an UV-sensitive phenotype, suggesting an additional role for RF-A in NER, like its 
mammalian counterpart (131). 
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Figure 6. Scheme of mammalian NER mechanism. Model of the two different NER-
pathways, genome overall (GGR, see 4.5.3) and transcription coupled repair (TCR, see 
4.5.2). Step A and B, lesion recognition (4.1) and stalling of RNA pol II (4.5.2). Step B 
and C, lesion demarcation and local unwinding (4.2). Dual incision on either site of the 
lesion, step D (4.3). Repair replication and ligation, respectively step E and F (4.4). 
4.4 Repair replication 
The last step in the NER mechanism, gap-filling of the excised patch, is probably 
the least specific, but this part of the process is used most frequently for assaying NER, 
both in vivo (UDS) and in vitro. DNA repair synthesis is performed by common DNA 
replication factors. 
In early studies with permeabilized cells and specific inhibitors, it was shown that 
the DNA polymerases <5 and E act in mammalian NER (106). Studies with cell-free 
extracts revealed that PCNA, a DNA pol. <5 and E accessory factor, is involved in repair 
synthesis (171, 227). It was suggested for some time that PCNA acts in NER, since it is 
localised to specific spots in the nucleus after UV-irradiation (repair patches) 
independently of the cell-cycle (28). With the recently established in vitro reconstituted 
repair reaction, it was shown that efficient repair-synthesis occurred after addition of the 
mammalian replication factors: PCNA, RF-C, RPA and DNA pol. E (228). DNA pol. <5 can 
substitute for pol. E, but it produces repair patches which are not easy to ligate. RF-C 
assists PCNA to load on a gapped DNA template (189), a NER-like intermediate. After 
PCNA assembly on single strand gaps, it forms an anchor site for the polymerase and 
stimulates the processivity of DNA pol. E (or 0) (189). The yeast homologs of both DNA 
polymerases <5 and E also have been shown to be involved in UV-damage repair (22). 
Only double mutants of pol. <5 and E are UV-sensitive (22), suggesting that each activity 
can be substituted by the other. 
Finally, the NER process is completed by sealing (ligation) of the newly 
synthesized DNA to the existing DNA. DNA ligase I was predicted to be a likely 
candidate for this action, since mutations in the corresponding gene can give rise to a 
UV-sensitive phenotype (14). Addition of purified ligase I to the reconstituted NER 
reaction induced ligation, although not very efficiently (1). No other ligases have been 
tested so far. Whether other activities, in addition to a ligase, are necessary for 
completion of the N ER reaction, is under investigation (1). 
4.5 Differential NER 
Induction of lesions after UV-irradiation is not homogeneous throughout the 
genome. The type of damage and its relative frequency depend on the location in 
chromatin and on the transcriptional status of specific sequences (62, 153, 188). 
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Distribution of CPDs, rather than 6-4PPs, in core nucleosome regions, exhibit a 
periodicity of 10.3 bases (62). This indicates that shielding by histones is an important 
parameter in lesion formation, since this periodicity is identical to a single helical turn 
in duplex DNA. 
Not only is the induction of lesions non-uniform, but also a differential rate of 
repair is present at distinct parts of the genome (15). The repair rate is primarily 
determined by the transcriptional activity, rather than a non-homogeneous distribution 
of lesions on nucleosomes (100). However, nucleosome stability influences the rate of 
repair and of transcription. Moreover, different types of lesions influence the repair rate, 
e.g. 6-4PPs are repaired much faster than CPDs (152). 
4.5.7 Active gene repair 
The pioneering work of Hanawalt and Bohr (17) revealed an accelerated NER in 
actively transcribed regions of the genome, when compared to N ER of the genome 
overall. This preferential repair of CPDs was first discovered in mammalian cells. The 
amplified DHFR gene of CHO cells was about 5 times more rapidly repaired than 
inactive sites of the genome (17). This transcription-coupled repair (TCR) is evolutionary 
conserved, from prokaryotes and yeast up to man (149,150,256). A notable and as yet 
unexplained exception is Drosophila (42), in which no TCR could be detected in 
embryonal cell strains. TCR was recently also demonstrated in in vivo irradiated 
epidermal cells of mice (203). 
Although transcriptional activity is regulated by intricate interactions between 
transcription factors and chromatin, it is not likely that preferential NER is driven only 
by the chromatin structure, since TCR is present in various types of organisms with 
completely different nucleoprotein structures. Moreover, TCR occurs also in in vitro 
reconstituted N ER reactions with purified E.coli enzymes, where no nucleoprotein 
complexes are present (218). 
Recently, evidence was provided that the 6-4PPs, which are faster removed than 
CPDs, also are targets for TCR (268). 
4.5.2 Transcription-coupled repair (TCR) 
Preferential repair of active genes is mainly caused by selective repair of the 
transcribed strand (150). This strand bias relies on RNA-polymerase" transcription, but 
is independent of the level of transcription (15). It is claimed, however, that the non-
transcribed strand of active genes is more efficiently repaired than silent or non-coding 
loci (161, 272). These observations suggest that NER is regulated at three hierarchic 
levels: the first, accelerated repair of transcribed strand; the second, preferential repair 
of active genes; and the third, slow repair of transcriptionally silent regions. 
The biological significance of a proficient TCR is reflected in the N ER-deficient 
Cockayne syndrome (CS). Cells derived from CS-patients (of both complementation 
groups), have defective RRS (recovery of RNA synthesis) after UV, but a normal UDS (see 
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3.2). This phenomenon can be explained by a deficient TCR, which forms the basis of 
the repair defect in C5 (267, 273). Preferential repair of the transcribed-strand suggested 
that specific factors are required to couple NER to the process of transcription. Two 
candidates of transcription-repair coupling factors are C5A and C5B, respectively encoded 
by the recently cloned and sequenced genes CSA (82) and CSB (263). However, nothing 
is yet known of their specific function in coupling repair to transcription. 
The protein sequence of C5A contains the consensus of five "WD-repeats" (82). 
This type of motif is present in many proteins, and these proteins are believed to possess 
a regulatory, rather than a catalytical function (170). Many of these WD-repeat proteins 
reside in multi-protein complexes. C5A is thought to associate with p44 (a component 
of TFIIH) and with C5B (82). CSB encodes a potential helicase (263), since it contains the 
seven conserved domains which define a large superfamily of DNA and RNA helicases 
(67). In addition, C5B shows a striking homology of the entire region spanning the seven 
helicase domains with proteins belonging to a new sub-family of helicases, the 5NF2 
sub-family (67, 263). The exact function of these proteins is not yet known, but there is 
evidence that some of these polypeptides reside in large complexes, which playa role 
in chromatin modulation. None of the members of this sub-family of helicases have been 
shown to possess DNA-unwinding activity. The fact that Moll (a member of the 5NF2 
sub-family), removes TFIID from template DNA (5) suggests a protein-DNA dissociating 
activity. These domains might therefore define an energy-consuming activity, required 
for either DNNRNA unwinding or stripping proteins from DNA in a processive manner. 
Other members of the 5NF2 sub-family, are required for efficient transcription of specific 
target genes or function as a global transcription factor (83a). 
A functional prokaryotic homolog of the TCR-factor is the E.coli transcription 
repair coupling factor (TRCF) encoded by the mfd gene. TRCF specifically directs NER 
to stalled (on UV-Iesions for example) RNA polymerase (RNAP) complexes (219, 220, 
221). No DNA nor RNA-unwinding activities can be measured for TRCF, despite the 
presence of helicase domains in the protein sequence (219). It has been shown, 
however, that TRCF itself binds specifically to stalled RNA polymerase complexes and 
to DNA in an ATP-dependent manner. TRCF dissociates RNAP complexes stalled on UV 
lesions from DNA and recruits repair factors to the damaged site, via a direct interaction 
between TRCF and UvrA (220). Helicase motifs in TRCF are likely to be involved in 
DNA-binding and A TP hydrolysis, which changes the conformation of TRCF with a 
concomitant stripping off bound proteins (RNAP) from DNA. 
A similar function might be expected for C5B with C5A, i.e. directing core 
mammalian NER-factors to a stalled polymerase ternary complex. However, stalled RNA 
polymerase II complexes in mammalian transcription elongation may not be simply 
removed from the template after arresting, as in E.coli (49). Templates containing a single 
CPD efficiently block mammalian RNA polymerase II elongation. It has been postulated 
(49) that elongation factor 511 (TFII5) together with the C5-factors, plays a role in directing 
NER to a stalled RNAP complex. 511 plays a role in promoting elongation complexes 
through transcriptional pause sites. The activity catalyses transcript shortening (tracking 
back of the ternary complex) of nascent RNA on pause sites or when RNAPII is stalled 
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at a CPD (49). However, SII alone is not able to stimulate bypass of stalled RNAPII over 
a UV-Iesion, and may need the cooperation of CSA with CSB. 
The yeast homolog of CSB, RA026 was recently cloned (266). Disruption mutants 
of this gene, have a deficient TCR. However, in contrast to mammalian mutants (266), 
these cells are not sensitive to UV-irradiation, suggesting that UV-resistance in this 
organism is primarily due to the GGR pathway. 
4.5.3. Global genome repair IGGR) 
The repair defect in XP-C cells is caused by a deficiency in the repair of the non-
transcribed strand of active loci and the overall genome (GGR), while TCR is unaffected 
(274). These findings fit well with earlier cellular observations. In contrast to the other 
XP and CS groups, XP-C cells, do not have a defective recovery of RNA synthesis after 
UV treatment (RRS) (144). 
The XP-C correcting factor (X PC), independently purified by two groups (140, 
225), consists of two polypeptides of 125 kDa and 58 kDa which are stably associated 
(140). The size of this complex is in agreement with the hydrodynamic properties of the 
correcting activity as determined by Shivji and coworkers (225). Micro-sequencing both 
proteins allowed the cloning of the corresponding genes (140). The gene encoding the 
125 kDa protein is a N-terminally-extended version of a previously isolated incomplete 
XPC eDNA (116). Surprisingly, the 58 kDa polypeptide is encoded by one of the two 
human homolog's of the S.cerevisiae RA023 repair gene: HHR23B. To date, no known 
human NER syndromes have been associated with the HHR23B gene and a simple 
explanation might be that the highly homologous HHR23A diminishes the effect of loss 
of HHR23B function. The notion that HHR23B is a ubiquitin(-like) fusion protein suggests 
that this polypeptide may function as a molecular chaperon for XPC, since ubiquitip 
moieties can serve as a molecular-chaperon (56). In contrast to XPC, HHR23B i: 
abundantly expressed and only a minority of HHR23B is associated with XPC (van de 
Spek, ms. in prep.). This suggests a second non-NER function for HHR23B. The singh 
yeast homolog (Rad23) definitely plays a role (directly or indirectly) in both NER 
pathways (TCR and GGR) (145, 288). 
Limited amino acid homology exists between human XPC and yeast Rad4 (116). 
However, the XPC-complex functions in GGR, whereas Rad4 is indispensable for both 
NER pathways in yeast (145, 275). In addition to the difference in function of yeast 
Rad23 and human HHR23B, a further divergence concerning TCR is present between 
the two species. Yeast rad7 and rad16 mutants both behave as functional homologs of 
the XPC-complex, because they are specifically involved in GGR (8, 275). However, 
human XPC and HHR23B do not share homology with Rad7 or Rad16 and no 
mammalian counterparts of RAD7 and RAD16 have been identified to date. The notion 
that RAD7 interacts with SIR3, a protein involved in transcriptional silencing of 
chromatin (180), suggests a role for RAD7 in chromatin modification. 
At present it is only possible to speculate upon the function of the XPClHHR23B-
complex in NER. Its unique involvement in GGR suggests that this complex uncouples 
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NER from the tight connection with transcription. With the intrinsic high affinity for 
ssDNA (140), this complex may enhance unwinding or stabilize partly melted regions 
around a lesion, and facilitate the action of the excision nucleases. Binding to ssDNA 
might occur in the opposite strand to where RPA is bound. This DNA-protein complex 
could form a substrate for the further assembly and action of NER enzymes. In this 
model, the XPCfHHR23B-ssDNA complex competes with stalled RNAPII in recruiting the 
excinuclease. 
XPC correcting activity is indispensable for in vitro repair (1, 140, 225), which 
indicates that it is involved in the core of the NER reaction. However, NER activity in 
this assay is independent of transcription and thus exclusively reflects GGR. 
4.6 Higher order NER complexes 
Although most of the important 'players' in mammalian NER are identified, it is 
not known yet how these factors assemble on a lesion and how they interact with each 
other. Recently, several reports appeared in the literature dealing with proposed 
interactions between NER factors. However, many of these studies are either based on 
associations in a rather artificial environment (immobilized fusion proteins), or after 
overexpression in yeast (two-hybrid system). In both systems, transient or low affinity 
interactions can be selected, which might not reflect the in vivo situation. 
A central role for the XPA protein is likely in view of the very severe NER-
deficient phenotype of XP-A cells (35). Biochemical studies with XPA suggest that this 
factor serves as a nucleation point in the repair reaction. Interactions of XPA (in addition 
to that with damaged DNA), have been described with ERCCl (123, 125, 165, 184), 
RPA2 (81, 141) and TFIIH (183). Binding of both ERCCl and RPA to XPA has a 
synergistic effect on the DNA damage-specific binding affinity of XPA (81, 165). In yeast, 
TFIIH association with Rad14 (XPA) is reported to occur via Rad23 (73), although in a 
later report by the same authors, Rad23 was stated to be associated with Rad4 (72). 
RPA2 is claimed to interact with XPG (81), whereas XPG (Rad2) and XPC (Rad4) might 
be associated with TFIIH (10, 50). Several of these assumed interactions are dependent 
on isolation conditions (159) and could not be confirmed by other laboratories (1, 279). 
Using specific isolation conditions, even a NER super-complex, designated, 
"repairosome", was purified from yeast cells (247). The majority of the different yeast 
NER factors are claimed to reside in this repairosome, whereas this isolated complex is 
not active in a reconstituted NER reaction (247). Also the amount of each of the NER 
factors residing in this complex is not known. 
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Chapter 5 
Transcription/repair factor TFIIH 

Transcription/Repair Factor TFIIH. 
Basal transcription initiation factor TFIIH plays an important role in RNA 
polymerase II-driven transcription. As discussed in chapter 4.2.3, TFIIH possesses a dual 
function in transcription and NER. Elucidation of the role of TFIIH in basal transcription 
will also provide clues to its role in NER. 
5.1 Basal transcription factors 
As for nucleotide excision repair, transcription of protein-encoding genes by RNA 
polymerase II (RNAPII), is a multi-step process. Basal transcription is likely to start by the 
sequential loading of transcription factors onto a core promoter region. It is generally 
accepted that prior to the assembly of an initiation complex, the dense chromatin 
structure has to be modulated or made accessible (47, 294). 
The assembly of the initiation complex, as described below, can be considered 
as a working model, since the exact order of loading of factors is not rigorously 
established (29, 37, 299). Transcriptional start site selection on minimal promoters 
requires binding of the TATA-box binding protein (TBP). TBP is not only involved in 
RNAPII transcription, but also plays a central role in RNA polymerase I and polymerase 
III-driven transcription (37, 65). TBP, together with the other basal transcription factors 
is sufficient to initiate basal, but not activated transcription. For the response to 
transcriptional activators, TBP has to be incorporated into (holo)TFIID: TBP plus TBP-
associated factors (T AFs) (65). 
The role ofTFIiA (a three subunit factor) in basal transcription is controversial. The 
requirement of TFIIA depends on the purity of transcription factors in reconstituted 
systems. While TFIIA is not essential, it promotes loading and stabilizes the association 
of TFIID on the promoter (23). Negative transcriptional regulators disrupt the TBP-DNA 
interaction in an ATP-dependent manner. Mot1 (a yeast TAF), is such a negative 
regulator, possibly involved in stripping TBP from the DNA. Addition of excess TFIIA 
suppresses this Mot1 inhibitory action (5). TFIIA probably stabilizes TFIID binding and 
is involved in complex formation in activated transcription in conjunction with the TFIID 
TAFs (91). 
Basal factor TFIIB is thought to act as a bridging factor between the initial complex 
DNA-TFIIA-TFIID (DA-DNA complex) and RNAPII. TFIIB interaction is important in the 
accuracy of start site selection (37). Some upstream transcriptional activators interact with 
TFIIB and are considered to assist in the formation of the initiation complex (223). 
TFIIB forms a nucleation point for RNAPII. The delivery of the large RNAPII 
complex to the DAB-DNA is facilitated by TFIIF which is directly associated with RNAPII 
(68). Moreover, TFIIF, which consists of two subunits: RAP30 and RAP74, prevents 
nonselective binding of RNAPII to DNA (68). In addition to the absolute requirement of 
TFIIF in transcription initiation, TFIIF is also engaged in the elongation stage of 
transcription (68, 251). 
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The actual polymerase, RNA polymerase II (RNAPII), is a multi-subunit enzyme. 
The composition of mammalian RNAPII is not yet completely known. The largest subunit 
of human RNAPII was recently cloned (151). In contrast, yeast RNAPII is well 
characterized. It consists of 12 polypeptides (298) varying in size from 240 to 10 kDa 
(RPBl-12). The different subunits have been cloned and display a high degree of 
evolutionary conservation among eukaryotes. The homology extends to prokaryotic 
counterparts of the two largest subunits (resp. ~' and ~). Neither the stoichiometry and 
architectural composition nor the specific function of each of the subunits are resolved 
yet. The two largest subunits (220 and 150 kDa) bind respectively to DNA and to 
ribonucleotides (298). 
A feature not found in the prokaryotic RNA polymerase is the presence of a highly 
conserved hepta-repeat (YSPTSPS) at the C-terminal domain (CTD) of the 220-240 kDa 
subunit (41). The number of repeats varies from 17 in Plasmodium falciparum to 52 in 
mammals. The CTD is an efficient target for phosphorylation, which occurs as a response 
to transcriptional activators and is thought to be effective during elongation (41). The 
CTD kinase activity, displayed by TFIIH, will be discussed in the next paragraph. 
Recently, it was observed that RNAPII is incorporated into an, even larger, higher order 
complex: "RNA polymerase II holoenzyme", comprised of approximately 30 different 
polypeptides (RPBs, TFIIF and SRBs)(l 09, 112, 113). These associated factors are together 
referred to as the "mediator". The mediator acts in transmitting the response of 
transcriptional activators to the basal machinery, by phosphorylating CTD (109). 
Recently, two of these SRBs (SRB 1 0 and SRB 11) were identified as a cyclin/cdk-like 
complex, specifically kinating CTD in response to activators (127). Besides activated 
transcription, the mediators also stimulate basal transcription (109, 113). 
5.2 Activities of TFIIH 
ATP hydrolysis is required to convert the preinitiation complex into a 
transcription- competent complex (37). However, none of the above mentioned basal 
factors possesses any catalytic activity, including ATPase. Human TFIIH, previously also 
called BTF2 (63), its rat homolog factor c5 (36, 222) and yeast equivalent factor b, now 
renamed (y)TFIiH (53), all exhibit ATPase activity and are essential for in vitro 
transcription. Entry of TFIIH into the preinitiation complex is supported by TFIIE (58). 
TFIIE is a tetramer containing two subunits of 56 kDa and two of 34 kDa protein (37). 
TFIIE does not only aid in the loading of TFIIH onto the preinitiation complex, but it also 
stimulates the different TFIIH catalytic activities (132, 179). Until recently, no specific 
activity could be attributed to TFIIE. However, recent observations indicate that TFIIE 
might function in melting the template DNA, independent from TFIIH (90). 
5.2.1 ATPase and helicase activities 
Different activities can be ascribed to the multi subunit TFIIH, composed of at 
least B or 9 different polypeptides (Table 4)(55, 201). The ATP-hydrolysing activity of 
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TFIIH is DNA-dependent and specific for ATP (36,179,202). In addition, TFIIH displays 
also a bidirectional helicase activity (211, 212) and contains the two hel icases, XPB and 
XPD (50, 211). Recently, ATPase and 3' .... 5' helicase activities of XPB were actually 
shown with an E.coU-produced recombinant protein (202), later confirmed with XPB 
produced by the Baculovirus system (134). The yeast XPB homolog (Rad25/SsI2) also 
displays helicase activity (74). XPD catalyzes the opposite direction of unwinding, 5' .... 3' 
helicase (241). 
Table 4. Homology and properties of HIIH. 
Human TFIIH Yeast HIIH 
subunit" cloned gene subunit" cloned gene 
protein properties 
782(p89) XPBIERCC3 843(p105) SSL21RA025 3/~5' helicase 
760(p80) XPOIERCC2 778(p85) RA03 5/~3' helicase 
548(p62) p62 642(p75) TFBI 11 
460(p41) p52 495(p55) TFB2 -
395(p44) p44 461(p50) SSLI 2 Zn'+ -fingers 
346(p38)" Mo151cOK7 306(p33)" KIN28 CDK-like kinase 
303(p34) p34 1 Ssll-like Zn'+ -finger 
323(p34)" cyclinH 393(p47)" CCLI) homology to cyclins 
312(p32)" MATI 312 TFB3 ring Zn" -finger 
For references to the subunits and respective genes, see Roy, 1994 and Feaver, 1994 
and references therein. 
1) subunits are presented as number of amino acids, based on ORF of cloned gene, 
with size in 50S-PAGE between brackets. 2) subunits of CAK activity, either asociated 
with TFIIH, or in a free form. 
TFIIH helicase is thought to convert the closed DNA with the pre-initiation 
complex into a more open configuration, allowing RNAPII to enter the elongation phase 
(212). Using an abortive transcription assay, Tjian and coworkers (66) have provided 
evidence that TFIIH and TFIIE are not essential for the initiation step, but act in a 
transition stage between initiation and elongation, referred to as "promoter clearancell 
(66, 143). The authors argued that TFIIH is not involved in unwinding the template prior 
to initiation but directly following it, and that TFIIH plays a role in dissociating (clearing) 
the pre-initiation complex from the promoter. TFIIH and TFIIE (and ATP hydrolysis) are 
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dispensable for transcription from negatively-supercoiled templates, but are required for 
transcription from linear templates (186, 259). Superhelicity of the template may provide 
partially unwound regions, explaining the optional requirement of a helicase (TFIIH). The 
in vivo implications of this are somewhat confusing, because after the process of 
nucleosome opening (decondensation) prior to transcription, superhelicity can be 
induced, suggesting that unwinding by TFIIH is not absolutely required in vivo. 
However, genes encoding TFIIH components are essential for viability in yeast (71,84, 
169, 185, 297), consistent with an indispensable role for TFIIH in transcription in vivo. 
5.2.2. CTD-kinase activity 
In addition to ATPase and helicase activities, TFIIH also possesses a 
phosphorylation activity specific for the C-terminal repetitive domain (CTD) of the largest 
subunit of RNAPII (132). The function of CTD phosphorylation is not yet known, 
although it is generally accepted that it plays a role in the elongation stage of 
transcription (41). Isolation of elongating RNAPII complexes showed that the majority is 
hyper-phosphorylated RNAPII (RNAPllo). Initiation of reconstituted transcription using 
hypo-phosphorylated CTD (RNAPlla) is as efficient as with RNAPllo, suggesting that CTD-
kinase activity is not required for in vitro transcription. However, core-TFIIH fractions, 
without kinase activity, are inactive in basal transcription (246). Recently, Kim and 
coworkers reported that when using the holo-RNAPII complex CTD-phosphorylation 
stimulates not only activated but also basal transcription (109). Moreover, CTD deletion 
mutants are not viable in several organisms (41), although such a truncated protein is still 
functional in vitro. The conversion of RNAPlia into RNAPlio might also playa role in the 
release of RNAPII from the initiation complex (264). 
CTD-kinase also consumes ATP, which is likely to be performed by another 
(intrinsic) component of TFIIH than the DNA-dependent ATPase (XPB and XPD), since 
a distinction can be made on the basis of a differential sensitivity to inhibitors (202). 
Moreover, in a transcription assay, using RNAPII which lacks the CTD, ATP is still 
required. 
The CTD kinase activity of TFIIH can be dissociated from the core TFIIH complex 
(201,246). The components (3 both in human and yeast) responsible for CTD kinase 
have recently been identified (55, 201). Analysis of these subunits revealed that the 
largest kinase subunit (~ 40 kDa), is highly homologous to the Xenopus Mo 15 gene 
(229). Mo15, and its equivalents in different species, were originally identified as the 
catalytic subunit of the CDK-activating kinase or "CAK" (255). 
CAK is an important activator (kinase) of several CDKlcyciin complexes, which 
are involved in cell-cycle regulation (33, 173). Surprisingly, it turned out that Mo15, 
based on its amino acid sequence, also belongs to the family of cyclin-dependent kinases 
(CDK's), and is now designated "CDK7". CAK also contains, besides CDK7, two other 
subunits, p34 and p32 (255), which were also identified as being associated with TFIIH. 
The 34 kDa component turned out to belong to the family of cyclins and is termed 
"cyclin H" (57, 138). The identity of the other subunit (32 kDa) is not yet known. 
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TFIIH-associated CAK is able to phosphorylate both CTD of RNAPII and 
CDK/cyclin complexes (201). However, the target sequence for phosphorylation of CTD 
(Y5PT5P5) is rather different than the consensus T-Ioop region in CDK's (33, 173). An 
explanation for this apparent discrepancy is that by the assembly of the initiation 
complex CAK is physically situated in the proximity of CTD and because of that, able 
to phosphorylate this other (distinct) target. 
5.3 Dual involvement of TFIIH. 
Highly purified TFIIH specifically corrects the NER defect in XP-B, XP-D and TTD-
A, both with microinjection and in the in vitro repair assay. With the cell-free NER-assay 
it was shown that TFIIH directly acts in NER, since in this assay no transcription nor 
translation can occur, due to the lack of NER-genes in this reaction. Correcting activities 
of XP-B, XP-D and TTD-A exactly co-elute with transcription- and helicase- activities of 
TFIIH (appendix IV, V). NER-competent cell Iysates and purified TFIIH fractions can be 
deprived of repair activity after immuno-precipitation with antibodies directed against 
some components ofTFIiH (anti-XPB, -p62, -p44, -p34) (93, 279). These data suggest that 
the entire transcription initiation factor, TFIIH, is probably involved in NER. The dual 
functionality of the entire TFIIH complex is also evident from recent studies with yeast 
TFIIH (54, 74, 247,286). Moreover, several mutant alleles of TFIIH subunits, rad3, 55/2, 
5511 and tfbl are UV-sensitive, suggesting a role in NER (71,142,285,297). NER-activity 
and viable function (basal transcription) of Rad25!XPB can be uncoupled as shown by 
different 55/2 alleles (71, 185, 248) again indicating that the repair defect is not caused 
by a deficiency of transcription of repair genes. Anbtibody injections against several 
TFIIH components inhibits both NER and transcription (appendices IV and V)(201), 
providing for the first time evidence that TFIIH functions in transcription in vivo. 
It was postulated by Gulyas and Donahue (71) that 5s12 acts in translation 
initiation, probably by a RNA-unwinding activity (of the artificial stem-loop structure), 
which enables ribosomes to assemble on the mutant HIS4 RNA. However, in retrospect, 
with the current knowledge and with transcriptional expression data from the original 
paper (71), it is very likely that 5s12 functions in transcription. Suppression of the hi54 
mutant phenotype by the 55/2-1 allele is probably due to a gain-of-function mutation in 
the SSL2 gene. The specific mutation in 55L2 may result in a more potent helicase 
function of TFIIH, which enables this complex to unwind even the altered structure of 
the leader sequence of the HIS4 gene. This will result in a higher transcription of the 
mutant HIS4. However, for the the other "translation-component" of TFIIH, 5s11 it is 
somewhat more complicated. Although 5s11 is a core component ofTFIiH (54, 93), some 
5511 alleles do not affect transcription, whereas they influence translation (297) 
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Chapter 6 
Concluding remarks 

Concluding Remarks 
Previously, the N ER-related syndromes xeroderma pigmentosum, Cockayne 
syndrome and trichothiodystrophy were considered distinct hereditary diseases. Genetic 
analysis of rare NER-deficient individuals with a complicated and heterogenous set of 
clinical symptoms (appendices I, II, III and V) revealed a large genetic overlap between 
these repair disorders. Severe cases with clear CS features were genetically linked to the 
XPG gene (appendix I). Mutational analysis of the two severe XP-G/CS patients showed 
a seriously affected XPG (S.Clarkson pers. comm.). Recently, three other cases with either 
CS symptoms only, or with combined XP/CS features were assigned to the same locus 
(B. Hamel, submitted; A. Raams, NGJ. Jaspers and W. Vermeulen, unpublished 
observations). An even more heterogeneous array of clinical symptoms was observed in 
complementation groups XP-B and XP-O, ranging from XP to XP/CS to TTO (21, 101, 
278)(appendices II and V). This genetic overlap and clinical heterogeneity within 
complementation groups argues in favour of the postulated model (Figure 4) that the 
previously distinct genetic syndromes are part of a large clinical continuum of "NER-
deficent syndromes". The very different features are due to locus and allelic-
heterogeneity, in combination with different expression due to genetic background and 
additional roles of NER factors in other cellular processes (see 4.2.3 and 6.1). 
6.1 TFIIH involvement in NER syndromes 
The observed link between the XPB, XPO and TTOA subunits with the TFIIH 
complex may provide a clue for the previously unexplained diverse features in these 
groups (appendix V). Most of the symptoms displayed by CS and TTO, such as 
neurodysmyelination, impaired sexual development, retarded growth, dental caries, 
cataract, and dismorphic facies, had been difficult to rationalize on the basis of a 
defective NER. The specific correlation between these features and mutations in TFIIH 
prompted us to postulate that part of these symptoms are a reflection of a subtly 
disturbed transcription due to a defect in TFIIH. We proposed to designate these 
syndromes (XP-B, xp-o and TTO-A) as: "transcriptionlrepair syndromes" (18)(appendix 
V). Extrapolation of this hypothesis led to the suggestion that pure "transcription 
syndromes" could also exist, without disturbed NER. Non-photosensitive forms of TTO 
and CS are likely candidates for such a transcriptionally defect. Conversely, classical XP-
o patients can be explained as having only a disturbed NER (see Figure 7, appendix V). 
To verify this hypothesis, these variant forms of CS and TTO can be screened for 
mutations in one of the TFIIH-encoding genes, a survey which is currently in progress. 
An obvious and important question in this model is: why does a mutation in a 
basal transcription factor only affect transcription of specific genes? The most simple 
explanation is that TFIIH is not required for transcription of all genes, but only for a 
subset of genes. The necessity for TFIIH might depend on the topological state of the 
promoter region, and by inference, the chromatin structure. This would mean that TFIIH 
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is an auxiliary transcription factor, only necessary for in vitro runoff assays and for 
transcription of genes, e.g. in highly condensed chromatin or in a relative relaxed status. 
However, the fact that all known components of TFIIH are essential for viability in yeast 
renders this assumption less likely, although it does not rule out this possibility. 
A second, more likely, explanation is that the TFIIH function in the postulated 
transcription syndromes is only marginally affected. Serious alterations in its function are 
presumably lethal. A slightly lower transcription, either by diminished initiation or by a 
less efficient elongation, only affects those cellular processes whose functioning critically 
depends on the level of transcripts (see appendix V). 
Another reason for the selective effect of TFIIH mutations on transcription levels 
might be a reduced stability of the complex as a consequence of a mutation in one of 
the components. The effect of an altered stability will mainly be apparent in terminally 
differentiated cells, where the majority of the genome is transcriptionally silent, and the 
cells are specialized in high level production of a few proteins. The majority of the 
salient features in CS and TTD are expressed in highly differentiated tissues of neuro-
ectodermal origin. 
A fourth explanation is that TFIIH functions as a regulatory element for some 
transcriptional activators. Mutations which modify the structure of TFIIH could reduce 
the response of the activator signals on the basal transcription machinery. A new group 
of factors which serve as intermediates between basal transcription and activators are 
found to co-purify with RNAPII, and are designated "mediators" (109)(see also chapter 
5.1). Two of the mediator components form an active CDKlcyciin pair (127), comparable 
(but different) to the CDK7/cyclin H pair, present in TFIIH. Both kinases are involved in 
CTD phosphorylation, and both likely function in concert to potentiate RNAPII by hyper-
phosphorylation. 
This hypothesis does not explain, however, the "CS" features of some patients of 
CS-A, CS-B and XP-G. The transcription-repair coupling factors CSA and CSB may play 
a role in shuttling TFIIH from its transcription mode into the repair mode andlor visa 
versa. A disturbed functioning possibly also affects transcription in addition to TCR. 
When the 3' incision (near the lesion) by XPG is performed late in the excision reaction, 
at least after the action of TFIIH, a malfunctioning of this activity may sequester TFIIH 
in frozen repair intermediates. In both cases, a reduced amount of TFIIH would become 
available for transcription, resulting in the observed features. In this model, however, CS 
features are secondary to improperly-processed repair intermediates and thus dependent 
on the amount of lesions. On the other hand, the very severe CS symptoms in many 
cases of early onset CS, suggest that these features do not depend on DNA damage. CSA, 
CSB and XPG may have an additional, as of yet unresolved, (dual) role in transcription, 
similar to TFIIH. 
6.2 DNA repair versus cell-cycle control. 
In addition to the induction of DNA repair, exposure to genotoxic agents also 
affects cell-cycle progression, transcriptional control, and it may provoke apoptosis. These 
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responses to DNA damage play an important role in preservation of genomic integrity. 
Cell-cycle progression is regulated by a variety of "cellular checkpoints". Some of these 
checkpoints are activated by DNA damage and consequently induce a cell-cycle arrest, 
allowing the cell to process the lesions. Regulation and communication between 
checkpoints, transcriptional control and repair should be present. Several cell-cycle 
controlling factors have been found to be transcriptional regulators; some influence the 
replication machinery. 
The intriguing observation of a CDKlcyciin pair in TFIIH makes it tempting to 
speculate upon a possible cell-cycle controlling function for TFIIH, in addition to its 
repair and transcription role. If indeed TFIIH is functional in cell-cycle regulation, it is 
a candidate manager in the genotoxic response. CDKlcyciin complexes are important 
cell-cycle regulators (173). Activation (by phosphorylation) of these complexes is 
performed by CAK, or CDK7/cyclin H (33). CAK activity is not differentially expressed 
and is equally active throughout the phases of the cell-cycle (255). The TFIIH-associated 
kinase may be a target in the signal transduction pathway(s) (e.g. after genomic stress), 
which influence both transcription and cell-cycle progression. It would be interesting to 
identify the kinase which activates CDK7 and see whether it fits in such a model. 
A potential target for phosphorylation by CDKlcyciin complexes is RPA, since 
CDKlcyciin pairs are able to phosphorylate RPA in vitro (51). RPA has an essential role 
in NER and in replication: this makes RPA a likely candidate as a regulator of both 
replication and repair. Moreover, RPA2 (p34) is differentially phosphorylated throughout 
the cell-cycle (48) and hyper-phosphorylated after exposure to genotoxic agents (e.g. UV-
irradiation)(27, 130). Hyper-phosphorylation inhibits in vitro DNA replication (27). 
During the NER process, TFIIH may unwind the template and provide a good substrate 
for RPA to bind (see 4.3.3 and 4.6). TFIIH kinase activity (CAK) would then be in close 
proximity to RPA and may be able to catalyse phosphorylation of the 34 kDa subunit. 
The altered status of RPA is still capable of acting in NER, but is non-functional in 
replication. By this process, RPA is forced into repair (in the equilibrium between repair 
and replication) either by potentiated recruitment to repair patches or a conformational 
change. Whether hyper-phosphorylated RPA is active in NER has to be investigated. At 
least the phosphorylation status of RPA2 does not influence XPA binding (124). In 
contrast to the above proposed model, Pan and coworkers (182) recently reported that 
the phosphorylation status of RPA neither influences in vitro repair nor replication. 
However, no hyper-phosphorylated RPA was used, and the absence of kinase activities 
was not shown in their in vitro reaction. 
Another important regulator of cell-cycle progression in response to genomic stress 
(at the Gl/S checkpoint) is p53 (40, 206). This protein is stabilized by DNA damage and 
is responsible for the transcriptional activation of some damage-inducible genes (133). 
p21 (WAF1, CIPl or SDI1) is one of the p53-activated genes and acts as an inhibitor of 
G liS CDKlcyciin complexes. In addition, p21 also binds to PCNA and inhibits in vitro 
replication (59, 280). In contrast, p21 does not affect the function of PCNA in the repair 
reaction in mammalian extracts (126, 226). In conclusion, p21 inhibits DNA replication 
after damage, but allows repair to continue. 
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A third candidate regulator of cell-cycle and DNA repair is GADD45, which is 
also transcriptionally induced by p53 after DNA damage (89). GADD45 also interacts 
with PCNA (232), and it is claimed to stimulate NER and to inhibit S-phase entry (232). 
However, the in vivo significance of this postulated regulatory role of GADD45 between 
NER and replication is in debate (206). 
An observed association between TFIIH and p53 protein (281, 283) might even 
connect the major cellular responses to DNA damage, including apoptosis. Although this 
association is confirmed in vivo, it only modulates the helicase activity of TFIIH, but not 
its transcriptional potency (283) nor its repair activity (unpublished observations). 
Recently, it was found that p53-induced apoptosis is delayed in XP-B and XP-D cells 
(282). The p53 apoptotic pathway is likely to be independent of transcription, so the 
observed delay of apoptosis in these cells cannot simply be explained by a subtle 
transcription defect (282). Moreover, p53-independent apoptosis is not altered in XP-B 
and XP-D. On the other hand, it is difficult to imagine that all different interactions and 
pleiotropic functions of TFIIH in very vital cellular processes are displayed by a single 
protein complex. Direct in vivo evidence, where all components are expressed at 
physiological levels, is required to verify the biological relevance of all the postulated 
TFII H functions. 
6.3 Future perspectives 
The recently attained successful in vitro reconstitution of NER is probably the most 
powerful tool for further elucidation of the mammalian NER mechanism. Although a 
variety of important NER factors are characterized and assigned to a specific step in the 
process, a complete picture is not yet available. The in vitro NER-assay has already 
recognized previously unknown essential NER factors like RPA and the recently 
described initiation factor 7 (lF7). This factor has to be further characterized before a 
specific function can be attributed to this activity. With the aid of this reconstituted N ER 
and by using well-defined artificial substrates, the sequence of events during NER can 
be unravelled. Unfortunately, not all factors are completely purified yet, nor is the native 
composition of each factor known, particularly in the cases of the TFIIH and ERCC1-
ERCC4 complexes. Purification of these complexes with classical protein purification 
protocols is laborious and yields only minute quantities. In addition, the native 
composition of quite intricate protein complexes may be destroyed. Moreover, the 
ERCC1-containing complex seems to be refractory to further purification (1, 269). A 
potential solution to this problem might be the use of recombinant tagged genes. When 
such a fusion gene is stably transfected into a mammalian recipient cells, purification 
from mass cultures can be performed with the aid of specific affinity (based on the tag) 
chromatographic columns. The advantage of this system is that it reduces the number of 
purification steps. Furthermore, purification through elution from affinity columns, is 
performed by competition with specific ligands instead of high salt or detergent washes, 
which are deleterious to delicate protein interactions. The relatively mild purification 
conditions may be helpful for the isolation of intact (native) complexes. 
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Although the current in vitro repair assays have permitted further insight into the 
mammalian NER mechanism, this system has limitations as well, e.g. the enhancement 
of NER by transcription cannot be measured in this system. Several attempts have been 
undertaken to develop a cell-free TCR repair assay without success. It is likely that the 
chromatin structure contributes to NER. However, the relative contribution of chromatin 
structure to NER cannot be addressed in present in vitro assays. 
6.4 Mouse models. 
A second important line of research is the generation of DNA repair-deficient 
mice. Specific inactivation of repair pathways will facilitate the analysis of genotoxic and 
mutagenic properties of unknown compounds under physiological conditions. Repair-
deficient animal models will be valuable for cancer research in general, and in particular 
for assessing the systematic influences of environmental and endogenous factors on 
carcinogenesis. Generation of either knock-out or subtly mutated repair deficient mice, 
by gene replacement is currently in progress in several laboratories. Mice with mutant 
NER genes, mimicking the situation in existing human repair syndromes, can help to 
elucidate the correlation between genotype and the consequent phenotype at the level 
of a whole organism. Interbreeding of a particular repair mutant mice into different 
mouse-strains will be helpful in determining the contribution of the genetic background 
on the phenotype. Moreover, genetic crosses of repair-deficient mice with existing 
tumour suppressor and/or cellular checkpoint mutant mice (p53, Rb, etc) can be 
performed. This is of potential interest for the research on the relationship between cell-
cycle control, DNA repair and carcinogenesis. 
The first report of a NER-deficient mouse appeared in 1993 (148). Growth of 
ERCC1-deficient (-/-) mice is severely retarded, when compared to heterozygote (+/-) and 
homozygote (+/+) littermates. Unfortunately, ERCC1-deficient mice die within a few 
weeks after birth. The cause of death is unclear, but severe liver and kidney pathology 
is observed in addition to iron deposition in the spleen. No other clear abnormalities, 
except for stunted growth and cellular repair deficiency, are apparent in these mice. The 
high mortality at a very young age may provide an explanation for the absence of a 
human syndrome due to ERCC1 deficiency. 
Recently, XPA-deficient knock-out mice were independently generated in two 
laboratories (43, 166). These mice grow normally, and except for defective cellular NER, 
they do not express any other phenotype. This is in sharp contrast with the human XP-A 
patients, which display severe neurological abnormalities. This species specific difference 
in phenotypic consequences of a repair defect is a potential problem in interpreting 
results obtained from studies on mouse models. The human-rodent repair paradox, might 
be a serious drawback. However, XPA mice were found to be extremely susceptible to 
skin cancer after treatment with carcinogenic agents. Thus, despite the above 
discrepancies with the XP-A patients, these mice serve as a valid model for studies of the 
relationship between repair-deficiency and carcinogenesis. In addition, homozygous XPC 
knock-out mice are also highly susceptible to UV-induced skin malignancies and display 
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UV-induced skin pathology (31, 207). 
Currently, generation and analysis of mice, either knock-outs for CSB (B. van der 
Horst, pers. comm.) and subtle mutations in XPB and XPD are in progress (I. Donker, J. 
de Boer and G. Weeda pers.comm.). 
Knock-out mice of two different mismatch repair genes, MSH2 and PMS2, show 
an enhanced micro-satellite instability and are cancer-prone (7, 45). 
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Summary 
The genetic information stored in the nucleotide sequence of the DNA is 
vulnerable to alterations induced by internal cellular DNA damaging metabolites and by 
environmental DNA damaging agents. Unremoved DNA lesions interfere with essential 
processes such as transcription and replication, which may even lead to cell death. 
Accumulation of DNA injuries results also in enhanced mutagenesis. Mutations can 
cause cellular malfunctioning. Alterations in cell growth controlling genes are an early 
step in the process of carcinogenesis. Furthermore, mutations in germ cells can lead to 
congenital diseases. To diminish these deleterious consequences all living organisms are 
equipped with a complex network of sophisticated DNA repair processes. Most of the 
DNA repair processes are highly conserved during evolution. An important repair 
mechanism for the removal of a wide range of bulky chemical adducts in DNA and UV-
light induced DNA lesions is nucleotide excision repair (NER). The consequences of 
accumulation of DNA damage are briefly discussed in chapter 1, an introduction to the 
NER-mechanism is presented in chapter 2. A more extensive overview of the current 
knowledge on mammalian NER is presented in chapter 4. 
Several hereditary disorders which have a defect in one of the DNA repair 
pathways are recognized. The rare, UV-sensitive, cancer-prone disease xeroderma 
pigmentosum (XP) is generally considered as the prototype repair syndrome and is 
caused by a defect in NER. XP patients are marked by a dry, aged-like skin and 
pigmentation abnormalities on sun-exposed areas. In addition, patients have a highly 
elevated risk for skin cancer development. This disorder is accompanied by a complex 
and heterogeneous set of clinical features, including neurologic deterioration. Two other, 
UV-sensitive, genetic syndromes with defective NER have recently been discerned, 
Cockayne syndrome (CS) and trichothiodystrophy (TTD). However, the most prominent 
features exhibited by these diseases are of neurologic and developmental origin. These 
features are difficult to explain on the basis of a defective DNA repair, in contrast to the 
XP features, UV-sensitive skin and enhanced skin cancer. A small group of patients is 
recognized which even expresses a combined phenotype of both XP and CS (XP/CS). 
In addition to a broad spectrum of clinical traits, these NER-syndromes are also 
heterogeneous at the genetic level. Genetic complementation analysis with the aid of 
somatic cell fusions revealed that, at least for XP and CS, multiple genes are responsible. 
Within the group of XP patients seVen genetic complementation groups (XP-A, -G) are 
identified and two for CS (CSA, CSB). An overview of the clinical symptoms and genetic 
complexity of the NER-syndromes is provided in chapter 3. The experimental work 
described in appendix papers I and II (microneedle injection and classical somatic cell-
hybridisation), corroborates the phenotypical overlap between XP and CS. Paper II 
describes the assignment of two new cases (siblings) to the very rare XP 
complementation group B. These patients express the hallmarks of both XP and CS, they 
display however, a much less severe phenotype than the original XP-B patient. Analysis 
of the XPB/ERCC3 gene from these patients uncovered a mutation in the N-terminal 
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region of the encoded gene product. In addition, in paper I evidence is provided for a 
further extension of the genetic overlap between XP and CS, by the assignment of two 
severe CS patients to XP group G. Within at least three complementation groups (XP-B, -
D, and -G) this XP/CS overlap is now confirmed. 
Also the repair defect of the brittle hair disease trichothiodystrophy (TTD) 
appeared not to be restricted to one gene. Previously, UV-sensitive TTD patients were 
only found within XP group D. Genetic analysis of a single patient, described in 
appendix paper III, revealed that the repair defect in this particular patient resides in a 
previously not identified NER gene. The NER defect is complemented by all the known 
XP groups (including XP-D) and thus this patient (TTDl BR) represents a new NER-
deficient complementation group, TTD-A. A further extension of genetic complexity 
within TTD is shown in appendix paper V, where the mild UV-sensitive TTD-phenotype 
of two siblings is linked to the XPB/ERCC3 gene. 
The observation that the XPB gene product is associated with the b<\sal 
transcription factor TFIIH, sheds new light on the previously unexplained clinical features 
observed within this complementation group. In appendix paper IV experimental 
evidence is provided, with the aid of microneedle injections and an in vitro NER system, 
that the XPB protein in the context of transcription factor TFIIH is functional both in NER 
and basal transcription in vitro and in vivo. Moreover, it is even likely that the entire 
TFIIH complex functions in both processes. Because of the observed connection of NER 
with basal transcription, a short introduction on the mechanism of basal (RNA 
polymerasell-driven) transcription is presented in chapter 5. A better understanding of the 
exact function of TFIIH in transcription may also be helpful to further unravel the NER 
mechanism. A functional and significant role for the observed DNA-unwinding activity 
of TFIIH, can be envisaged for both NER (chapter 4) and transcription initiation (chapter 
5). 
The work presented in appendix paper V, further establishes the concept of the 
involvement of the entire TFIIH in NER. Besides XP-B, also the repair defect in XP-D and 
TTD-A are restored with highly purified TFIIH preparations. Immuno-depletion 
experiments confirm a physical linkage of XPB, XPD, and TTDA, with the core of TFIIH. 
The observation that patients with a mutated TFIIH component exhibit a heterogeneous 
phenotype with features partly unexplained by a DNA repair defect, leads us to propose 
the 'transcription syndrome' model (appendix V). In this model the neurologic and 
developmental abnormalities, observed among CS and TTD individuals are explained by 
a subtly disturbed functioning of TFIIH in transcription of a specific set of genes, whose 
transcription is critically dependent on optimal TFIIH activity. The validity and 
implications of this model are discussed in appendix paper V and in chapter 6. 
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Samenvatting 
De integriteit van de genetische infarmatie, die apgeslagen ligt in de nucleotide 
valgarde van DNA, staat bloat cellulaire metabalieten en amgevingsfactaren (a.a. UV-
licht en tallaze chemische verbindingen), die het DNA kunnen aantasten. DNA 
beschadigingen verstaren essentiele cellulaire processen zaals transcriptie en replicatie. 
DNA schades kunnen tevens leiden tot een permanente veranderingen in de base-
valgarde van een gen; wanneer dit gebeurt in geslachtscellen kunnen aangebaren 
afwijkingen het gevalg zijn. Mutaties in genen kunnen oak het narmale functianeren van 
de cel verstaren. Veranderingen van de basevalgarde in genen, die de celgroei 
cantraleren, zijn een belangrijke factor bij het ontstaan van kanker. Oarzaken en 
gevalgen van DNA schades zijn kart samengevat in haafdstuk 1. 
am het haofd te bieden aan de nadelige gevalgen van DNA veranderingen zijn 
aile arganismen uitgerust met een ingewikkeld en efficient stelsel van DNA herstel 
processen. Een van deze DNA herstelmechanismen is nucleotide excisie reparatie of 
NER, dat zargt vaar de verwijdering van een groat aantal verschillende DNA lesies 
(waaronder DNA schades, veroarzaakt door UV-liehtl. In haafdstuk 2 wardt kart de 
werking van NER beschreven. Dit DNA herstel proces is gecanserveerd gedurende de 
evalutie, het mechanisme in zaogdier cellen lijkt sterk ap dat van de darmbacterie 
(E. coli). NER is een ingewikkeld proces, waarbij een groat aantal verschillende factaren 
betrokken zijn. Allereerst maet de schade herkend worden, aan weerszijde wardt een 
knip gemaakt en de lesie wardt verwijderd, waarna het antstane gat weer wardt 
apgevuld. De individuele stappen en werkzame factaren worden besproken in haafdstuk 
4. 
Er zijn verschillende erfelijke ziekten bekend, die veroorzaakt worden door een 
defect in een van de DNA herstel pracessen. Het meest bekende vaarbeeld is xeroderma 
pigmentasum (XP), een zeldzame autasamaal recessieve aandaening met een aver-
gevaeligheid vaar zanlieht en aanleg vaar huidkanker, die berust ap een gebrekkig N ER. 
XP patienten hebben een droge, perkamentachtige huid met pigmentatievlekken ap 
plaatsen die blaatstaan aan zanlieht. Verder vertanen de patienten een uitgebreid en 
variabel scala aan symptom en, waarander neuralagische afwijkingen. Bij twee andere 
erfelijke aandaeningen is recent oak een NER defect aangetaand: Cackayne's syndroam 
(CS) en triehathiadystrofie (TTD). Naast een avergevaeligheid vaar zanlieht, zijn de 
meest in het aog springende kenmerken van deze syndromen neurolagische- en 
antwikkelings-staarnissen. In tegenstelling tot de afwijkingen in de huid, kunnen deze 
verschijnselen bij CS en TTD maeilijk verklaard worden door een gebrekkig DNA 
herstel. In haafdstuk 3 staan de klinische verschijnselen van XP, CS en TTD samengevat. 
Oak in genetisch apzieht zijn deze syndromen heterogeen: meerdere genen 
blijken verantwaardelijk te zijn vaar een efficient NER (haafdstuk 3). Wanneer 
gekweekte huidcellen van verschillende patienten met elkaar gefuseerd worden, wardt 
bij bepaalde cambinaties het DNA herstel defect apgeheven (gecamplementeerd). Op 
deze manier zijn bij XP zeven camplementatiegroepen (XP-A tim XP-G), en dus genen, 
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gevonden en bij CS twee (CS-A en CS-B). Er zijn ook enkele patienten, die duidelijk de 
karakteristieken van zowel XP als CS (gecombineerd XP/CS) vertonen. Tot voor kort 
werden deze patienten aileen gevonden in XP groep B en D (beide een patient). Met 
behulp van micronaald injecties en celfusies zijn in appendix artikelen I en II meerdere 
XP!CS patienten gekarakteriseerd. Twee broers met milde verschijnselen van XP (geen 
huidtumoren ondanks gevorderde leeftijd) en CS, blijken te behoren tot de uiterst 
zeldzame XP complementatiegroep B (beschreven in appendix artikellD. Het ziektebeeld 
van deze personen is veel minder ernstig dan de oorspronkelijke XP groep B patient, 
hetgeen een klinische heterogeniteit binnen die groep aantoont. Analyse van het 
XPB(ERCC3) gen van deze patienten bracht aan het licht, dat bij het gecodeerde eiwit 
slecht een aminozuur veranderd is. De overlap tussen XP en CS is verder uitgebreid met 
een derde XP-groep, doordat twee ernstige CS patienten bij XP groep G blijken te 
behoren, hetgeen beschreven staat in appendix artikel I. Het samen voorkomen van XP-
en CS-verschijnselen in tenminste drie groepen doet vermoeden, dat XP en CS 
verschillende manifestaties zijn van een deficient NER. 
Ook het DNA herstel defect van trichothiodystrofie (TTD) is niet tot een gen 
beperkt. Tot voor kort werden aile UV-gevoelige TTD patienten gevonden in XP groep 
D. In appendix artikel III, wordt echter de genetische analyse beschreven van een UV-
gevoelige TTD patient, waarvan het herstel defect wordt gecomplementeerd door aile 
bekende XP groepen (ook XP-D). Deze patient vertegenwoordigt dan ook een nieuwe 
complementatie groep (en een niet eerder ge'identificeerd gen): TTD-A. Een nog verdere 
uitbreiding van de genetische complexiteit binnen TTD wordt behandeld in appendix 
artikel V, waarin wordt aangetoond dat het UV-gevoelige fenotype van twee andere TTD 
patienten berust op een defect XPB gen. 
Het XPB eiwit blijkt een onderdeel te zijn van een complexe eiwitfactor (TFIIH), 
die een rol speelt bij de initiatie, van door RNA polymerase II gestuurde, transcriptie. 
Met micronaald injecties en een in vitro NER-systeem, wordt in appendix artikel IV 
bewijs geleverd, dat het XPB eiwit in de structuur van het TFIIH complex een dubbele 
rol vervult, zowel in transcriptie als in NER. Met behulp van sterk gezuiverde TFIIH 
fracties en genoemde methoden in appendix V aangetoond, dat naast XPB, ook XPD en 
TTDA deel uitmaken van het TFIIH eiwitcomplex. Met hulp van specifieke antilichamen 
tegen andere (dan XPB, XPD of TTDA) TFIIH componenten, wordt aangetoond dat 
mogelijk het gehele TFIIH complex (9 verschillende eiwitten) een rol speelt in NER. 
TFIIH heeft een helicase (ontwinden van de dubbele helix structuur van DNA) activiteit. 
Dit is waarschijnlijk ook de gemeenschappelijke functie van TFIIH in transcriptie en NER. 
In hoofdstuk V wordt kort het mechanisme beschreven van de initiatie van basale (door 
RNA polymerase II gestuurde) transcriptie. Kennis over dit proces en de rol van TFIIH 
hierin is indirect oak van belang voor inzicht in NER, gezien de parallellen tussen de 
beide mechanismen. 
Patienten met een gemuteerde TFIIH component (XPB, XPD of TTDA), vertonen 
symptom en, die moeilijk te rijmen zijn met een NER defect. Mogelijk zijn deze 
verschijnselen te verklaren vanuit een verstoorde transcriptie functie van TFIIH. We 
stellen dan oak voor, dat deze aandoeningen aangeduid kunnen worden als een nieuwe 
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klasse van erfelijke afwijkingen,"DNA herstel/transcriptie syndromen" (appendix V), 
Waarschijnlijk bestaan er ook afzonderlijke "transcriptie syndromen", waar aileen de 
basale transcriptie functie is aangetast en het DNA herstel mechanisme normaal 
functioneert, zoals bijvoorbeeld bij TTD patienten die geen verstoord NER hebben 
(appendix V en hoofdstuk 6), 
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Xeroderma Pigmentosum Complementation Group G 
Associated with Cockayne Syndrome 
w. Vermeulen,' J. Jaeken,t N. G. J. Jaspers,' D. Bootsma,* and J. H. J. HoelJmakers* 
'MGC Department of Cell Biology and Genetics, Erasmus University, Rotterdam; and tDlvlslon of Metabolism and Nutrition, 
University Hospital Gasthulsberg, leuven, Belgium 
Summary 
Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) acc two rare inherited disorders with a clinical and 
cellular hypersensitivity to the UV component of the sunlight spectrum. Although the two traits acc generally 
considered as clinically and genetically distinct entities, on the biochemical level a defect in the nucleotide 
excision-repair (NER) pathway is involved in both. Classical CS patients are primarily deficient in the 
preferential repair of DNA damage in actively transcribed genes, whereas in most XP patients the genetic defect 
affects both "preferential" and '~overall" NER modalities. Here we report a genetic study of two unrelated, 
severely affected patients with the clinical characteristics of CS but with a biochemical defect typical of XP. By 
complementation analysis, using somatic cell fusion and nuclear microinjection of cloned repair genes, we assign 
these two patients to XV complementation group G, which previously was not associated with CS. This 
observation extends the earlier identification of two patients with a rare combined XV jCS phenotype within 
XP complementation groups Band D, respectively. It indicates that some mutations in at least three of the seven 
genes known to be invohred in XP also can result in a picture of partial or even full~blown CS. We conclude 
that the syndromes XP and CS are biochemically closely related and may be part of a broader clinical disease 
spectrum. We suggest, as a possible molecular mechanism underlying this relation, that the XVGC repair gene 
has an additional vital function, as shown for sOllle other NER genes. 
Introduction 
Acculllulation of DNA damage, caused by chemical or 
physical agents, call hamper transcription as well as rep-
lication and can induce mutations. To prevent these 
deleterious consequences, all living organisms are 
equipped with a network of DNA repair systems (for an 
extensive review, see Friedberg 1985). One of the best-
understood and universal DNA repair mechanisms is 
the nucleotide excision-repair (NER) pathway. This is a 
multistep process that recognizes and removes lesions 
from the DNA by a dual incision around the lesion in 
the damaged strand and excision of some flanking nu-
deotides (Huang et al. 1992), followed by repair synthe-
sis (also referred to as "unscheduled DNA synthesis" 
ReceivedjJnuJfY 31, 1993; rel'i,ion received ~IJrch 17, 1993. 
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(UDS1), llsing the nondamaged strand as template, and 
ligation. In this way the system eliminates a wide variety 
of stnlctliraIiy unrelated lesions. Detailed studies on 
the repair of unique genes have led to the differentia-
tion of NER into two subpathways: preferential repair 
of the transcribed strand of active genes to a slower and 
less efficient "overall genome" repair (Bohr 1991; Han-
awalt 1991). 
The importance of the NER system is reflected by 
the existence of two rare, human, hereditary diseases 
caused by a defective excision repair: xeroderma pig-
mentosum (Xl') (Cleayer 1968) and Cockayne syn-
drOine (CS) (Venema et al. 1990a). Cells from most ex-
cision-defective XP patients are impaired in both NER 
subpathways, and some are impaired in the "overall" 
pathway alone (Venema et al. 1990b). In CS patients, 
however, the repair deficiency seems to be restricted to 
the preferential subpathway (Venema ct a!. 1990a). 
Since nontmnscribed sequences represent the bulk of 
the genome, measurement of repair sYllthesis (i.e., UDS) 
in whole cells primarily reflects the mte of the "overall" 
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NER modality, As a consequence, CS cells display nor-
mal rates of UV -induced UDS, whereas XP cells have 
UDS levels reduced to a varying extent, Since UV-in-
duced DNA damage acts as a block to tmnscription, 
the rate of RNA synthesis is depressed following UV 
exposure, and subsequent recovery is dependent on 
preferential NER. CS patients' cells thus fail to recO\'er 
RNA synthesis rates, as do those XP cells with defec-
tive preferential NER. 
Clinically, the two autosomal recessive disorders 
show dear differences as well as similarities. They share 
an extreme sun sensitivity of the skin. XP patients ex-
hibit, in addition, other pronounced clltaneous abnor-
malities: atrophic skin with hyper- and hypopigmented 
spots in sun-exposed areas, in most cases combined 
with skin malignancies at an early age (Clea\'er and 
Kraemer 1989), The disease is frequently associated 
with progressive neuronal degeneration, In CS patients, 
cutaneOLlS abnormalities are less pronounced and are 
often restricted to sun sensitivity, whereas neurological 
disease is obligate and of a different type than that in 
XP (Nance and Berry 1992). Nellrologk-al dysfullction-
ing is predominantly due to demyelination in the cases 
of CS, while the neurological abnormalities of Xi' arc 
believed to be based on primary neuronal degeneration 
(Robbins et al. 1991).ln addition, retinal degeneration 
(salt-and-pepper pigmentation) together with retinal ar-
tery narrowing arc characteristically associated with 
CS. Often intracranial caleifications are observed in CS 
patients but not in XP. Although different in origin, 
some neurological features, such as microcephaly, sen-
sorineural deafness, and psychomotor retardation are 
shared by the two syndromes. A striking difference be-
tween XP and CS is the absence of cancer predisposi-
tion in CS patients, compared with a 2000-fold in-
creased risk of developing cutaneous malignancies in 
XP individuals (Cleaver and Kraemer 1989), Within 
both DNA repair syndromes the clinical manifestations 
are rather heterogeneous. At the genetic level this heter-
ogeneity is partly reHected by the existence of seven 
distinct genetic complementation groups in XP (XP-A 
to XP~G) (Vermeulen et al. 1991) and at least two com-
plementation groups within classical CS (CS-A and CS-
B) (Tanaka et al. 1981; Lehmann 1982), But eyen within 
somc groups the clinical picture may vary considerably. 
In only two cases a combination of clinical hallmarks 
of XP and CS has been reported, and these ha\'e been 
assigned to XP groups B (Robbins ct a!. 1974) and D, 
respectively (Lafforet and Dupuy 1978; Johnson et a!. 
1989; Vermeulen et al. 1991). Robbins (l988) has pro-
posed to consider this XP /CS combination a distinct 
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clinical entity, called "Xp~cs complex." On the other 
hand, the exceptional conjunction could also fall 
within the extreme clinical heterogeneity encountered 
in some of the XP complement<ltion groups, which 
could imply that the distinction between XP and CS is 
smaller than originally thought. 
Here we report a genetic study of tWO unrelated pa-
tients combining yery severe CS symptoms with a 
strongly reduced level of UDS typical of XP cells, Both 
are assigned to the rare XP complementation group G, 
which previously was not associated with CS, This find-
ing demonstrates that the overlap between XP and CS is 
more extensiye than believed thus far and that it in-
volves at least three of the seven excision-deficient XP 
complementation groups. 
MaterIal and Methods 
Cell Strains, Culture Conditions, and Cell Hybridization 
All primary fibroblast cultures (table 1) were grown 
on Ham's FlO medium (Gibco) supplemented with 
11 % FCS (Biological Industries), 100 IU penicillin/ml, 
and 100 ~lg streptomycin/m!. Prior to Sendai virus-me-
diated cell hybridization, the cytoplasm of each fusion 
partner was labeled by culturing for 2-3 d in the pres-
ence of latex beads of different sizes Uaspers and 
Bootsma 1982; Vermeulen et al. 1991); the cells were 
rrypsinized, mixed in a 1:1 ratio, and extensively 
washed with PBS to remove free beads, Fused cells were 
seeded on coyerslips and were cultured under standard 
conditions for 2 d prior to assays of UV -induced UDS 
or RNA synthesis recovery. Homopol}'karyons, to be 
used for the microinjectioll experiments, were gener-
ated in the same way, except that the addition of latex 
beads was omitted and only one cell stnlin was used for 
the fusion. 
Microneedle Injection 
Nuclear microinjection of cDNA was performed ac~ 
cording to a method described elsewhere (van Duin et 
al. 1989), In short, XPBC/ERCC3 eDNA was cloned 
into the mammalian expression vector pSVL, yielding 
the plasmid pSV3H (\X'eeda et al. 1990) dissolved in 
PBS at a concentration of 100 J.lg/ml and, with the aid 
of a glass microneedle, injected into one of the nuclei of 
XP homopolykaryons. Coverslips with injected and un-
injected cells were cultivated for 24 h to permit expres-
sion of the introduced cDNA before they were assayed 
for their repair capacity. 
UV-induced UDS 
The UDS assay (Vermeulen et al. 1986) was per-
formed 2 d after fusion and 1 dafter microinjection. 
Table I 
Repair Activity of Cell Strains Used 
Cell Stmin 
XI'(SILV 
xrCS2LV ... 
CS3BE (eS-A) ., 
CSlBE (eS-B) ........... . 
XP25RO (XII,A) ... , •. "., •.. 
XPCStBA (XP-B) . 
XI'lBI (Xp·G) ..... 
C5RO (non1ul control) 
Cells were washed with PBS, irradiated with 15 11m2 
UV-C light (Philips TUV lamp), incubated for 2 h in 10 
~lCi [methyPH]-thymidinc (50 Cijmmol; Amersham}j 
ml containing culture medium, were washed with PBS, 
and were fixed and dipped in a photo-sensitive emul-
sion (IHord K2). Repair capacity was quantitated by 
grain counting after autoradiography. 
RNA Synthesis Recovery 
RNA synthesis recovery after UV irradiation (Leh-
mann 1982; l\,'fayne and Lehmann 1982) was deter-
mined 2 d after fusion. Cells were UV irmdiated (10 
1/m2), cultivated for 16 h to recover, then incubated 
for 1 h in medium containing 10% dialysed FCS and 10 
~lCi {5,6-.lH}-uridine {50 Cijmmol; Amersham)jml, 
and finally were processed for amomdiography as de-
scribed above. The relative rate of RNA srnthesis was 
expressed as the number of autoradiogmphic gmins 
over the UV-exposed nuclei (Guv) divided br the num-
ber of grains over the nuclei of nonirradiated cells on 
parallel slides (Go) (RNA srnthesis; Guv/Go)· 
Results 
Summary of Clinical Symptoms of Patients 
Patients NF and BT have been described in detail 
elsewhere Daeken et al. 1989). These unrelated patients 
are designated herc as "XPCSILV" and "XPCS2LV," 
respectivelr. The most important clinical srmptollls are 
brienr recapitulated herc. 
XPCS I LV.-Psychomotor retardation and micro-
cephaly of this girl were noted at the age of 9 mo. She 
attained <l maximalleyel of development of 8-10 mo. 
Her skin was very sensitive to sunlight, and she had 
several small pigmelllcd spots on facc, trunk, and limbs. 
Nerve conduction velocity was normal. Salt-and-pep-
UDS 
(% of nomla!) 
80-100 
5 
80-100 
80-100 
100 
Source 
Jtcken CI ;11. 1989 
Jaeken et "I. 1989 
J,leken et a1. 1989 
Lehmann 1981 
Lehm.ll1ll 1982 
\'\', Vermeulen ct aI., 
unpuhlished data 
Keijzer et at 1979 
per retinal pigmentation and retinal artery narrowing 
werc noted. She died from bronchopneumonia at age 
6.5 years. 
XPCS2LV.-This boy did not reach a level of psycho-
motor development above 2 mo and exhibited extreme 
microcephaly. Dysplastic cars and large extremities 
were apparent at age 6 wk. His sun-sensitive skin exhib-
ited pigmented spots on trunk and limbs. Nerve con-
duction velocity was decreased, and visual <lnd audi-
tory-evoked potentials were <lbsent. Salt-and-pepper 
retinal pigmentation but no intmcranial calcification 
were observed. He died from a pulmonary infection at 
age 20 mo. 
At the cellular level, both patients showed pro-
nounced UV sensitivity and a reduced mte of ovemll 
thymidine-dimer removal, as measured in a mdioimmu-
noass<ly. 
Determination of UV-induced UDS 
To further ch<lracterize the repair phenotype of these 
patients, the level of UV -induced UDS was determined 
and compared with the levels of UDS found in repair-
competent <lnd reference Xi> mId CS cell stmins. Table 
1 shows that XPCSILV and XPCS2LV cells exhibit a 
strongly reduced UDS (..,;;;5% of repair-proficient cells; 
C5RO). This level is in the same mnge as is lIs11all), 
found for representatives of Xl' complementation 
groups A, B, and G and is significantly lower than the 
residual UV -induced UDS of XP groups C, D, E, and F 
(~15% of repair-proficient cells), whereas the UDS in 
CS cells is in the wild-type mnge (CS1 BE, CS3BE, CS-
TK, and CSRO; table 1). 
Microinjection with the Cloned XPBCjERCC3 cDNA 
The combination of clinical symptoms and the bio-
chemical features of XPCSILV and XPCS2LV resem-
93 
Table 2 
MlcrolnJectlon of the XPBC/ERCC3 eDNA 
UDS 
Injected Cells DNA' UV lrmJiatiun (% of norm.ll) 
XPC51BA pSV3H + 80-100 
XrcSlllA .. + 8 
XPCSIBA pS\l3H 0 
XI'CSILV . pSV3H + 5 
xrCSILV " + 5 
Xl'CSlLV . pSV3H + 5 
XrCS2L V """ + 5 
• Vector pSV3H contains Ihe human XPBCjERCC1 gene doned 
into the IllMlll11Jli.m expression Hetor pSVL. 
hie most closely those of the exceptional XP group B: a 
low residual UDS and combined XPjCS clinical symp-
toms. To investigate whether the XP-like CS patients 
indeed belong to this complementation group, nuclei 
were microinjccted with eDNA from the recently 
cloned human excision-repair gene XPBC/ERCC3, 
which specifically corrects the repair defect of XP-B 
(Weeda ct al. 1990). As shown in table 2, the introduc-
tion of this gene failed to enhance UV-UDS, in both cell 
strains, whereas, in a pamllel experiment, fibroblasts of 
XP-B (XPCS1BAj W. Vermeulen, unpublished data) 
were corrected, by the XPBCjERCC3 eDNA, to the 
level seen in normal celts. The microinjection resuit" 
indicate that patients XPCSILV and XPCS2LV are not 
members of XP group B. 
Complementation with XP-A and XP-G 
In light of the low leyel of UDS, only two other C.Ul-
didate XP complemenhHion groups exist: A and G. 
Therefore XPCSI LV and XPCS2LV fibroblasts were 
hybridized to representative cell strains of these groups. 
Both XP jCS cell strains were fully complemented by 
XP-A cells (XP25ROj table 3), as is eyident from the 
approximately normal UDS in the heterokaryons. An 
XP-G representative (XP2Blj table 3) caused no such 
complementation. Consistent with this obsen'ation, 
XPCSILV and XPCS2LV failed to complement each 
other. From these results we conclude that the two 
CS patients belong to the rare XP complementation 
group G. 
Complementation with CS Cell Strains 
To investigate the relationship between the two XP j 
CS patients and classical CS, additional complementa-
tion studies were performed with known CS patients' 
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cells. In view of the normal UDS levels in CS cells, we 
utilized the feature of RNA synthesis recovery in these 
experiments, which is suitable for complementation 
analysis of CS (Lehmann 1982). 
A significant degree of recovery occurred after fusion 
of XPCSI LV and XPCS2LV cells with CS3BE (CS-A), 
CSIBE (CS-B), and XPCSIBA (XP-B) (table 4)_ Consis-
tent with the absence of UDS complementation ob-
seryed between XPCS1LV and XPCS2LV cells, no 
complementation also was found between these lines 
with RNA synthesis recoyery as a repair parameter. As 
regularly observed in correction of RNA synthesis re-
covet)' (Lehmann 1982), the RNA synthesis rates in 
complementing heterokat)'ons did not reach the level 
ohserved in normal control cells (i.e., CSRO). This phe-
nomenon can be explained hy several possible mecha-
nisms (discussed by Troeistra et al. 1992), but which of 
these possibilities is correct has remained unresolved so 
far. The significant correction exerted by all CS strains 
tested, hmvcver, clearly excludes assignment of 
XPCSILV and XPCS2LV to any of the known classical 
CS groups. 
Discussion 
Seveml clinical hallmarks exhibited by the two se-
verely affected patients analyzed here categorize them 
as CS, as opposed to classical Xt'. These include the 
retinal abnormalities, the decreased physical and men-
tal development, and the conduction abnormalities in 
some peripheral nen'es. Furthermore, lateral ventricles 
were found to 'be slightly or moderately enlarged, al-
though intracranial calcifications were not noted. It is 
possible that this trait, characterized as "not consis-
tently observed in CS individuals" (Nance and Bert)' 
1992, p. 78), would have become apparent at a more 
advanced age. 
On the other hand, there are also some features remi-
niscent of XP. Small pigmented spots were observed on 
tnlllk, limbs, and (in XPCSILV) face. It cannot be ex-
cluded that these cutaneous symptoms typical for XP 
would have become more prominent when the patients 
would have been older. Also, the absence of skin cancer 
mol)' be due to their young age. In this respect it is worth 
noting that the occurrence of skin tumors is relatively 
rare in XP group G: in only one patient (of the seven) 
was a basal cell epithelioma reported, and this occurred 
at a rather late age (32 years), 
Although the CS symptoms are more prominent than 
the XP features, the repair defect of both patients is 
typical of XI': UV-induced UDS is severely reduced {in 
Table 3 
XP Complementation-Group Analysis 
Type-of Grains/Nucleus UDS 
Fused CellS> Binucleate Cell (Mean ± SEM) (a,b of normal response) Complementation? 
XPCSILV X XP15RO(A) XPCSILV 2±O 3 
XP25RO 2±O 3 
Heterodikaryons 40± 2 63 Yo; 
XPCSILV X XPIBJ(G) ,., XI'CSILV 2±O 3 
XPIBI 2±O 3 
Heterodikar),ons 2±O 3 No 
XPCS21.V X XP1SRO(A) .... ,. XPCS2LV 3±O 3 
XP25RO 2±O 2 
Heterodikaryons 60 ± 3 68 y" 
XPCS2LV X XPIBl(G) ........ XPCSILV 2±O 2 
XP2BI 2±O 2 
Heterodikaryons 3±O 3 No 
xrCS1LV X XPCS2LV ... ,"" XPCS1LV 2±O 2 
XPCS2LV 2±O 2 
Hcterodikaryons 3±O 3 No 
XP25RO(A) X Xl'lBJ(G) ....... XP25RO 2±O 2 
XPIBI 2±O 2 
HeteroJikaryons 64 ± 3 73 Yo; 
• Letters in parentheses are XP complementation group. 
contrast to classical CS). The failure to recover RNA 
synthesis rates after UV exposure is a characteristic of 
CS and most XI' cells. This property permitted us to 
perform complementation analysis using both pamme-
ters. Our analysis indicates an unequivocal assignment 
of the NER defect to XP group G and excludes assign-
ment to XP group A and the known classical CS com-
plementation groups. The inability of the microinjeaed 
Table 4 
CS Complementation-Group Analysis 
MEAN ± SEM RNA SYNTIIESIS, 
16 h 1'0srUVA 
TYPE OF Guv (10 J/ml) Go{O J/ml) 
FUSED CELLS' BtNUCLEATE CELL (grains/nucleus) (grains/nucleus) GUy/Go COMPLEMENTATION? 
XPCS1LV X (S3I1E{A) XPCSILV 7± 1 64 ± 2 .Il 
CS3BE 13 ± 1 68 ± 3 .19 
HeleroJikaryon 39 ± 2 65 ± 2 .60 
XPCS1L V X CSlBE(B) ....... XPCS1LV 8 ± I 80 ± 3 .10 
CS1BE 15 ± 1 75 ±3 .20 
Heterodikal)'on 42 ± 2 81 ± 3 .52 
XPCSILV X XPCSlBAb ••••• , XPCSILV 11 ±l 76 ± 2 .14 
XPCSIBA 12 ± 1 76 ± 2 .16 
Heterodikaryon 57 ± 2 77± 2 .74 
XPCSILVX XPCS2LV ....... XPCSILV 5 ± 1 78 ± 2 .06 
XPCS2LV 5 ± I 72 ± 2 .07 
Heterodikaryon 4±1 71 ± 2 .06 No 
Normal cells (CSRO) ......... Not fused 86 ± J 84 ± 2 1.04 
• Letters in parentheses are CS complementJtion group. 
b New patient of XP complementation group II (W. Vermeulen, unpublished J.lla). 
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Table 5 
Clinical and Biochemical Features of XP-G Patients 
liDS 
XP-G Age Jt U\'~ (,~:, uf Acute SUIl Pigmem.1tiol1 Skin Rt'tM,lc.l Ncufl)I()~i'\ll Mia,,· O..:ubr 
PJlion! Refer.;:I1(e' Di.lgJlUSis Scmililil)' normal) Senlili\ily? S)mptnms' Cal1(u? GrO\\th1 Ahn()muljti~,? ,,'plul)? Ahn(lmuiitie,? 
XrlBl . 1,2 16 }'~Jrs S X ;;;5 reI ++ No Yfl Yo \\5 No 
XPJBR J 6 )'~J'" S x ,,;:5 Yes ++ Nu Yes y" Yes Unknown 
XI'JIKO .. J? j"<Jf, 5 X 25 Yes + Y6~ N" N" N" No 
XI'124l0. H }'<J[\ , 15 Yes + No N" No No No 
XPI2SI.O. 11)cM' 15 reI + Nu No No No No 
XI'CSILV. 9 mo 9X <5 Yn ± No reI \'e; Yo Yes 
XPCS1LV. 6 wk 9x ,,;5 \\', ± No Yc; Yr- Yl'S Yes 
• 1 ~ Chc(,hrough J.nd Kinmont (197S); 1 = Keij1er el J1. (1979); 3 ~ Arlw ct al. (19S0); 4 = Jch,h:l\hi el J1. (19~'i); 5 = NOtnHt JI. (1987); and 6 = jark,n {t .11. 
(1989), 
~Cellubr lenlitilit), to UV-C imdi.1lio!l of Xl'-G pltient~, .:compa,eJ with 1101llB! dono, ,.:1k 
'++ = Selctl' Xl' pigmentltion; + ~ d('Jr XP pigmenminl1 hl't k,s >[\W~; Jnd + = m,ld Jnd limited pigmentJtinll. 
d Ila.ul cell epilhdi"nu Jt age 37 }ear>. 
XPBC/ERCC3 gene to currect tbe UOS, in agreement 
with normal RNA synthesis recovery after hybridiza-
tion to XP-B cells, ruled out XI' complementation 
group B. The assignment of both stf<lins to the same 
complementation group is consistent, since the}' were 
unable to complement each other's defect with re-
gard to both UDS and recovery of UV-blockcd tf<ln-
scription. 
The assignment of XPCSILV and XPCS2LV to XI' 
group G further extends the clinical heterogeneity 
within this group, which is summarized in table 5. Until 
now the G group comprised five patients, none of 
whom has been reported to he associated with CS. 
Within XI' group G the clinical symptoms vary from 
mild cutaneous and no neurological abnormalities 
(Xp31KO, XP124LO, and XP12SLO) to se\'ere derma-
tological and neurological impairment (Xp2BI and 
XP3BR). For most clinic,ll manifestations, there is a 
reasonable correlation between the severity and the 
magnitude of the NER defect. The exception are the 
cutaneous abnormalities. The patient exhihiting the 
highest residual UDS (XP31KO; 25%) is the ani}' XP-G 
patient who developed skin tllmor, which appeared at a 
relatively late age. 
Symptoms characteristic of CS h,we been reported so 
far in two XI' C;1ses. One is patient XPI IBE, the only 
representative of XP group B (identical to CS group C), 
and the other is patient XpCS2 from XI' group O. The 
latter group also shows extensive clinical heterogeneity 
(reyiewed by Johnson and Squires 1992), Thus, XP 
groups B, D, and G resemble each other with regard to 
concurrence of XI' and CS symptoms and (for 0 and G) 
the pronollnced heterogeneity. The genes responsible 
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for XI' groups Band D, XPIJCjERCC3 (Weeda et 011. 
1990) and XPDC/ERCC2 (Fletjer et ,11. 1992; also see 
citation of Weber, in Lehmann et a\. 1992), have re-
cently been isolated and show striking parallels. Hoth 
are postulated to encode hclicases, based on tbe basis 
of the presence, in the predicted amino acid sequence, 
of seven consecuti\'e motifs that arc ,1ssociated with a 
sllper£.unily of DNA- and RNA-unwinding enzymes. 
Furthermore, hOlh human genes have strongl}' con-
served yeast cognates with a distinct "as yet uncharac-
terized" vital function, in ilddition to their role in NER. 
It is likely that the human repair genes also participate 
in a process essential for viability. The rarity of XP-B 
and the striking heterogeneity of clinical symptoms of 
XP-D arc certainly consistent with the hypothesis that 
the affected genes are vital and tolemte only a limited 
set of mutations disturbing the repair-but not the vi-
wi-function. Likewise, a possible explanation for the 
severit)" heterogeneity, and rarity of XP-G could be an 
additional essential fUllction for the XPGC gene, in 
analogy with XP-B and XP-D. 
The findings reported here identify a third XI' com-
plementation group in which patients with CS presenta-
tions occur. In the case of XP-B and XP-D, the Xl'jCS 
patients clearly show a combination of the typical skin 
lllanifeShltions of XP and the characteristic neurologi-
cal and other features of CS. The distinctive clinical 
features of the XP jCS patients in XI' groups Band 0 
have prompted Robbins et aJ. (1988) to define a distinct 
clinical entity, the "XP-CS complex." However, for the 
two XP-G individuals described here, the clinical traits 
of CS prevail, whereas those characteristic of XI' arc 
only marginally expressed, This demonstrates that the 
heterogeneity, at least within group G, Cim range from 
exclusively Xl' to virtually only C5, and it argues against 
a narrowly defined "XP-CS complex" in this comple-
mentation group. 
Furthermore, this observiltion may have important 
implications for a rigid distinction between Xl' and CS. 
In this respect it is relevant to note that recently three 
siblings were described with clinical symptoms asso-
ciated with Xl' but with a repair defect typical of CS 
(Greenhaw et al. 1992), In this case, however, no (C5) 
complementation group assignment was performed. A 
clue to the resolution of the problem of heterogeneity 
may come from the molecular analysis of the genetic 
defect in clinically different patients of the same com-
plementation group, Unfortunately, at present this is 
not possible for Xp-G, as the XPGC gene has not yet 
been cloned. A relevant answer probably will come 
soon from mutation determination in the XPDC/ 
ERCC2 gene of various Xp-D patients. Anal>'sis of ad-
ditional Xl' /CS patients will reveal whether specific 
mutations correlate with il specific phenotype and will 
help to link the clinical features with the molecular 
defects. Thus, for one Xl' /CS patient (XpllBE; XP 
group il), <l single gene defect has been demonstrated 
(Weeda et al. 1990) to be responsible for the entire 
complex clinical phenotype. 
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Clinical Heterogeneity within Xeroderma Pigmentosum 
Associated with Mutations in the DNA Repair and 
Transcription Gene ERCC3 
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Summary 
The human DNA excision repair gene ERCC3 specifically corrects the nucleotide excision repair (NER) defect 
of xeroderma pigmentosliOl (XP) complementation group B. In addition to its function in NER, the ERCC3 
DNA heHcnse was recently identified as one of the components of the human BTF2/TFIIH transcription factor 
complex, which is required for initiation of transcription of class II genes. To date, a singlc patient (XPllBE) 
has been assigned to this XP group B (XP-B), with the remarkable conjunction of two autosomal recessive DNA 
repair deficiency disorders: XP and Cockayne syndrome (CS). The intriguing involvement of the ERCC3 protein 
in the vital process of transcription may provide an explanation for the rarity, severity, and wide spectrum of 
clinical features in this complementation group. Here \ye report the identification of two new XP-B patients: 
XPCSlDA and XPCS2BA (siblings), by microneedle injection of the cloned ERCC3 repair gene as well as by 
cell hybridization. Molecular analysis of the ERCC3 gene in both patients revealed a single base substitution 
causing a missense mutation in a region that is completely conserved in yeast, Drosopllila, l)tOuse, and human 
ERCC3. As in patient XPllBE, the expression of only one allele (paternal) is detected. The mutation causes a 
virtually complete inactivation of the NER function of the protein. Despite this severe NER defect, both 
patients display a late onset of neurologic impairment, mild cutaneous symptoms, and a striking absence of skin 
tumors even at an age of >40 years. Analysis of the frequency of hprr mutant T-Iymphocytes in blood samples 
suggests a relatively low in vivo mutation frequency in these patients. Factors in addition to NER deficiency 
may be required for the dcvelopment of cutaneous tumors. 
Introduction 
Rare human hereditary syndromes with a predisposi-
tion toward the development of cancer-such as 
Bloom syndrome, Fanconi anemia, ataxia telangiecta-
sia, and xeroderma pigmentosull1 (XP)-are believed to 
be based on a defective DNA repair mechanism or on 
,1Il impaired cellular response to damage inflicted to 
DNA. XP is the prototype of these disorders, as it is the 
most intensively studied at the genetic, biochemical, 
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and molecular level. Patients suffering from this auto-
somal reccssi\'e disease arc extremely scnsitive to the 
UV spectrum of solar irnldiation (Cleaver and Kraemer 
1989). This hallmark of thc disease is reflected by an 
atrophic skin with (a) hyper- and hypopigmented spots 
on sun-exposed areas and (b) a >1,OOO-fold increased 
risk of developing skin cancer. Some patients also ex-
hibit early and severe neurological degeneration. A 
striking heterogeneity is observed among XP individ-
uals, varying from patients with only mild skin lesions 
to those with severe deyelopmental disorders such as 
dwarfism, microcephaly, and ncurologic (ataxia and 
memal retardation) abnormalities (Robbins et a!. 1991). 
This heterogeneity is only partly explained by the in-
\'olvement of multiple distinct genes as rcvealed by the 
identification of seven XP complementation groups 
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(XP-A through XP-G) (Vermeulen et al. (991). The pri-
mary defect in lUost XP patients resides in a disturbed 
nucleotide excision repair (NER) pathway (Cleaver 
1968) (for a recent review on NER, see Hoeijmakers 
1993). A subpopulation of XP patients, designated 
"XP-variants," appears to have a defect in the poorly 
defined post replication repair system (Lehmann et al. 
1975). NER consists of two subpathways: (1) preferen-
tial repair of the transcribed stmnd of tmnscriptionally 
active genes and (2) the slower and less efficient ovemll 
genome repair (Bohr 1991; Hanawalt 1991). Informa-
tion available to date indicates that both NER sllbpath-
ways are impaired in the various forms of XP, with the 
notable exception of XP group C, in which only the 
ovemll genome repair system appears to be affected 
(Venema et al. 1990b). Defective NER call be moni-
tored biochemically by measuring the UV-indllced 
DNA repair synthesis referred to as "unscheduled 
DNA synthesis" (UDS). Absence or reduced levels of 
UDS are found in XP groups A-G. Recently, it was 
demonstmted that another human genetic syndrome 
associated with UV sensitivity, Cocbyne syndrome 
(CS), is also based on a defect in NER. Here only the 
preferential repair of active genes is disturbed, whereas 
the ovemll repair (responsible for the hulk of UDS) is 
normal (Venema et al. 1990a). Consequently, UDS Ie\,-
els in CS fall within the normal mnge. In addition to a 
UV-sensitive skin (without pigmentation abnormali-
ties), neurological dysfunction due to demyelination of 
neurons and calcification of basal ganglia is obligate for 
the diagnosis of CS. General developmental impairment 
is often also seen (Nance and Berry 1992). Although CS 
is based on a partiall)' deficient NER, no signifi(ant 
increased frequency of skin cancer is observed. Clinical 
and genetic heterogeneit)' is apparent in CS (Lehmann 
1982). A class of extremely rare individuals with a con-
junction of features of both syndromes ("XP-CS" com-
plex) bas been recognized. Three XP complementation 
groups arc implicated (XP-B, XP-D, and XP-G). The 
genes responsible for the defect in XP-B, XP-D, and 
XP-G have recently been cloned; they are, respectivel)' 
ERCC3 (XPBC), ERCC2 (XPDC), and ERCCS 
(XPGC) (\Xfeeda et al. 1990; Flejter et al. 1992; Leh-
mann et al. 1992; O'Donovan and Wood 1993; Scherl), 
et <11. 1993). The ERee3 gene product was identified as 
olle of the components of the human BTF2/TFIIH 
transcription factor, which is required for initiation of 
transcription of class II genes (Schaeffer et <11. 1993). 
Until now XP-B has consisted of a single patient 
(XPllBE), who dispb}'ed severe features of XP as well 
as CS and who developed numerous skin tumors at an 
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early age. Mutational analysis of thc ERee3 gene of 
this patient revealed that only one allele was detectably 
expressed and that it contained a splice-acceptor muta-
tion in the last exon, causing a C-terminal fmmeshift at 
the protein leyel (Weeda et al. 1990). The few remain-
ing fibroblasts of this patient grow poorly. Recently we 
received fibroblasts from two brothers, designated 
"XPCSIBA" and "XPCS2BA," who have combined XP 
and CS symptoms (Scott et aI., in press). In the present 
paper we report both the assignment of these two pa-
tients to XP-B and the identification, at the molecular 
level, of the mutation in ERee3 in these patients, 
Material and Methods 
Cell Strains, Culture Conditions, and Cell Hybridization 
Human fibroblast cultures C5RO (control), XP25RO 
(XI'-A), XPllBE (XP-II), XPCS2 (XP-D), XI'CSILV 
(XP-G), XPCSIBA, and XPCS2BA (assigned to XP-B; 
present paper) were grown in Ham's FlO medium sup-
plemented with 11% FCS and antibiotics (lOO U peni-
cillin/ml and 100 flg streptomycin/ml). Lymphoblas-
toid cells were grown in RPMI medium supplemented 
with 10% FCS and antibiotics. 
Three days prior to cell hybridization, each fusion 
partner was labeled with latex beads of different sizes 
by adding a suspension of beads to normal culture me-
dium (Vermeulen et al. 1991). After trypsinization, 0.5 
X 106 cells of each werc mixed in a 1:1 ratio, washed 
extensively to remove free beads, and fused with f3-pro-
piolactone-inactivated Sendai. virus. Fused cells were 
seeded onto cO\'erslips, incubated for 2 d under normal 
culture conditions, and assayed for UV -induced UDS, 
which was measured by autoradiography as described 
below. Homopolykaryons, to be used for the microin-
jection experiments, were generated as described 
above, llsing only one cell strain and omitting the addi-
tion of latex beads. 
MicroneedJe Injection 
Plasmid eDNA (lOO ~Ig/ml) in PBS was injected into 
one of the nuclei of Xl' homopolykaryons by lIsing a 
glass micro capillary, as described elsewhere (Van Duin 
et al. 1989). For each experiment at least 50 homopoly-
bryons were injected. Coverslips with injected cells 
were cultured for 24 h to allow expression of the in-
jected cDNA before they were assayed for their repair 
capacity by means of UV -induced UDS. 
UV-fnduced UDS 
The UDS assay (Vermeulen et 011. 1986) was per-
formed 2 d after fusion and 1 d after injection, In brief, 
cells grown on coverslips were washed with PBS, irra-
diated with 15 J/m2 UV-C(Philips TUV lamp), immedi-
ately incubated for 2 h in culture medium containing 10 
!lCi (methyPH) thymidine (50 Cijmll10lj Amersham)/ 
ml, washed with PBS, and fixed. Coverslips with radio-
actively labeled cells were mounted onto slides and 
dipped in a photosensitive emulsion (Ilford K2). After 
exposure (2-7 d) slides were developed and stained. 
Repair capacity was quantitated by counting llutoradio-
graphic grains above the nuclei of ;;.50 cells. UDS levels 
are expressed as the percentage of UDS of normal cells 
on an identicall), treated coverslip culture in the same 
experiment. 
In Vivo Mutant Frequency ot the hprt Locus 
Mutant frequency estimations were undertaken by 
published procedures (Cole et al. 1988, 1992). In brief, 
for each determination, a mass culture of mononuclear 
cells (""",107 cells) was incubated overnight in RPtvll 
1640 medium supplemented with 10% human AB 
serum, before being cloned in 96-\yell microtiter tmys 
in the presence of mitogen (phytohemagglutinin), le-
thally irradiated Iymphoblastoid feeder cells, and the 
T-cell growth factor interleukin-2 (IL-2). For bprt mu-
tant selection, the cells were plated at high density (1 
X 104/well) in the presence of the purine analogue 6-
thioguanine (6TG), in which nonllllltants are unable to 
grow. To determine cloning elliciency in the absence of 
selection, a low cell density (3 cells/well) was used. The 
plates were scored for negative (no colony) wells after 
15-20 d incubation, and the mut;mt frequency was cal-
culated from the zero term of the Poisson distribution. 
Under the conditions llsed in our experiments, mono-
nuciear cell cloning efficiencies of """,50% in the ab-
sence of selection are routinely obtained; thus a high 
percentage of the T-Iymphocytes in the sample arc capa-
ble of colony formation in vitro. Therefore the mutant 
frequenc), should reflect the in vivo situation. 
RNA Iso/ation, DNA Amplification, and Mutation 
Detection 
RNA was isolated by the LiCljurea method (Au!fray 
and Rougeon 1980). The RNA was used for preparing 
cDNA with ERCC3-specific primers (as described by 
Weeda et al. 1990). Amplification was performed by 32 
C)'cles of, consecutively, 2 min denaturing at 95°C, 2 
min annealing (the temperature was dependent on the 
primers used), and 3 min extension at 70°C (Saiki et al. 
1985). Amplified DNA Wits spotted onto Hybond 
filters (Amersham)and was UV-cross-linked and hybrid-
ized to wild-type ;1I1d mutant 32P-labeled primers. The 
amplified DNA was purified and digested with the ap-
propriate restriction enzyme and subsequently was 
cloned into a M13mp18 vector for sequence analysis by 
the dideoxy-chain termination method (Sanger et al. 
1977) lIsing T7 DNA polyllJemse (Pharmacia). Oligonu-
cleotide primers for cDNA, DNA amplification, and 
DNA sequencing were synthesized in an Applied Bio-
system DNA synthesizer. The primers for mutation de-
tection in cells of XP patients XPCSIBA and XPCS2BA 
were p68, 5'-CCCAAGACTfCTTGGTGG-3'; p69, 5'-
CCCAAGACTCCTTGGTGG-3', 
eDNA Constructs 
The wild-type ERCC3 cDNA expression plasmid 
(pSVH3) and the mutant containing the XPIIBE muta-
tion (pSVH31vf), lIsed for microinjectiol1 into XP-B fi-
broblasts, have been described elsewhere (\X1eeda et <11. 
1990). The ERCC3 gene harboring the mutation pres-
ent in the two brothers was constructed as follows: the 
5' part of PSYH3 was replaced b}' a 0.7-kh EcoRljSacI 
DNA fragment that was synthesized by means of PCR-
amplified ERCC3 cDNA derived from mRNA isolated 
from cells of patient XPCSIBA, yielding pSYH3M2. 
Results 
UV-induced UDS 
A detailed description of the clinical features of XP 
patients XPCSIBA and XPCS2BA (two brothers of 
unrelated parents) has heen presented elsewhere (Scott 
et .11., in press). The din;C<ll p.1ttcrn is most consistent 
with the "XP-CS complex" phenotype Seen in a vcr)' 
limited number of patients with NER deficienc}'. The 
features of these patients, together with those of four 
other XP-CS complex patients, are summarized in table 
1. The repair capacity of the fibroblasts from the two 
individuals (XPCS 1 BA and XI'CS2BA), compared with 
the level found in normal repair-competel1t fibrohlasts, 
is severely rcduced, in contrast to classical CS, which 
exhibit normal levels of UDS. This is consistent with 
the high sensitivit), of their fibroblasts to the cytotoxic 
effects of UV-C, as demonstrated by a colony-sun'ival 
assay (Scott et ilL, in press) and our own unpublished 
observations. The level of residual UDS is in the same 
range as is usually found in XP-A, -B, and -G (i.e., <10% 
of normal) <lnd is well below the 30%-50% residual 
UDS displayed by XPCS2 (XP-D). These findings make 
XP-B and -G likclr candidates in the relatively mildly 
affected individuals. 
Mfcroneedle Injection of ERCC3 cDNA 
Microneedle injection of the ERCC3 cDNA specifi-
cally corrects the NER defect in XP-B cells, but not in 
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Table I 
Features of XP-CS·Complex Patients 
Feature cs' XPCS1/1LVJ XPllBE' xrcSl/21~Af 
Cutaneou~: 
rhotoacrmatitis .. ............... + ++ ++ ++ ++ ++ 
Pigmentation abnormalities .... ++ ++ ++ + 
Skin cancer ... >1,000 times +(1 years) +(18 j'eafs) -(>40 yeaI5) 
Neurologic: 
Prim,lry defect ilemyelination DegenerJtion Demyelination Unknown Dem)'clination Demyelination 
Ganglia cakification ... + Unknown + + 
Psychomotor retMdalion ... + -I+~ + + + +/-• 
Hearing impairment ''', ..... + -I+~ + + + +j_h 
Reflexes ... Hyper Hypo Hyper Unknown Unknown Hyper 
Retinal pigmentation 
"." + + + + + 
Developmental: 
D)'smorphic d\\'Jrt1sm ... + -(+)S + + + 
Immature sexual development + -I+t + + + + 
MicrocephJI)' ...... + -(+f + + + 
Biochemical! cellular: 
UDS (% o( control) 100 1-50 30-50 <5 5-10 5-10 
UV sensitivity (in situ)1 , .... Modemte Severe/moderate Unknown Severe Se"ere 5elwe 
Non:.-SIJIUS of feJtures is as fullows: + '" presence of symptom; ++ = severe phenotype; and - = absence of feJture • 
• N.mee and Berry (1992). 
b Robbins et al. (1991). 
'XP-D (Vermeulen el at. 1991). 
J Xr-G (Veroleulen et al. 1993) . 
• XP-B (Robbins et ,11. 1974). 
f XP-B (present study). 
~ Absent in classic.11 XP; present in XI' with neuropathology. 
h i'resent, hut rdatively late onset. 
i Weight and height not .IS low as in CS, bot at the 3d percentile. 
I Colony SUITivJI after UV irradiJtion, (ompm'J with control ceHs. 
XP cells of other complementation groups (Weeda et 
al. 1990). To examine whether the ERCC3 eDNA was 
able to correct the repair defect in cells of patients 
XPCS1BA and XPCS2BA, the eDNA in a mammalian 
expression vector was introduced into the nuclei of 
homopolykaryons of both patients. The results, shown 
in figure 1 and quantified in table 2, demonstrate that 
injected XPCSI BA and XPCS2BA fibroblasts were able 
to achieve normal UDS levels. The nuclear labeling W;lS 
UV dependent, and no correction was obtained lIsing 
an inactiye ERCC3 gene containing the XPllBE muta-
tion. These data clearly demonstrate that the repair de-
fect is corrected by the ERCC3 gene and that both 
patients belong to XP-B. 
Complementation by Cell Hybridization 
The complementation assignment via the micro nee-
die injection was verified by using the classical cell hy-
bridization technique. When XPCS1BA cells were 
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fused to XP-A fibroblasts (fig. 2A and table 3), dear 
complementation was observed up to the normal level 
of UDS, found in NER-proficient cells. In contrast, no 
complementation occurred after fusion with either Xi'-
B cells (fig. 28 and table 3) or cells from the sih 
XPCS2BA. These data confirm the assignment of both 
patients to X[l-H, by microneedle injection. 
Determination of the ERCC3 Mutation 
Analysis by Southern and northern blot h)'bridiza-
tion made it clear that, in the cells of both patients, the 
ERCC3 gene is not detectably rearranged and is nor-
mally expressed; the RNA has the expected size of 2.8 
kb (data not shown). This suggests that the presence of 
a gross alteration in the gene is rather unlikely. Se-
quence analysis 011 PCR-amplified mRNA of patient 
XPCS1BA revealed <l single base substitution (T...".C 
transversion; see fig. 3) in the 5' part of the eDNA, 
resuiting, at the protein le\'el, in a phenylalanine (F)-to-
Figure I Effect of microinjection of EReC3 cDNA on UV-
induced UDS in XPCSIBA fibroblasts. Shown is a microgfJph of a 
XPCSI UA homopolykaryon (a/Tow) microinjectcd with wild.type 
ERee3 eDNA in one of the nuclei and subjected to the UDS proce-
dure. The injected eel! has a considerably brger number of grains 
abo"e its nuclei than do the noninje<:ted, surrounding mononuclear 
cells. In fact, the number of nuclear grains above the injected cell 
reaches thai of repair-proficient fibroblasts assayed in parallel. The 
ceH containing the heavily labeled nucleus W,lS in S-phase during lH_ 
TdR incubJtion. 
serine (S) amino acid substitution at position 99. No 
other changes were observed in the remainder of the 
ERCC3 eDNA. To determine whether this was the in-
herited mutation, the relevant part of the ERCC3 
cDNA of the two patients and their parents and of 
Table 2 
HeLa eDNA was amplified and subjected to dot blot 
analysis. The filters wcre hybridized with 32P~labeled 
wild-type-specific (p68) and mutant-specific (p69) oligo-
nucleotide probes, HeLa control DNA (fig, 4) hybrid-
ized only to the wild-type ERCC3 oligonucleotide 
probe, whereas the eDNA of both patients hybridized 
only with the mutant-specific probe. PeR-amplified 
eDNA from the father, howevcr, exhibited clear hybrid-
ization with both probes. This indicates that the father 
is heterozygous for the Ulutation. Sinee only the pater-
nal allele of ERCC3 can be detected, the maternal allele 
of the patient must contain another small mutation 
causing complete either absence or a greatly reduced 
level of ERCC3 transcript. 
A eDNA construct carrying the XPCS1BA mutation 
(PSVH3M2) was microinjected into XPCS2BA fibro-
blasts. As demonstrated in table 2, no significant in-
crease of UDS is observed with this mutant eDNA. 
These experiments indicate that the XPCS1BA muta-
tion completely inactivates the ERCC3 repair function, 
as was previously also shown for the XPllBE mutation 
(table 2). 
In Vivo Mutant Frequency at the hprC Locus 
The frequency of 6-thioguanine~resistant T-Iympho-
cytes in blood samples from the two patients was com-
pared with similar information from our database on 
normal control subjects and other excision-defective 
patients, over the relevant age range. We have pub-
ERCC3 eDNA MlcrolnJectlons Into XPCS I BA and 2BA Fibroblasts 
CELL STRAIN eDNA iNJECITD 
XPCSIBA 
XrCSlBA 
XPCS2BA 
XPCSIBA ..... . 
XPCSlBA 
XPCS1BA , .. 
XPCS2BA ..... . 
ORO ........ .. 
• fRCC3 cDNA (wild-type). 
b Uninjected pol,.kac),on. 
pSV3H' 
• 
pSV3H' 
• 
pSV3H' 
pSV3HM< 
pSV3HM2d 
<: fRee3 eDNA containing the XPllBE mutation, 
J ERCe3 cDNA containing the XPCSlBA mutation. 
UV IRRADIATION 
(lSJ/ml) 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
UDS 
(mean ± SEM) 
Grains per Nucleus % of Control Value 
120± 8 
10 ± 2 
138 ± 10 
12 ± 2 
2 ± I 
13 ± 2 
1O± 2 
ISO± 11 
SO ± 6 
6 ± 1 
93± 7 
7 ± 1 
1± 1 
7± 1 
6± 1 
100±S 
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A 
B 
Figure 2 Cell h)'oridiwion of XPCSIBA with XP-A and Xl'-
A fibrobbsts. A, 1'.lonok.uyons (expressing no detectable ODS): 
XP15RO,containingsnul! (0.8 11m) latex beads, and XPCSIBA, con-
taining !JIgI' (l.O 11m) latex beads. The hCIerodikaryon (arrow) gener-
ated by Sembi viruS-St!n1UIJted fusion ofXP15RO{A)and XPCSIIIA 
fibroblasts, identificll by the presence of 1\\'0 types of beads, re.Khes 
a UDS !cl'el of NER-compctent fibrob!Jsrs, which ,Ire visualized as 
JutofJdiographic gr,lins above the nuclei of the h)'brid cell. H, Fusion 
between XPllBE (O.S-l1m be'lds) and XPCSlllA (1.0-l1m beads). No 
increase in UV-induced UDS is observed above the nuclei of the 
heterodibryon (IIrrOIl'), compared with the monokaryons. 
Iished (Cole ct al. 1992) additional results on older XP 
patients, consisting of three XP variants and an unusual 
XP-C excision-defective patient 65 years of age, 
As shown in figure 5, the excision-defective XI> pa-
tients as a group have an elevated mutant frequency 
compared with normal, nonsmoking subjects, Statisti-
cal analysis of these data has confirmed the conclusion 
of Cole et aL (1992) that the increase in hprt mutants in 
XPs is highly significant. However, the mutant frequen-
cies of both XPCS1BA and XPCS2BA arc at the top of 
the range for normal donors. When there is matching 
for age, a formal statistical analysis that tests for the 
inclusion/exclusiort of the two patients' nlllhUlt fre-
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Table 3 
Complementation Analysis by Somatic Cell Hybridization 
FUSED CELLS 
(complement group) 
AND TYPE OF DIKARYON 
XP15RO (A) X XPCSlBA: 
XPCSlBA, .............. 
XP15RO ......... ,',., •.••.. 
Heterodibryon ............. 
XPIIBE (B) X XPCSIBA: 
XPCSIIIA ... 
XPllBE ",,, .. " 
Heterodibryon .. 
XPCS1BA X XPCS1BA: 
XPCSIRA .................. 
XPCSlBA .. ................ 
Heterodikaryon 
C5RO (comrol) ............. 
ODS' 
(mean ± SEM) 
Grain per % of Control 
Nucleus Value 
3 ± 1 7±1 
I ±l 1 ± 1 
37 ± 1 90±5 
3 ± 1 7 ± 1 
J ± 1 7±1 
3 ±'I 7±! 
J±l 7± ! 
3 ±! 7±1 
3 ± 1 7±1 
41 ±3 100 ± 7 
guency in the normal or XI' populations shows that 
they are not significantly different from normal donors, 
nor can they be discriminated from the population of 
Xps (we are indebted to Dr. M. H. L. Green of the 
MRC Cell Mutation Unit for undertaking this analysis). 
A 
wt 
GATC 
B 
mutant 
GATC 
/~ 
T 
T 
\j~ c· 
Figure 3 Nucleotide sequence analysis of the XPCSIBA mu-
tation. Nucleotide sequence of a part of the fRee3 eDNA of 3 
wild-typeJllefe (WI), from Hela (A) and from patient XPCSIBA (mu-
tant) (B). 
DNA 
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Figure 4 Dot blot analrsis of thl' fRee] in the XPCSBA 
familr, Amplified DNA from HeLl, XPCSIBA (PI), XPCS2BA (1'2), 
XPCSH5BA (F Ifather]), and Xl'CSH4aA (M [mother)) (in lane C, no 
eDNA was added) was spotted onto a nylon filter and hyhridized 
with .llabeled wild-trpc (Cloned \1fT) probe .mu with a mutant oligo. 
nucleotide (Cloned Mutant) probe (see experimental procedures), As 
J control for the specificitr of h~'bridiz<lIjon of the mutant and wild-
type EReel'specific oligonucleotide, plasmid DNA fwm clones 
PSVH3 (Le., wild.trpe).lnd PSVH3M2 (Le., XPCSIBA and 2BA mu-
tant) was spotted in send) dilutions. 
Two other XP patients, XP125LO and XP7NE, also 
clearly fall within the normal range, We have shown 
elsewhere (Cole et al. 1988) that smoking can increase 
the frequency of mutants recovered from normal do-
nors. Among the population of XP patients discussed 
here, only one, XP12SLO from XP-G (who is indicated 
by a distinctive symbol in fig. S), had any history of 
smoking. We note that he only commenced this habit 
during the period in which we began ollr study of this 
mutant frequency. 
Discussion 
Cultured fihrohlasts of two brothers with relatively 
mild clinical symptoms of XP and CS and with a vir-
tually complete deficiency of NER were assigned to the 
extremely rare XP-B. The assignment was performed in 
two ways: by microinjection of the cloned ERCC3 re-
pair gene and by the classical somatic cell hyhridiz,.ltion 
technique. Microinjection of NER genes has seveml 
advantages compared with the cell-fusion method: (1) 
It is a direct assay that scores for a positi\'e result (i.e., 
induction of UDS). Assignment by cell fusion, on the 
other hand, is based on the absence of complementa-
tion (i.e., no correction of UDS). (2) 1 ... 1ultiple copies of 
the gene can be injected into a nucleus, circumventing 
problems due to low levels of expression, (3) Only a 
limited number of cells are required, which may be im-
portant when only poorly growing cells are a\'ailable. 
(4) Microinjection of a cloned NER gene excludes the 
possibility of intragenic complementation, which may 
complicate cell hybridization results. (S) Finally, mi-
croneedle injection permits assessment of NER genes 
for which no corresponding human complementation 
group has been identified thus far, This holds for genes 
for which only rodent mutants are known, sllch as the 
ERCCl gene (Van Ouin et al. 1989), and for which 
complementation analysis by cell hybridization is com-
plicated by the occurrence of poor interspecies cell fu-
sion and instability of the resulting hybrids (Thompson 
et a!. 1985). In addition, candidate repair genes for 
which no mammalian mutants are known can he tested 
using direct nuclear injection. This may he relevant for 
mammalian genes that have been isolated on the basis 
of sequence homology with cloned DNA repair genes 
of lower species, e,g., Saccharomyces cerevisiae or S. 
pombe (Koken et aL 1991). These considerations make 
the microinjection technique a useful additional 
method for complementation analysis, particularl), in 
view of the fact that the number of cloned mammalian 
NER genes is rapidly increasing, At present, at least 
seven NER genes have been isolated: ERCCl (Wester-
veld et al. 1984); five genes involved in XP-nameIy, 
XPAG (Tanaka et al. 1989), ERGGJ (XPBC) (Weeda er 
al. 1990), XPCC (Legerski and Peterson 1992), ERCC2 
(XPDC) (Weber cited in Lehmann et al. 1992; Fleiteret 
al. 1992), and ERCCS (XPGC) (O'Donovan and Wood 
1993; Scherly et al. 1993)-and, finally, one gene, 
ERCC6 (CSBC), mut.ued in CS complementation 
group B (Troelstra et 011. 1992). 
The results presented here deline the callsatiYe muta-
tion in the ERCC3 gene, responsible for the phenotype 
.. 1000 
~ ~ 0 ~ 
100 D 
" ~D G~ 0 0 b r ,., u c 0 ~ 10 , o~ f &, ~~~OOo~ <T ~ 
~ o F (XP7NE) XP/CS c G (XP125LO) 
t! , 
:; 
,1 
0 10 20 30 40 
Age (years) 
Figure 5 IJprt mutant frequenq' in dn-ubting T-l}'ll1phocytcs 
in normal, nonsmoking subjects ;lOU in XP patients, frequency of 
IJprt mutants is set Jgainst the Jge of the donoTS, who are normal, 
nonsmoking donors (0), .m XP nommoker (0), ,m XP smoker (b), 
and XPCSIBA anu XrCS2Bt\ (,6,), 
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Mutation 
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Figure 6 Amino acid sequence (onserv.lIioll of the mutated 
region in ERee3. XPCSIBA and 21lA mutations in a conserved re-
gion of the ERCCJ protein are shown. There is homology between 
the amino acid sequences of ERCC3, around position 99 of human, 
mOllse, Drosophila, and SlIcd"IrOIll),CCS cut'llisiae. Homologolls re,j-
dues are boxed with a dashed linc, and the conserved phcnrlJlanine is 
boxed with a solid tine. The amino acid substitution into a serine is 
indicated h}' an arrow, 
of the XPCSI BA and XPCS2BA patients, A single-base-
pair suhstitl1tiol1 resulting in an amino acid change of it 
phenylalanine to a serine at position 99 is found in the 
only allele that is detectably expressed in thcsc patients, 
This phenylalanine resides in a region to which, as yet, 
no specific functional domain has been assigncd, How-
evcr, as shown in figure 6, this residue has not changed 
in the long evolutionary distance that separatcs yeast 
from man, and it is part of a protein segment that is very 
strongl}' conserved during eukaryotic cvolution, This 
indicates that this portion of the protcin has an impor-
tant function that may not tolerate much change, 
A comparison of the original XP-B casc (XPII BE) 
with thc two patients described here reveals a rcmark-
able clinical heterogeneity, DNA repair studies with fi-
broblasts indicate the same low levd «10% of thc nor-
mal level) of UDS, the absence of cyclobutane 
pyrimidinc dimer removal, and a low UV-C sun'ival in 
colony-forming assays, in all three patients (Scott et al., 
in press), However, dcspite a common severe deficiency 
in NER as measured in fibroblasts, the two newly iden-
tified XP-B cases are much less sc\'erely affected (Scott 
ct ai" in press) than is the original patient (Robbins et al. 
1974), The original XP-B patient presented numerous 
cutaneous malignancies before sbe was 18 },cars old, 
while the two new patients were free of skin cancer 
after the}' were 40 years old, despite the fact that appar-
ently tbey took few precautions to protect themselvcs 
from sunlight (SCott ct aI., in press), 
The absence of skin cancers in these patients suggests 
that processes in addition to defects in NER may con-
tributc to carcinogenesis, NER is considercd to be 
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error frce in human cells (Bridges and Brown 1992), and 
thus any incrcasc in skin cancer may reflect the effi-
ciency of, or thc overloading of, error-prone repair pro-
cesses such as daughter-strand repair. Differences in 
immul10slIrveillance are also belicved to be involved in 
the process of tumorigenesis. Howcver, although there 
have been a number of reports of immune dysfunction 
in XP patients (Cole et al. 1992), including deficiencies 
of natlll',\1 killer-cell activit), in various XP, CS, and 
TTD patients (Lehmann and Bridges 1990; Mariani et 
al. 1992), 110 consistent pattern providing an adequate 
cxplanation for the discrepancies in tumor predisposi-
tion has emerged from these studics, 
Since there is ample evidence indicating that muta-
tion is an important early initiation stcp in carcinogene-
sis, it was of interest to see whether the new XI' patients 
have a significantly increased frequency of hprt muta-
tions in circulating T-Iymphocytes. We havc previously 
shown that XP patients with residual repair synthcsis 
measured in fibroblasts tholt ranges from 15% to ap-
proximately that in wild-type cells have, as a group, a 
highly significantly incrcascd frequency of this muta-
tion in T-cells (Cole et 011. 1992), Since thcrc is no cvi-
dence that cells from XI' donors howe an elevated spon-
tancous mutant frequcnC)', whereas they arc clcarly 
hypermutable by UV, it was postulated that thc raised 
in vivo frequency is also induced, possibly by exposure 
of the lymphocytes to sunlight as they pass through the 
skin (see Cole et al. 1992, and references thcrcin). Fig-
ure 5 shows that the hprt mutant frequency in thc two 
new XI' /CS cases is clearly not greatly elevatcd com-
pared with that in normal subjects, despite both the 
almost total deficienC)' in NER and the clear hypcrsensi-
tivity of their Iymphocytcs to the lethal effects of both 
UV-C and UV-B (I. Cole and C. F, Arlett, unpublished 
data), All XP patients whom wc had studied previously 
had, with two exceptions (Xp125LO [Xp-G] and 
XP7NE [XP-F]) been shown to have an elevated in vivo 
hprt mutant frequen'}' in T-cclls (Cole et al. 1992). 
XP7NE has no cellular hypersensitivity to the lethal 
cffects of UV-C, in either T-cells or fibroblasts (Arlen 
ct al. 1992), In addition, we have recently shown that in 
T-IYll1phocytcs there is no hypersensitivity to UV-B, for 
either XP7NE or XP125LO (I, Cole and C. F, Arlett, 
unpublished data), These individuals are free of skin 
cancer. It is plausible that their normal mutant fre-
quency reAects the abscnce of target-cell hypersensitiv-
ity to wavelength of UV irradiation relevant to the in 
vivo situation, However, T-l)'mphoc)'tes from thc XI' / 
CS patients described here are hypcrsensitive to both 
UV-C and UV-B (data not shown); thus their normal 
mutant frequency and lack of skin cancer set them 
apart from the other XP patients with elevated mutant 
frequencies. Possible explanations for the absence of 
skin cancer in the two new XP jCS patients include (1) 
an increased efficiency of alternative repair pathways 
(sllch as recombination repair), which may compensate 
fOf the reduced NERj (2) modified immune sUfveil-
lance; or (3) the nature of the mutation in the ERCC3 
gene. It is worth noting that the ERCC3 gene has addi-
tional functions in the cell, beyond its role in excision 
repair. The work of Gulyas and Donahue (1992), 
Mounkes et a\. (1992), and Park et al. (1992) indicates 
an additional essential function of the ERCC3 gene in 
yeast and Drosophila. Schaeffer et al. (1993) identified 
the ERCC3 gene product as one of the components of 
the human transcription factor BTF2/TFIIH required 
for a late step in the initiation of transcription of class II 
genes. These findings shed new light onto the clinical 
features of XP and XP ICS, which were difficult to rec-
oncile solely on the basis of deficient NER (Bootsma 
and Hocijmakcrs 1993). Partial dysfunction of ERCC3 
may have a subtle effect on gene expression, resulting in 
retarded growth, immature sexual development, and 
demyelination of neurons. A part of the symptomatol-
ogy of these patients and, probably, of CS in general 
might be due to a control function, of the involved 
genes, in transcription. The dual involvement of 
ERCC3 could also provide an explanation for the rarity 
and pronounced clinical heterogeneity of XP-B, per-
haps including the predisposition to cancer. 
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Summary 
The sun-sensitive, cancer-prone genetic disorder xeroderma pigmentosum (XP) is associated in most cases with a 
defect in the ability to carry out excision repair of UV damage. Seven genetically distinct complementation 
groups (i,e" A-G) have been identified. A large proportion of patients with the unrelated disorder 
trichothiodystrophy (TID), which is characterized by hair-shaft abnormalities, as well as by physical and mental 
retardation, are also deficient in excision repair of UV damage. In most of these cases the repair deficiency is 
in the same complementation group as is XV group D. We report here on cells from a patient, TIDIBR, in 
which the repair defect complements all known XP groups (including XP-D). Furthermore, microinjection of 
various cloned human repair genes fails to correct the repair defect in this cell strain. The defect in TTDIDR 
cells is therefore in a new gene involved in excision repair in human cells. The finding of a second DNA repair 
gene that is associated with the clinical features of TID argues strongly for an involvement of repair proteins 
in hair-shaft development. 
Introduction 
Nucleotide excision repair of UV-induced damage in 
DNA is a complex process involving 6 genes in Esche-
richia coli, to or more genes in Saccharomyces cerevi-
siae, and at least 11 genes in mammals (Hoeijmakers 
and Baotsma 1990; Lehmann et ,,\. 1992; Riboni et al. 
1992). In mammals the different genes are defined by 
two sets of complementation groups~namely, (a) the 
UV-sensitive rodent mutants (11 groups) and (b) pa-
tients with XP (7 groups) and Cockayne syndrome (CS) 
(2 groups), The recent cloning of some of these human 
DNA repair genes has demonstrated significant overlap 
in the two sets of complementation groups. The 
ERCC3 gene, cloned by its ability to correct the UV 
sensitivity of certain rodent mutants, has been shown 
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to correct the defect in a patient with clinical symptoms 
of both XP and CS from XP complementation group B 
(Weeda et al. 1990). Similarly, the ERCC2 gene corrects 
the UV sensitivities of several XP-O cell strains (Fleiter 
et al. 1992; C. A. Weber, cited in Lehmann et aJ. 1992, 
pp. 6-7), and ERCC6 has recently been shown to 
correct the deficiency in CS patients from CS comple-
mentation group B (Troelstra et a!. 1992). 
Trichothiodystrophy (TTO) is a rare genetic disorder 
whose clinical symptoms are quite different from those 
of XP and CS. Sulfur-deficient brittle hair is associated 
with mental and ph}'sical retardation, ichthyosis, an un-
usual facies, and, in many but not all patients, sun sensi-
tivity. Unlike in XP, there are no reports of skin cancer 
associated with this disorder. Nevertheless, cells from 
photosensitive patients with TID are, like XP cells, 
deficient in excision repair of UV damage. The extent 
of this deficiency is very heterogeneous between cells 
from different patients (Stefanini et al. 1986, t 992; 
Lehmann et al. 1988; Broughton et al. 1990). Cell fu-
sion experiments have shown that, in all but three TTD 
cell strains examined so far, the repair deficiency is in 
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the same complementation group as is the defect in XP 
group D (Stefanini et al. 1986, 1992, 1993; Lehmann et 
al. 1988). In the three exceptional cases (two from re-
lated patients), complementation was observed with 
XP-D cells. In the present paper we show that aile of 
these, TIDlBR, from a 16-year-old boy with a severe 
deficiency in excision repair, was able to complement 
the excision-repair defect in all XP complementation 
groups, and we show that complementation was not 
intragenic. This cell strain is therefore a representative 
of a new excision-repair complementation group. 
Clinical Description 
The patient (described 11 years ago in Jorizzo et a!. 
1982) had typical symptoms of TID (characteristic 
hair-shaft abnormalities with reduced sulfur content, 
collodion baby, short stature, ichthyosis, bilateral con-
genital cataracts, and asthmatic attacks). Material for 
the current study was taken in 1988. A recent examina-
tion at age 20 years showed that he had had recurrent 
infective exacerbations of his asthma and that he re-
mains severely growth retarded (height and weight be-
low the 3d centile) and of limited intelligence but not 
severely mentally retarded (IQ 70-80). His ichthyosi-
form erythroderma continues. He has developed lim-
ited joint contmctures of the hands that are due to the 
severe ichthyosiform involvement of the palms, and he 
has limited mobility. Despite all his problems, he retains 
a friendly personality with pleasingly good humor. 
He has been sensitive to sunlight since early child-
hood, but, apart from sun sensitivity, his clinical fea-
tures arc quite distinct from those associated with XP 
patients. There is no significant freckling or other pig-
mentary changes. There are no telangiectases or actinic 
keratoses, nor ha\'e there been an)' skin tumors. There 
is no conjunctivitis or keratitis in the eyes, nor is there 
any sign of mental deterioration. 
His immune function has been reported by Norris et 
aJ. (1990), who found that his CD3+ cells were at the 
lower end of the normal range, with a CD4+ jCD8+ 
ratio in the normal range. His lymphocytes showed a 
reduced response to phytohemogglutinin. Natural 
killer cell activity was in the normal range. 
Methods 
The procedures llsed in these studies have all been 
described in earlier work. Complementation studies 
were carried out as described elsewhere (Vermeulen et 
a!. 1991; Stefanini et al. 1992). Microinjection experi-
ments using cloned DNA repair genes were as de-
scribed by Van Duin et a!. (1989). An ERCC2 cDNA 
product was synthesized by using reverse tmnscriptase 
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Table I 
Response ofTTDIBR Fibroblasts to UV Irradiation 
Normal TIDiBR TID2GL 
Cell survival (DwJm-2) 6.6 1.6 l.l 
ODS (<1,{) of normal 
at 10 Jm-2) ............... 100 15 8 
RNA s},nthesis (% of 
nomlll at 15 Jm-2) .....• 100 12 9 
CyclobUlalle dimer excision 
(% remoyed in 24 h) , ••• 55 2 15 
6-4 Photoproduct exci,ion 
(% removed in 3 h) ..... 75 l' 18 
NOTE.-fhta from Hroughton et 31. (1990), 
(RT)-PCR and then was used to screen a human eDNA 
library. A full-length ERCC2 eDNA clone was identi-
fied, and the ERCC2 eDNA subsequently was inserted 
into the mammalian expression vector pSLM (Koken et 
al. 1992) for use in the microinjection experiments. 
Results 
UV Response of Fibroblasts 
Table 1 summarizes our previously published results 
on the response to UV irradiation of TTDIBR cells, 
which are compared with a normal cell strain and with 
TTD2GL, a TTD cell strain with a severe DNA repair 
defect in the XP-D complementation group (see Leh-
mann et a!. 1988, in which this cell strain was desig-
nated "P2"). Both cell strains have very pronounced 
defects in excision repair. The defect in TTD2GL is 
slightly more severe, TTD2GL being one of the most 
sensitive cell strains of the many TTD strains that we 
have examined (Stefanini et al. 1986, 1992, 1993). (The 
measurement of cyclobutane dimer excision is subject 
to large experimental errors, and the difference be-
tween TTD1BR and TID2GL in table 1 is not signifi-
cant.) 
Complementation 
The severe deficiency in unscheduled DNA synthesis 
(UDS) following UV irradiation of TTD1BR (table 1) 
enabled us to carry Ollt complementation studies by 
fusing these cells with other TID cell strains and with 
XP cells from complementation group D, followed by 
measurement of UDS in binucleate heterokaryons. Re-
sults of these experiments are shown in figure 1 
(TTDSPV, XPI7PV, and XP3NE). The level of UDS in 
the nuclei of heterokaryons was, in all cases, consider~ 
fusIon partner 
II partMr 
EX) TTD1BR 
o hetero~ilryons 
Figure I Cumplementation of TTDlBR. TTDIBR cells were (used with the indicated cdl strJins, following labeling of each fusion 
partner with different-sizcd latex be,lds. TI1C fused cells were UV irradiatt'd (10-20 Jm-1) and UDS me,lsured hy autoradiography following 
lH·thpllidine incorporation. The horizont.lllines show the grJins per nucleus in nomul cells in the same experiment. 
ably higher than that in homokaryons of either fusion 
partner in the same culture, and it approached that in 
normal controls. Thus TTDIBR cells clearly comple-
ment the repair defects in TID8PV, XP3NE, and 
XPI7PV, which have all previously been shown, by 
complementation analysis, to fall into the XP-D com-
plementation group. This confirms our preliminary re-
sult reported elsewhere (Stefanini et ai., 1993), 
These observations suggest that the defect in 
'n'DIBR is not in the XP-D gene, but they do not 
exclude the possibility of intragenic complementation. 
In order to evaluate this possibility, microneedle injec-
tion experiments were performed with the XP-D gene. 
It has recently been shown that the previously cloned 
ERCC2 gene (Weber et al. 1990) is in fact the XP-D 
gene (Flejter et al. 1992; C. A. Weber, cited in Lehmann 
et al. 1992, pp. 6-7). As anticipated, microiniection of 
ERCC2 eDNA, cloned into a mammalian expression 
vector, into various XP and TID representatives of 
group D restored UV-induced UDS to normal levels 
(fig. 2A). In contrast, no increase in LJDS was found in 
injected TfDIBR cells (fig. 2B), nlling Ollt the possibil-
ity of intragenic complementation. This finding was fur-
ther substantiated by direct sequencing of ERCC2 
eDNA after amplification by PCR. No sequence alter-
ations were found in TTDIBR, whereas in other TID 
patients various mutations were found in the ERCC2 
gene (A. R. Lehmann and B. C. Broughton, unpublished 
observations), 
We next fused TTDIBR cells with XP cells from the 
other six XP complementation groups (i,e., A-C and 
E-G). Complementation was observed in all cases (fig. 
1), To examine intragenic complementation for other 
XP and CS groups and to assess whether TTDtBR 
might he the human equivalent of some excision-defi-
cient rodent complementation groups, three cloned 
human excision-repair genes that we have available-
ERCCI, ERCC3 (XPBC), and ERCC6 (CSBC)-were 
microinjected into TTDIBR cells. In no case was UDS 
restored. These results show that TIDIBR is a repre-
sentative of a new excision-repair complementation 
group. 
Discussion 
We have shown that the severe defect in excision 
repair of UV damage in TIDt BR cells is complemented 
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A 
I: . ': 
" :~~/tr·g~ .. ' 
' ... 
Figure 2 MiCfoiojection of ERCC2 into TfDIBR (eUs. The 
ERCCl (DNA inserted into a mammalian e.\pression vector was in-
troduced into homopolykaryons of XPIBR (a representative aU linc 
of XV-OJ (A) and TIDlBR (B) by microncedle injection into one of 
the nuclei. To permit clI:pression of the inje.:tcd DNA, cells were 
incubated for 24 h after inje(tion, Subsequently, the fibroblasts were 
UV irwliated (15 J/ml), incuh.lted in the presence of lH-thymidine 
for 2 h to label repair patches, and were fixed and processed for 
autoradiogcaphy, The nuclei of the injected XPlBR polykaryon (the 
binuclear cell) (A) shOl>;' a complete correaion of UDS (apparent 
from the high number of autoradiographic grains above both nudei), 
in contraSI to the neighboring, nOllilljecteJ monobr),ons. No induc-
tion of UDS is yisib!e in the injected po!yk.u)·on of TID! BR (D). 
by all known XP complementation groups and is not 
corrected by several doned human DNA repair genes. 
TTD1BR is therefore a representative of a new exci-
sion-repair complementation group not yet found in 
the population of XP patients, in contrast to previously 
reported TTD cell strains deficient in excision repair, 
which fall into the XP-D complementation group (Ste-
fanini etal.1986, 1992; Lehmann et a\. 1988). n'D1BR 
therefore represents the second group in which defec-
tive DNA repair is associated with hair-shaft abnormali-
ties, ichthyosis, and the other features of TTD (while 
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showing none of the features of XP). This argues 
strongly for a causal relationship, rather than the 
chance association of independent genes involved in 
DNA repair and hair-shaft development. The involve-
ment of DNA repair genes in apparently unrelated pro-
cesses is not unprecedented. Three recent papers have 
shown that the EReC3 excision-repair gene is also in-
volved in transcription/translation. Gulyas and Dona-
hue (1992) identified yeast-suppressor mutants that 
could overcome a block to translation of the his4-316 
mRNA, caused by a strong, artificial stem-loop struc-
ture in the 5' untranslated region. One of these suppres-
sor genes, designated "SSL2," turned out to be the 
yeast homologue of the human ERee3 repair gene. 
Intriguing observations have also been made with the 
Drosophila homologue of this gene (Mounkes et a!. 
1992). A mutant designated "haywire" was character-
ized by male sterility, UV sensitivity, and defects in the 
central nervous system, and it displayed abnormalities 
in microtubule-based processes of spermatogenesis. 
These properties appeared to result from a mutation in 
the Drosophila homologue of ERCC3. Both the yeast 
and Drosophila ERCC3 counterparts (and probably 
also the human gene) were shown to have an undefined 
function essential for cell viability, a function distinct 
from their role in excision repair. These observations 
suggest that the ERee3 gene product has two different 
functions (one involved with excision repair and the 
other involved with control of transcription/transla-
tion), which are not obviously related. This has been 
confirmed very recently by Schaeffer et al. (1993), who 
demonstrated that the 89-kD subunit of the transcrip-
tion factor TFIIH (BTF2) corresponds to the EReC3 
gene product. It is thus plausible to suggest that both 
the ERCC2 gene product (which has several features in 
common with the ERCC3 protein) and the new gene 
defective in rr01BR cells may also be im'oived in two 
apparently unrelated processes-namely, excision re-
pair and another process involved in hair-shaft develop-
ment. The clinical phenotype of the patients (e.g., XP or 
ITO) may depend on the way in which the causative 
Illutation affects one or the other or both of the hy-
pothesized functions. Further experiments should pro-
vide evidence supporting or disproving these specula-
tive ideas on the relationship of excision-repair defects 
to hair-shaft abnormalities. 
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Communicated by D.BooLSma 
ERCC3 was Initially Identified ns a gene correcting the 
Ilucleotlde excision repair (l\'ER) derecl of xeroderma 
pigmentosum complementation group B (XP-B). The 
recent finding that its gene product Is Identical to the 
pS9 subunit of basal transcription factor BTF2{TFIIH), 
opened the possibility that it Is not directly hl\'oh'ed In 
l'.'ER but that it regulates the transcription of one 
or more l\'ER genes. Using an ;/1 ~';I'O mlcrolnjectlon 
repair assay and an ;11 ~';Iro NER system based on 
cell-free extracts we demonstrate that ERCC3 In nTF2 is 
directly implicated in excl~lon repair. Antibody depletion 
experiments support Ute Idea that the p62 BTFl subunit 
and perhaps the entire transcription factor function in 
l'.'ER. i\licroinJedlon experiments suggest Ihat exogenous 
ERCC3 can exchange nilh ERCC3 subunits in the 
complex. Expression of a dominant negatlw K436 ---> R 
ERCC3 mutant, expected to ha\'e lost all helicase 
acthity, completely abrogates NER and tratl~cription and 
concomitantly Induces a dramatic chromatin collapse. 
These fUldlngs establt~h the role ofERCC3 and probably 
the entire BTF2 complex in transcrlpllon ;11 v;ro which 
was hltherlo only demonstrated ill .';Iro. The results 
strongly suggest that transcripHon Itself is a critical 
component for maintenance of chromatin structure. The 
remarkable dual role of ERCCJ In l'.'ER and transcription 
provides a clue in understanding the complex clinical 
features of some Inherited repair syndromes 
Key words: BTF2/chromatin structure/ERCC3/nuc1eotide 
excision repair/repair syndromes 
Introduction 
An intricate network of DNA repair systems protects the 
genetic information from continuous deterioration due to the 
damaging effects of environmental genotoxic agents and 
inherent chemical instability of DNA. Thus these systems 
prevent mutagenesis leading to inborn defects, cell death 
and neoplasia, and may counteract the process of ageing. 
© Ox/old Univelslty Press 
Nucleotide excision repair (NER) is one of the major, cellular 
repair pathways. It removes a wide range of structurally 
unrelated lesions (such as UV-induced pyrimidine dimers 
and chemical adducts) in a complex multi-step reaction. The 
mechanistic details of this process in eukaryotes are-in 
contrast to Escherichia coli-poorly understood, but a 
general picture is emerging. After recognition of the DNA 
injury by a process not yet resolved, the damaged strand 
is incised on either side of the lesion, 27 - 29 nucleotides 
apart (Huang el al., 1992). Excision of the patch, which 
appears to require one or more single strand binding proteins, 
such as HSSB (RP-A) (Coverley el al., 1992) is followed 
by gap-filling, mediated by DNA polymerase 0 andlor (' in 
a reaction dependent on PCNA (Nichols and Sancar, 1992: 
Shivji et al., 1992). Finally, ligation is required to seal the 
newly synthesized repair patch to the pre-existing DNA (for 
recent reviews see Grossman and Thiagalingam, 1993; 
Hoeijmakers, 1993a,b; Sancar and Tang, 1993). In fact, in 
most, if not all, organisms at least two NER sub-pathways 
exist. Special factors allow for the rapid and efficient 
removal of lesions in the transcribed strand that interfere 
with ongoing transcription (transcription-coupled repair). 
The other SUb-pathway deals with the slower repair of 
the rest of the genome (genome overall repair; Hanawalt 
and Mellon, 1993). 
The dramatic consequences of impaired NER are illustrated 
by three distinct, inherited diseases characterized by 
sun (UV) hypersensitivity, elevated genetic instability 
and a striking clinical and genetic heterogeneity. These 
are the prototype repair disorder xeroderma pigmentosum 
(seven complementation groups: XP-A -XP-G), Cockayne's 
syndrome (two groups: CS-A and CS-B) and PIEIDS (al 
least two groups, one of which is equivalent to XP-D) 
(Stefanini el af., 1986, 1993: for a review see Hoeijmakers, 
1993b). XP is marked by severe cutaneous abnonnaIities, 
including a strong predis!X)sition to skin cancer, and frequently 
progressive neurological degeneration (reviewed in Cleaver 
and Kraemer, 1989). CS exhibits poor general development 
and neurodysmyelination. No increased frequency of skin 
cancer is noted in this disorder (Lehmann, 1987; Nance and 
Berry, 1992). The repair defect in CS is limited to the 
sub-pathway of transcription-coupled repair (Venema ef al., 
1990). Patients with PlBIDS manifest mosl of the CS 
symptoms and, curiously, the hallmark of another disease 
called trichothiodystrophy: ichthyosis and brittle hair and 
nails (the latter may be due to a reduced synthesis of a 
cysteine-rich matrix protein) (peserico ef al., 1992; Bootsma 
and Hoeijmakers, 1993). In exceptional cases individuals 
display a combination of XP and CS. These have been 
assigncd to XP complementation groups B, D and G 
(Vermeulen el al., 1991, 1993, 1994). 
Recently, the gene responsible for one of these, the XP-B 
gene: ERCC3 (Weeda ef al., 1990), was unexpectedly found 
to be identical to the p89 subunit of basal transcription faclOr 
BTF2 (TFIIH) (Schaeffer ef al., 1993). Human TFIIH, its 
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rat counterpart factor 0 and its yeast equivalent factor bare 
one of the seven or so components required for proper 
transcription initiation of RNA polymerase IT in vitro from 
a number of model promoters (Conaway and Conaway, 
1989; Feaver et al., 1991; Gerard et al., 1991; Flores et al., 
1992). The fonnation of an elongation-competent initiation 
complex involves a highly ordered cascade of reactions 
(reviewed in Sawadogo and Sentenac, 1990; Roeder, 1991; 
Gill and Tijan, 1992; Drapkin et af., 1993), initiated by the 
binding of factor TFIID to the TAT A box and completed 
by binding of TFIIJ. The multi-subunit BTF2 consists of a 
minimum of five proteins: pS9, p62, p43, p41 and p35. The 
role of this factor is at least 2-fold. First, the human 
BTF2/TFIIH as well as the rat {) factor are associated with 
a protein kinase activity that specifically phosphorylates the 
C-terminai domain of the large subunit of RNA polymerase 
II (Lu et af., 1992; Serizawa et af., 1993b). Second, it 
exhibits a DNA helicase activity (Schaeffer et af., 1993) that 
is functionally required for ATP-driven local denaturation 
of the transcriptional slart site. The formation of an open 
configuration precedes the catalysis of the first phosphodiester 
bond of the transcript. Experimental evidence renders it 
likely that the ERCC3 gene product participates in the 
essential unwinding reaction (Schaeffer el 01., 1993). This 
is consistent with the identification of seven so-called 
'helicase motifs' in the ERCC3 amino acid sequence (\Veeda 
el al., 1990). 
The discovery of the ERCC3 -transcription connection 
provided an adequate explanation for several of the mysterious 
observations with respect to this gene, such as its unsolved 
essential function in yeast (Gulyas and Donahue, 1992; Park 
el at., 1992) and Drosophifa (Mounkes et at., 1992) and a 
poorly defined involvement in expression of certain genes. 
In addition to a direct participation of ERCC3 in both 
transcription and repair, this finding opened a second 
possibility to explain the ERCC3- NER connection. When 
the expression of one or more essential NER genes critically 
depends on the functioning of ERCC3, mutations in this 
gene might indirectly result in a NER defect (Gulyas and 
Donahue, 1992; Schaeffer et al., 1993). The aim of this 
study was to further define the role of ERCC3 in transcription 
and repair in vivo and in vitro. The work presented here 
has implications for understanding the complex clinical 
picture of XP-B and other forms of NER syndromes and 
provides evidence for the involvement of an additional BIF2 
component in NER. 
Results 
NER function of BTF2 me8sured by mfcrofnjection 
The presence of XP-B specific NER correcting activity 
in protein fractions obtained during the purification of 
transcription factor BTF2 was assessed by microinjection 
into living XP-B fibroblasts in culture. The effect of the 
injected proteins on the repair capacity of the cells is 
measured by UV-induced WlScheduied DNA synthesis (lIDS), 
visualized by in situ autoradiography and quantified by 
counting silver grains above nuclei (De Jonge el al., 1983). 
Figure lA shows the purification scheme of BTF2 (Gerard 
el (If., 1991) together with the results of the microinjection 
in XP-B and as a control in XP-G. It is apparent that 
BTF2-containing fractions induce correction in XP-B. The 
multinuclear XP-B cell shov.'fl in Figure IB has been injected 
with purified BTF2/TFIIH (hydroxyapatite fraction; Gerard 
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A PUrification scheme of BTF2(TFIIH) 
BTf2 pUlification step Correction of NER-defect 
HeLe WeE (Manley) 
Heparin ultroget (0.22-0.4M KCI) 
OEAE-sphelodex (O.Q7.{1, 17M KCI) 
In XP-8 xP-O 
+ 
NT 
NT 
+ 
NT 
NT 
SulphoplOpyl-SPW (O,38M KCI. peak) + 
Phenyl-SPW 
Hydroxyapatite 
glycerol gradient 
B 
(0 2M (NH4)2S04. peak) 
(0.37 M K·Pi, peak) 
+ 
+ 
+ 
Fig. I. Assessment of XP-B corrocling actMty by BTF2 using 
mkron~dle inJoction. (A) Copurilkation of XP-B repair corroction 
and transcription stimulation of BTFl. Peak fra<:tions of transcription 
stimulalol)' activity of each BIFl purification step (for details on the 
BIFl purifi,ation see Gerard it 01., 1991) were injected into the 
C}topJasm of XP·B or XP-O homopoli'k~'O!l!, followed by UV 
irradiation, incubation in the pr~sence of { HJTdR, fLulion and 
processing for autoradiography (see Materials and methods for details). 
The number of silver grains abol'e nudei is a reflection of the repair 
capacity of the cell, Fractions were scoroo positive when the injocted 
cells showed a lewl of UDS that was more than five times above the 
background of non-injected nelghbouring fibroblasts. WCE: whole cell 
extract. The samples of the first two pl.lritkation steps were vel)' 
diluted compared ""ith the WCE, (B) Micrograph of XP-B fibroblasts 
(XPCSIBA), mkroinjecled. with the highly pl.lrifled fraction 12 of the 
HAP chromatography column (see Figure 2), sho ..... ing induction of the 
UV dependent UDS in the injocled multi·nucleated. cell (arrow) 
COffijWed with the typical XP-B residual UDS le"e! as shovin by the 
surrounding unlnje<:ted mononudear cells. 
el al., 1991) and shows a level of UDS in the range of 
normal cells. In contrast, the non-injected neighbouring 
mononuclear cells exhibit the very low repair activity 
characteristic of XP-B. However, the correcting activity for 
XP-G fibrOblasts, which is present in the whole cell extract 
(WCE), does not copurify with DTF2 (Figure IA). To follow 
more closely the relationship between BIFl and XP-D 
correction the fractionation profiles of the last 1\\'0 purification 
steps, the hydroxyapatite (HAP) chromatography and the 
glycerol gmdient sedimentation were screened in a quantitative 
fashion. Figure 2 shows that there is a direct correlation 
between the repair complementing activity measured as 
UDS as well as ill vitro and the transcription activation 
determined in an ill vitro run·off assay using the adenovirus 
major late promoter with RNA polymerase II and all basal 
transcription factors except BIF2 (Fischer et al., 1992). In 
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Fig. Z. Cochromatography and (osedimentation of BTF1 transcription 
stimulating and XP·BfERCC3 repa!r-corre.::ting a(tivit!es. The 
tram<:riptionallyaclh'c fractions that were eluted from the phen),\·5PW 
column were successively applied on a HAP column and a 15-35% 
glycerol gradient. AU fractions were tWed for trarucription stimulation 
i1l vilro using the adenovirus major lale promoter. Repair aClh-ity was 
delennined in til'<) by mkronc.edle inje.::!ion into Ihing XP·B 
fibroblasts and In 171ro using a een·free NER assay. (A) HAP 
purificatlon step. The upper part shows the autoradiogram of the 
transcription assay, the middle part preSCnts Ihe results of grain 
couming (average number of grains per nucleus, 50 nudet countoo) of 
Xp·B eeUs mkrolnje.:ted with each fraaion and assayed for 
UV-Induced UDS. The lower two panels represent the I" lilro NER 
activities of the same fractions In 27-1, a rodent NER deficient cell 
strain of CQmplementation group 3. They show the stained gel to 
demomtrate equal loading and the autoradiogram to visualize repalr 
synthesis. The AAF-damaged plasmid is indicated v.ith • +'. the 
undamaged internal control with· - '. Fractions 4 and 12 of the HAP 
profile had undergone an eXIra cycle of freezing and thawing prior to 
this test. (Il) Glycerol gradient sedimentation. Transcription (upper 
part) and XP-B In n';'(> repalr activity (lower part) of the gl)"(erol 
fracUo~ were assayed as above. 
previous work it was shown that the transcription stimulation 
of BTF2 parallels its helicase activity (Schaeffer et at., 
1993). Thus, all BTF2 activities coincide with the XP-B 
specific NER correction over six purification steps. We 
conclude that microinjected BTF2 complex itself and not a 
minor contaminant causes restoration of the repair defect in 
living XP·B cells. 
NER function of BTF2 In an In vitro repaIr assay 
The results of the microinjection experiments do not exclude 
the possibility that ERCC3 is only indirectly involved in 
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Fig. 3. BTFl corre.:ts NER defe.:t of rodent complementation group 3 
{" 1'{lro. (A) If! \7lro complementation of NER dde.:t in CHO mutanlS 
of rodent complementation groups 3 (mutant 27-1) and 4 (mutant 
UV47). Reactions contained a damaged plasmid fpBKS, 3.0 kb) and a 
non-damaged internal control plasmid (pHMt4, 3.7 kb). 250 ng each. 
Protein cOrK'entration in all reactions was 200 jig. In tane 2 100 jig of 
protein of each mutant utract were mhed. After incubation in the 
presence of e2p]dATP to permit repair, DNA was isolated, linearized 
by restriction endonuclease treatment and size-fractionated by agaro,e 
gel ele<;lrophoresis. (n) III \71rO corre.:tion of NER dde.:1 of rodent 
complementation group 3 (mutant 27-1) by purified BIFl (fractions 4 
and 12 of the HAP chromatography shov.n in Figure 2). Lanes I and 
2 contained 200 jig protein, lanes 3 and 4 100 "g of extra<:t was used. 
The amount of protein ~ontributed by the BIFl HAP fractions is 
negligible . 
, 
, 
NER. It is feasible that introduced BTF2 corrects expression 
of one or more critical NER genes whose transcription is 
abolished by the ERCC2 mutation in XP-B. Therefore, we 
also measured correction of the XP-B defect in an ill vitro 
NER system (Wood el al., 1988) where transcription and 
translation cannot occur. Figure 3B shows the outcome of 
administration of highly purified BTF2 (fraction 12 of the 
HAP chromatography) to cell-free extracts of CHO mutant 
27-1. This mutant is a member of rodent complementation 
group 3, the equivalent of XP-B (Weeda et at., 1990). In 
the presence of purified BTF2, repair synthesis in the damaged 
plasmid reaches a level similar to that achieved by mixing 
a complementing extract (Figure 3A). No such correction is 
observed with fraction 4 of the HAP eluate, which does not 
contain BTF2 activity. In further testing all fractions eluted 
from this column in the ill \'itro NER assay we find that the 
repair and transcription profiles are again superimposable, 
as they were using the microinjection assay (Figure 2A, 
lower panel), These experiment!. demonstrate that ERCC3 
has a direct involvement in both transcription and NER. 
Configuration of ERCC3 In the NER leaction 
To determine whether the ERCC1 correcting activity in a 
whole cell exlract resides in a BTF2(-like} configuration 
antibody depiction experiments were conducted. A repair 
proficient HeLa cell extract was incubated with a monoclonal 
antibody against the p62 component of BTF2 (r'tbb3C9), 
immobilized on protein A -sepharose beads. After removal 
of the beads by centrifugation the remainder of the extract 
was tested for repair capacity ill \'itro. Figure 4 shows 
that removal of p62 causes a clear antibody dependent 
reduction in repair activity (lane 3, compared with lane 1) 
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Fig. 4. Monoclonal antibodies against p61 deplete a repair-comp.:tent 
HeLa e:>;tract from repair and ERee3 activity. HeLa ce!J.free extract 
(150 I'g protein) was i~ubated with Mab3C9 against the p62 BIFt 
subunit immobilized on protein A-sepharose CL-4B beads. After 
centrifugation to remove me bound proteins !hI! supem~tant was tested 
(or its repair and complementing activities using the in lilra NER 
assa)'. Lane J, HeLa exlract (undepleted 100 pg); lane 2, HeLa nlrae\ 
treated with protein A beads aloM (SO "8); Jane ), HeLa <'.'tract 
depleted with Mab3C9 (80 I'g); Jane 4, MabJC9-lrealoo HeLa e!(tract 
(40 I'g) mixed with extract of CHQ mutant UVJ3.5 (complementation 
group S, 100 1'8); lane 5, UV135 e.,tract alone (200 JIg); tane 6, 
Mab3C9·lreated HeLa e.'tract (40 p.g) mL\ed with utract of CHO 
mutant 11·1 (complementation group 3, 100 1'8); bIle 7, 27·] e~tract 
alone aOO pg). 
suggesting that p62 is also involved in NER. To see whether 
ERCC3 activity is still present the treated extract was 
mixed with an extract ofCHO group 3. It is apparent from 
Figure 4 that the (p62ykP!etcl_HeLa extract had also lost the 
ability to complement the group 3 (lane 6) but not the group 
5 defect Oane 4), which is equivalent to XP-G (O'Donovan 
and Wood, 1993; Scherly et al., 1993). These findings 
indicate that ERCC3 correcting activity in a repair-
competent HeLa whole cell extract is associated with p62 
and that the ERCC5/XP-G factor is not tightly bound to 
the p62 - ERCC3 complex. 
E((ect o( (ree ERCC3 protefn 
The purified BTF2 complex is quite stable, at least ill vitro, 
as the proteins involved remain associated even in I M KCI 
(Schaeffer et al., 1993). To find out whether the ERCC3 
protein can only function in NER when offered in the form 
of the BTF2 complex we tested the ability of ERCC3 protein 
overproduced in E.coli to complement the XP-B defect. 
Figure 5 shows a glutathione-agarose bound fraction 
containing the GST-ERCC3 fusion protein after SDS-
PAGE Oane 1) and the partially purified ERCC3 gene 
product released from the GST fusion protein after cleavage 
by thrombin (lane 3). The results summarized in Table I 
(lower part) demonstrate thai the recombinant GST-ERCC3 
fusion protein as well as free ERCC3 induce significant 
correction soon (within 4 h) after microinjection into XP-B 
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Fig. S. SDS-PAGE analysis of recombinant·produced ERCC3 fusion 
protein. Recombinant-produced fusion protein of GST -ERCC3 (using 
vector pGEX2T) \las part!)' purified on glutalhione-agarose beads and 
c\uted with 5 mM reduced glutathione (lane t). Lane 2, eluted 
proteins, after digestion with thrombin; lane 3, proteins released after 
thrombin cleange from irrunobilized fusion proteins on GSH beads. 
Arrows indicate the recombinant ERCC3 proteins. Other bands present 
in the Coomassh! stained gel are probably derived from C·lerminat 
dcgrndation products of GST - ERCC3 and contaminating E.coli 
proteins. 
fibroblasts. The fact that ERCC3 in the context of the 
BTF2 complex as well as free ERCC3 exerts correction must 
mean that the ERCC3 subunit is exchangeable. The notion 
that the correction by BTF2 is more rapid (within 2 h) and 
reaches Wild-type level is consistent with the idea that 
this complex rather than the free protein is involved in the 
NER reaction. Apparently, the N-terminal GST extension 
does not seriously interfere with ERCC3 functioning in 
the BTF2 complex. 
Consequence of Interference with ERCC3 (unctionlng 
(or NER and transcription 
The involvement of ERCC3 in transcription is derived from 
results using an ill l'itro transcription assay and a limited set 
of promoters (Gerard ef al., 1991), It is important to verify 
whether the protein perfoons such a function ill vil'o as well. 
Therefore, we assessed the effect of antibody injection on 
RNA synthesis (delennined by incorporation of eHJuridine) 
and on NER (as determined by the level of UV-induced 
eHJTdR incorporation) into normal fibroblasts. As a 
control, cells on the same slide were injected with preimmune 
serum of the same rabbit and with antibodies against the 
ERCCI protein, a NER component not residing in the BTF2 
complex. Previously, we presented the specificity of the 
antibodies (Schaeffer el al., 1993; van Vuuren ef aI" 1993). 
The results are summarized in Table I (upper part). The 
ERCC3 preimmune serum has no significant effect on the 
number of grains derived from transcription or NER. The 
ERCC I COntrol serum induces a total inhibition of excision 
repair, demonstrating that this protein is indispensable for 
NER. However, no reduction of general transcription is 
observed, demonstrating that transcription does not drop as 
a non-specific consequence of the inhibition of repair. The 
ERCC3 serum causes a significant but incomplete repression 
of transcription as well as repair synthesis. The partial effect 
can be explained in several ways. The antibodies cannot 
reach or block the activity of all ERCC3 molecules, e.g. 
because the antigenic sites are not accessible, Alternatively, 
Table I. Mkroinjection of ERCC3 protein, antibodies and DNA constructs in human cells 
Injected substances' Hours after % inhibition of % inhibition of NER activity In XP·B 
(UDS in % of normal) inje.:lion 
Anti-ERCCt (476) 24 
Anli·ERCe3 (1151) 24 
Preimmunc 1151 24 
1046 - R ERCC3 
1046 - R ERCC3 22 
1046 - R ERCC3 30 
K3-16 - R ERCC3 48 
w.t. ERCC3 30 
Re.:-. GST-ERCC3" 4-6 
Re.:-. ERCC)'" '-6 
No injection 
NERb 
97 
4l 
2 
0 
74 
93 
98 
10 
Rt .... A s)'nthesisb. 
0 
48 
, 
0 
70 
78 
" , 
39 
4l 
II 
'Pol}'donal rabbit serum (476, anli·ERCC!; lISJ, anti·ERCe3; preimmune 1151), ERCeJ cDNA in the mammalian expression vector pSVL 
(wiJd-t),pe and K346 - R mutant of ERC(3); GSH-purifkd recombinant fusion protein of GST-ERCC3 and thrombin-cul fusion protein of 
GST-ERCC3 on GSH column (see Figure 5). 
bCompared with uninjected cens present on the same slide. 
'Esti!llilted protein concentration 0,05-0.1 JIg/mi. 
the protein is only involved in part of the transcription and 
NER reactions in the cell. 
As an alternative manner of interfering with ERCC3 
functioning in \'il'o a DNA construct was designed carrying 
a mutation that is expected to have only a subtle effect on 
the tertiary structure of the protein but a drastic effect on 
its activity. For this the conserved lysine 346 in the nucleotide 
binding box (Weed a et al., 1990) was selected and replaced 
by arginine, thereby preserving the positive charge. It is 
known from other ATPases and helicases with GKT -type 
nucleotide binding domains that substitution of the invariant 
lysine reduces or completely abolishes ATP hydrolysis but 
does not necessarily affect ATP binding as such (Azzaria 
et al., 1989; Reinstein et al., 1990; Tijan et al., 1990). In 
the yeast RAD3 repair helicase it has been demonstrated that 
a similar K ..... R replacement does not interfere with 
ATP binding but blocked the hydrolysis step and helicase 
activity (Sung et al., 1988). Transfection of the mutant 
ERCC3 eDNA into the UV-sensitive, repair-deficient rodent 
group 3 cell line 27-1 demonstrated that the K346 -> R 
protein was unable to restore the repair defect (L.Ma, 
A,Westbroek, A.G.Jochemsen, G.Weeda, D.Bootsma, 
J,H,LHoeijmakers and A.J. van der Eb, manuscript 
submitted). An analogous mutation in the yeast homologue 
of ERCC3, RAD25, showed that the essential function of 
the protein was also inactivated (Park et al., 1992). To 
see whether this mutation exerts a dominant effect the 
K346 - R ERCC3 eDNA was microinjected into 
repair-competent fibroblasts. As a control the wild-type 
cDNA in the same vector was injected into cells on the same 
slide. Although at different time points some heterogeneity 
was seen in the magnitude of the effects, presumably due 
to differences in the level of expression, a sharp drop in UDS 
was registered within 22 h which was total by 48 h (see 
Figure 6D-F and for quantitative results Table I, middle 
part). Concomitantly, transcription fell down to undetectable 
levels (Figure 6A-C, Table I). This was closely followed 
by a dramatic change in nuclear morphology. At first (22 h) 
the nucleoli increased in size and became less densely 
stained, At later times the entire Giemsa-stainable chromatin 
material clumped in a small area, leaving the remainder of 
the nucleus emply. In contrast, the cytoplasm stayed 
remarkably normal in morphology (see Figure 6). None of 
these effects were observed in the cells injected with the 
wild-type cDNA construct which even exerts correction of 
the repair defect when injected into XP-B fibroblasts (Weed a 
el al .• 1990). We conclude that the K346 -- R substitution 
confers a dominant-negative effect on both transcription and 
NER and induces a dramatic chromatin collapse. 
Discussion 
The findings reported here demonstrate that the ERCC3 gene 
product functions directly in two quite different aspects of 
nucleic acid metabolism: basal transcription and nucleotide 
excision repair. 1bis confums and extends earlier observations 
by Egly and coworkers who identified the ERCC3 protein as 
one of the components of the BTF2ITFIIH complex required 
for proper transcription initiation of RNA polymerase II 
ill ~'itro (Schaeffer el af., 1993). Thus these results rule out 
the theoretical possibility raised by these and other remarkable 
observations with respect to the ERCC3 gene in the yeast 
and Drosophila systems, namely that the ERCC3-NER 
connection could be indirect, i.e. ERCC3 might control the 
expression of one or more (real) NER genes without being 
involved itself in this process (Gulyas and Donahue, 1992; 
Mounkes et al., 1992; Schaeffer et ai., 1993). In addition, 
this work establishes that the ERCC3 protein participates 
in the transcription machinery ill ~'i\'O; the evidence for this 
was hitherto only based on an ill l'itro transcription assay. 
Finally, this paper reveals the dramatic consequences of 
interfering with proper ERCC3 functioning ill ~i)'o via 
overexpression of dominant·negative ERCC3 mutant protein 
or by antibody injections. Our findings have direct 
implications for the functioning of ERCC3 at the molecular 
level and for the interpretation of some of the clinical 
manifestations of the associated human syndrome. 
Involvement of BTF2 In NER 
In what configuration does ERCC3 function in NER? The 
fact that purified BTF2 is able to correct the XP-Blrodent 
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Fig. 6, Effect of K346 - R ERCe3 mutant on tra!W.:ription and NER. Mkrographs A, n and C show the time dependent effect on RNA synlhesi!l, 
assayed by pulse labelling wilh eHjutidine, In control (wild-type) fibroblasts injwed with the ERCCJ eDNA encoding the K346 - R mutated 
protein. Mkrogrophs D, E and F demonstrate the effect on NER, as revealed bi' UV-induccd UDS. A and D were assayed 22 b, B and E 30 h and 
C and F 48 h after microinje.:tioo. Injected polykar)'oru (arrows) demonstrate a complete inhibition of RJ','A synthesis {no incorporation of 
(lH)uridine) as well as NER (abseoce of UDS in inje .. tM polykaryons) and a dramatic chromatin collapse. 
group 3 repair defect in l'h'o and ill vitro suggests, but does 
not prove, that the complex as a whole participates in the 
NER process, It is, however, not excluded that the ERCC3 
subunit dissociates from the complex and either functions 
alone or in a different complex in the NER reaction 
mechanism, An argument in favour of the involvement of 
BTF2 in NER is our finding that monoclonal antibodies 
against p62 are able to deprive a Hela WCE of its NER 
capability and all detectable ERCC3 activity, This suggests 
that at least the p62 subunit of BTF2ITFlIH is tightly 
associated with the majority of the ERCC3 molecules that 
are required for in ritro NER, A second inference from 
this observation is that the p62 protein may be yet another 
NER faclor, Whether the same holds for the entire BTF2 
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complex has to be established, The dual involvement of 
ERCC3 extends the emerging notion that the eukaryotic NER 
system recruits many factors from other systems that operate 
in the nucleus. From parallels with yeast it is likely thaI the 
recently discovered ERCCI, ERCC4, ERCCII and XPFC 
complex functions simultaneously in NER and in a mitotic 
recombination pathway (Schiesll and Prakash, 1990; Bailly 
el al., 1992; Bardwell el al., 1992: Biggerstaff et al., 1993: 
van Vuuren el al., 1993), Using the ill vitro NER assay 
Wood and coworkers have shown that the replication factors 
peNA and HSSB (RPA) also participate in the post-incision 
stages of the NER reaction (Coverley et al., 1992; Shivji 
et al., 1992) in addition to DNA polymerase 0 or f and ligase 
I. The dual usage of these proteins for different processes 
may be for economical reasons. Alternatively, it may be a 
reflection of the tight links of excision repair with other 
proeesses in the nucleus. 
Possible role of ERCC3 In NER 
What can be the role of ERCC3 and BTF2 in transcription 
initiation and NER? From the foregoing it is most logical 
to search for a common functional step for ERCC3 and 
perhaps the entire BTF2/TFIlH complex in both processes. 
It has been demonstrated that the human BTF2/TFDH 
complex as well as the rat counterpart exhibit two activities: 
a protein kinase that is able to phosphorylate the C-tenninal 
domain of the large subunit of RNA polymerase II (Lu et al., 
1992; Serizawa et al., 1993a,b) and a helicase activity 
(Schaeffer et al., 1993). The latter is likely to be associated 
with the p89 ERCC3 subunit. In this light at least two 
possibilities (or a combination) can be envisaged for a 
commOn catalytic function of ERCC3 in transcription and 
NER. (i) Induction of a loeally melted DNA confonnation 
for RNA polymerase to be loaded onto the template. In the 
context of NER a similar function can be imagined for putting 
a scanning complex onto the DNA or the incision complex 
at the site of a lesion. (ii) Unwinding of the helix as part 
of the translocation of the transcription or NER scanning 
complex along the chromatin, as suggested for the UvrA2B 
complex in E.coli NER (Grossman and Thiagalingam, 
1993). In both cases the ERCC3 protein or the BTF2 factor 
has to interact with components of the transcription as well 
as the NER machinery. Mutations in the ERCC3 protein 
found in XP-B patients (such as alteration of the C-terminus: 
Weeda et al., 1990) primarily inactivate NER. It is tempting 
to speculate that these regions are specifically involved in 
the interaction with other NER components. 
Interference with ERCC3 functIoning 
Microinjection of the K346 - R ERCC3 mutant construct 
induces a strong reduction or even a complete blockage of 
NER and general transcription. A similar effect-although 
quantitatively not as pronounced-was seen with anti-ERCC3 
antibodies. Selective inhibition of NER is not the reason for 
the dramatic decline of transcription, because antibodies 
against the ERCCI protein also cause a total blockage of 
NER but have no measurable impact on transcription. The 
inhibition of NER and transcription by K346 --+ R ERCC3 
occurs with similar kinetics, indicating that both proeesses 
are disturbed in an analogous fashion. Furthermore, it is 
observed relatively shortly after microinjection when taking 
into account that the injected gene has to be transcribed, the 
mRNA translated and the protein incorporated in a sufficient 
number of BTF2 complexes to exert the observed effect. 
For many genes expression is first registered 16~24 h after 
injection. Also the correction of the XP-B repair defect by 
injection of the purified ERCC3 protein is a quite rapid 
phenomenon: significant increase in UDS is seen within 4 h 
after injection. This suggests that exogenous ERCC3 is able 
to exchange with endogenous ERCC3 in BTF2 complexes 
in a relatively fast manner. One possibility is that the BTF2 
complex disassembles and reassembles at regular times as 
part of its reaction cycle and in this way incorporates new 
exogenous ERCC3 protein. For the dominant effect of 
mutant ERCC3 the following scenario seems most plausible. 
The conservative K346 --+ R mutation is not expected to 
perturb dramatically the tertiary conformation and fitting of 
the protein into the BTF2 complex. After incorporation into 
BTF2 and assembly of the preinitiation complex the reaction 
proceeds up to the stage in which the ATPase activity of 
ERCC3 is required. At this point the system is paralysed, 
frustrating the nonnal progression of both transcription and 
NER. When a critical threshold of poisoned transcription 
units is reached this proeess culminates in a complete and 
irreversible inhibition of transcription. Ironically, this 
catastrophic event will also shut down the expression of the 
injected ERCC3 mutant construci itself. 
BTF2 has been demonstrated to be involved in transcription 
by RNA polymerase II (Gerard et al .• 1991). It is not 
known whether it is implicated in RNA polymerase I and 
ill transcription as well. The effects of the dominant-negative 
ERCC3 mutant indicates that total RNA synthesis becomes 
impaired. This does not necessarily mean that ERCC3 
participates directly in all three modes of transcription. It 
is possible that the inhibition of e.g. RNA polymerase I is 
an indirect result of the bloekage of RNA polymerase n. 
The time-resolved consequences of selective inhibition of 
transcription by RNA polymerase II have hitherto escaped 
detection because severe mutants in this process are obviously 
not viable. In our transient microinjection system the most 
dramatic and earliest morphological effects concern the 
nucleus where the nucleolus seems to swell first and eventually 
aU chromatin appears to become clumped in one or a few 
regions, leaving the remainder of the nucleus empty. These 
alterations initiate already at a stage when inhibition of 
transcription is still not complete suggesting that the 
chromatin structure critically depends on ongoing transcription 
and functioning ERCC3. Probably all cellular proeesses 
which require proteins with a high turnover and a short 
mRNA half-life will be affected first. Morphologically, the 
affected cells show features resembling an early stage of 
apoptosis. However, further studies are warranted to establish 
a relationship with apoptosis. 
Consequences for the cllnfcal features of XP-S 
The very rare XP-B complementation group exhibits a 
number of clinical characteristics that are atypical for a 
NER defect and difficult to rationalize on the basis of a 
DNA repair problem. This includes many of the features 
these patients share with Cockayne's syndrome, such as 
neurodysmyelination, immature sexual development, absence 
of subcutaneous fat and a general gro\vth deficiency (Cleaver 
and Kraemer, 1989; Scott et at., 1993; Vermeulen et al., 
1994). In view of the additional function of ERCC3 it is 
tempting to assign at least some of these features to a subtle 
impairment of transcription. In mouse models evidence has 
been collected that the production of the myelin sheet is 
strongly detennined by the amount of mRNA for myelin basic 
protein (popko et al., 1987). Thus the neurodysmyelination 
may be related to a reduced expression of this protein. Viable 
mutations in the Drosophila homologue of ERCC3 designated 
'haywire' display sterility which is likely to be caused 
by reduced expression of .a-tubulin, required for spindle 
formation in meiosis (Mounkes et al., 1992). Perhaps 
the immature sexual development in XP-B could be due to 
the same problem. Recent findings in the field of basic 
transcription support the notion that the requirement of 
transcription factors may vary from promoter to promoter, 
depending on the sequence around the initiation site, the 
topological state of the DNA and perhaps other factors such 
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as the local chromatin structure (see Stanway, 1993 and 
references therein). This may explain the above features and 
the poor general development characteristic of this fonn of 
XP, In fact two other XP complementation groups, XP·D 
and XP-G, also display the remarkable clinical features of 
XP-B (Vermeulen et al., 1993), As demonstrated here the 
Xp·G factor is not present in the BTFl complex. If it is 
involved in transcription it is either present in another 
complex or it is only loosely associated with components 
of BTF2 and not essential for transcription. The latter idea 
is in agreement with the notion that the yeast homologue 
ofxp·G, RAD2 (Scherly el al., 1993) is also not an essential 
gene (Madura and Prakash, 1986). As noted before, XP-D 
and the corresponding gene ERCC2 have many parallels with 
XP-B and ERCC3, This has prompted the idea that the 
ERCC3 and ERCC2 proteins may interact and have a similar 
function (Weeda el af., 1990). Clinical heterogeneity in 
XP-D is even more pronounced than in XP-B and includes 
the peculiar brittle hair symptoms of trichothiodystrophy. 
We have recently obtained evidence that the functional 
overlap between repair and transcription also includes 
ERCC2, This is consistent with the idea that some of the 
clinical features of these rare pleiotropic disorders are due 
to basal transcription problems, 
Materials and methods 
Generar procedures 
Purification of nucleic adds, restrktion enz}nle digestion, gd clixtrophoresis 
of nucleic adds and proteins, transfomunion of E.co/i, etc, were performed 
according \0 standard procedures (Sambrook fI 01., t989). 
Purification of BTF2ffFIIH 
The purifkation of BIF2 and all other general tran.l;;ription factors required 
for the transcription asS.1y using the adenoviru.s 2 major late promoter as 
template "vas performed starting from HeLa cells as des.:riOOi earlier (Ger>'rd 
er 0/., 1991). 
MiCroneedle Injection and assay (or RNA synth6Sls end 
UV·/nduced unscheduled DNA synthesis 
Microneedle injection of XP·B fibrobta.1tS as well as control cells (ORO) 
\las performed as dc.scribed (Vermeulen (t al., 199~). Briefly, at least 3 
da)'s prior to microinj>xtion cells were fused with the aid of ina(tivated 
Sendai virus, seeded onto covcr.s!ips and (ultured in Ham's F-\O medium, 
supplemented with 12% fctal calf serum and antibiotics. After injoction 
of at [east 50 homopolykaryons (ells \leT<': incuNted for the desired time 
in nOrrTI.11 culture medium before bdng assayed. NER acthity was 
determined after UV-C light irradiation with IS 11m2, incubation for 2 h 
in [JHlth)midine (to I'ClIml; s.a.: 50 ClImnlDl)-containing culture 
medium, flution and e~posure to autoradiography. G,,l.ins above the nudei 
(> tOO) were counted and represent a quantitath'e measure for NER ac· 
tivity. RNA S)'nthcsis was determined also by counting autoradiographk 
grains above me nudei of inj.xted cells, after labelling whh eHluridine 
(l0 I'Cilml; s.a.: 50 Cilmnlol) during a putsc tabelling period of 1 h in 
nomu} (ulture medium. Protein prepJration5 (including antisera) were in-
j>xted into me cytoplasm, (DNAs were nticroinje.:ted into one of the nudei 
of polykal)·ons. 
fn vItro DNA repair essay 
Plasmids pBKS (3.0 kb) and pHMt4 (3.7 kb) were isolated from E.coli 
and extcmivel)1 purified as dosed circular D:-JA (Diggwtaff CI 01., 1991). 
pBKS was treated with 0.1 m~1 N-3cetoxy·2·a,etylaminofluoren<: (AAF) 
(a kind gift of R.Baan, TNO, Rijswijk), inducing mainl)' N-(guarune-
8-)']j-AAF adducts. AAF-modified pla.smids were colle,ted by repeated 
di-eth)l-ether extractions and ethanol predpitation (landegent el al., t93--1) 
and repurified on a neutral sucrose gradient. pHM14 lIas mock-twlted in 
pMallei. There are 15-20 AAF -guanine adducts ~r damaged plasmid. 
Repair-profident cell tines: HeLa. Chine,e Iwmter o\'al)' (CHO) cell 
strain CH09 and CHO NER mutants: 27-1 (complementation group 3), 
UV47 (CG 4) and UVI35 (CG 5) were cultured in a 1:1 mi\ture of Ham's 
F·\O and D~tEM medium (Gibo;:o) supplemented with \0% fetal (alf serum 
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and antibiotics. Cells were harvested and e,tracts wue prepared from 
2-5 m1 of packed cen peHet by the method of Manley as mooilied by WOCld 
fJ.lanley ct (II., 1983; WOCldct a!., (988). E,teacts Ileredial)'sed in 25 mM 
HEPES-KOH, pH 7.8, 0.1 M KCI, 12 mM MgCI1, I mM EDTA, 
2 mM DTT and 17% (vlv) glycerol and stored at -80'C. 
The reaction mhture (50 1'1) contained 250 ng of both damaged and 
oon..;lamaged pla.smid DNA, 45 m.\t HEPES-KOH (pH 7.8), 70 m.\t KCI, 
7.4 mM MgCl1• 0.9 ntM DTT, 0.4 mM EDTA, 20 jiM each of dCTP, 
dGTP and TIP, 8 jiM dATP, 74 kBq of [c..J1p]dATP, 2 mM AlP, 
40 m~1 phosphocreatine, 2.5 I'g creatine phoiphokinase, 3.45% glFerol, 
18 I'g bovine serum albumin and 200 jig of cell·free e.'tea;;t. The reaction 
was incubated for 3 hat 30'C, afternards the plasmid DNAs were isolated, 
linearized and separated on an agarose gel eJcctrophoresis. Data \lere 
analysed via autoradiography and quantified by SCintillation (ounting of 
e.,dsed DNA bands. 
For microinjection and antibody depletion e.'periments, me following 
antbera were used: (i) a rabbit polyclonal anti·ERCCI antiserum raised 
agaim:t a ubiquitin - ERCCI fusion protein and chara«~rized as previously 
deS<:"ribed (van Vuuren (/ oJ., 1993); (ii) a polydonal antiserum rai;OO against 
a GST-ERCC3 fusIon protein (ontaining an internal part (amino adds 
82-480) of ERCC3; (iii) a monoclonal antibody (Mab3C9) agalm:t the 
62 kDa polypeptide, a component of BIF2, used in depletion experiments 
was published earlier (Fischer el al., 1992). 
To deplete 150 I'g of repair-proficient HeLa e.~tract, anti-p62 antibodies 
(3 1'1 of ascites fluid) were immobilized on protein A -Sepharose CL·"m 
beads; after in(ubation \lith HeLa extract and centrifugation me supernatant 
\las used as a depleted Hela (.,tract and tested for repair activit)' in lino 
as deta.iled above (\'an Vuuren el 01., [993). 
Overproduction and purification of recambrnant fRCC3 protein 
ECCR3 cDNA cloned in pGEX2T was transferred to E.ca/i strain BUI 
and gene e.\pression was Induced during 3 h by IPTG. Cells were 
homogenized in PBS (containing 2 mM PMSP and 15% gl)'cerol) by 
50nlcation and e.,tracts were cleared by (cntrifugation. Fusion protein was 
purified by passing the cell homogenate through a glutathione-agarose 
containing column, proteins were eluted with 5 m..\t reduced glutathione 
(In 50 m..\1 Tri!, pH 8.0). Alternatively r.xombinam ERCC3 was deaved 
from the GST part by incuNting me irrunobilized fusion protein (on 
me glutathione-agarose beads) with thrombin (I-2 ng/"g protein) for 
45 min at 20'C. 
Site-directed mutegenesls 
Mutations in the ERCC] eDNA sequence werc made using the 
oligonudeotide directed, uracil-DNA method (Kunkel c/ 01., 1987). An 
internal fragment of ERCO was imerted In a M13 vector, and after mutation 
iruluction used to replace the wild·type fragment in the p.1rental plasmid 
pE3·WT. The desired mutation was verified by sequence anal),sis. 
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To counteract the deleterious effects of DNA dam-
age, a sophisticated network of DNA repair systems 
has evolved, which is essential for genetic stability and 
prevention of carcinogenesis. Nucleotide excision re-
pair (NER), one of the main repair pathways, can 
remove a wide range of lesions from the DNA by a 
complex multistep reaction (for a recent review, see 
Hoeijmakers 1993). Two subpathways are recognized 
in NER: a rapid "transcription-coupled" repair and the 
less efficient global genome repair (Bohr 1991; 
Hanawalt and l ... fellon 1993). The consequences of 
inborn errors in NER are highlighted by the prototype 
repair syndrome, xeroderma pigmentosum (XP), an 
autosomal recessive condition displaying sun (UV) 
sensitivity, pigmentation abnormalities, predisposition 
to skin cancer, and often progressive neurodegenera-
tion (Cleaver and Kraemer 1994)_ Two other excision 
repair disorders have been recognized, Cockayne's 
syndrome (CS) and trichothiodystrophy (TID), which 
present different clinical features. These are, besides 
sun sensitivity, neurodysmyelination, impaired physical 
and sexual development, dental caries (in CS and 
TTD), ichthyosis and sulfur-deficient brittle hair and 
nails (in TTD)(Lehmann 1987; Nance and Berry 1992), 
which are difficult to rationalize on the basis of defec-
tive NER only. The NER syndromes are genetically 
heterogeneous and comprise at least 10 different com-
plementation groups: 7 in XP (XP-A to XP-G), 5 in CS 
(CS-A, CS-B, XP-B, XP-D, and XP-G) and 2 in TID 
(ITD-A and XP-D) (Hoeijmakers 1993;Stefanini et al. 
1993b). Thus, considerable overlap and clinical hetero-
geneity are associated with a selected subset of com-
plementation groups, of which XP-D is the most ex-
treme, harboring patients with XP only, or combined 
XP and CS, or TfD (Johnson and Squires 1992). 
Recently, it was discovered that the DNA repair 
helicase encoded by the ERCC3 gene (Roy et al. 1994), 
which is mutated in XP-B (Weeda et at. 1990), is 
ttThese authors hal'e contributed equally to this work. 
identical to the pS9 subunit of the transcription factor 
BTF2/TFIIH (Schaeffer et al. 1993). ERCC3 in the 
context of TFITH is directly involved in NER and 
transcription in vitro as well as in vivo (van Vuuren et al. 
1994). Furthermore, another repair helicase, XPDI 
ERCC2, was recognized to be associated with TFIIH 
(Schaeffer et al. 1994), and it was shown Ihat a partially 
purified TFIIH fraction is able to correct the NER 
deficiency of XP-D in vitro (Drapkin et al. 1994). 111ese 
results reveal a link between two distinct DNA-
metabolizing processes: repair and transcription. 
Initiation of transcriptior: is believed to require the 
formation of an elongation-competent protein complex 
in a highly ordered cascade of reactions. A preinitiation 
(DAB) complex is formed by the binding of the mul-
tisubunit TFIID factor to the TATA box element of 
core promoters, stabilized by TFIIA and followed by 
the association ofTFIIB. The DAB intermediate stimu-
lates the entry of RNA polymerase II mediated by 
TFIIF. Initiation is completed by the ordered associa-
tion of TFIIE, TFIIHIBTF2, and TFIIJ (Roeder 1991; 
Gill and Tjian 1992; Drapkin et al. 1993). TFIIH/BTF2 
is thought to be involved in the conversion of a closed 
to an open initiation complex by local melting of the 
transcriptional start site and phosphorylation of the 
carboxy-terminal repeat of the large subunit of RNA 
polymerase II (Lu et al. 1992; Schaeffer et al. 1993; 
Serizawa et al. 1993), either at the preinitiation stage', or 
al a step between initiation and elongation, referred to 
as promoter clearance (Goodrich and Tjian 1994). 
Here \ve report that defects in the XPB/ERCC3 
subunit define a new TrD complementation group 
extending the clinical heterogeneity aS30ciated with 
ERCC3. Furthern'lOre, we demonstrate that probably 
the entire TFI1H complex has a dual role in transcrip-
tion and repair, as it harbors now at least three NER 
proteins, all associated with the TID and CS symp-
toms. The dual function ofTFIIH, and the link between 
mutations in this complex and the pleiotropic features 
of TfD and CS, strongly support the idea that some of 
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the clinical manifestations arise from defects in the 
transcription function of TFIIH. This provides for the 
first time a molecular explanation for the seemingly 
unrelated symptoms of these disorders and introduces a 
novel clinical entity, a heterogenous "transcription 
syndrome" complex, that may include many more in-
herited conditions. 
METHODS 
Purificatloll of BTF2/TFllH. TIle purification of 
BTF2 starting from HeLa whole-cell extract and involv-
ing sequential chromatography on Heparin-Vltrogel, 
DEAE-Spherodex, SP-5PW sulfopropyl, and-after 
ammonium sulfate precipitation-Phenyl-5PW Sepha-
rose and hydroxyapatite, was carried out essentially as 
described earlier (Gerard et aI.1991). In some fractions 
an additional purification step using heparin chroma-
tography was insertcd in the standard protocol before 
the Phenyl-5PW column. TIle in vitro assay for follow-
ing the transcriptional stimulation activity of BTF2 on 
an AD2~'lLP promoter containing template involving 
purified RNA polymerase II and all transcription fac-
tors except BTF2/TFIIH has been described in detail 
previously (Gerard et al. 1991). 
eelllilles aI/(/ extracts, TIw human cell lines used 
for microinjection and for complementation analysis 
were XP25RO and XPllPV (both XP-A), XPCSIBA 
and XPCS2BA (XP-B), XP21RO (XP-C), XPIBR, 
XPJNE, and ITD8PV (all XP-D), XP2RO (XP-E), 
XP126LO (XP-F), XP2BJ (XP-G), and TIDIBR 
(TID-A) and TID6VI (Slefanini et al. 1993b; Ver-
meulen et a1.1986, 1994). TIle primary fibroblasts were 
cultured in Ham's FlO medium supplemented with 
antibiotics and 10-15% fetal calf serum. 
For preparing cell-free extracts utilized for the in 
vitro repair assay, the following cell lines were used: a 
SV40-transformed line belonging to ITD-A 
(TIDIBRSV), human repair-proficient HeLa cells, 
mutant Chinese hamster cclls 43-3B, UV5, 27,1, UV41, 
and UV135 assigned to complementation groups 1, 2, 3, 
4, and 5, respectively (Busch et al. 1989). The cells were 
grown in a 1:1 mi:xture of FlO and DME?",f medium; 
antibiotics and 10% fetal calf serum were added. After 
harvesting and washing with phosphate-buffcred saline 
(PBS), cell-free extracts were prepared as dcscribed 
previously (Manley et aL 1983; Wood et al. 1988), 
dialyzed against a buffer containing 25 n1.\1 HE PES I 
KOH (pH 7.8), 0.1 101 KCI, 12 mM MgCI2' 1 mM EDTA, 
2 ruM DIT, and 17% (v/v) glycerol, and stored at 
-80'C. 
111 J'itro DNll. repair assay. Plasmid pBluescript 
KS+ (3,0 kb) was damaged by treatment with 0.1 mM 
N-acetoxy~2~acetylaminofluorene (AAF) (a kind gift of 
R. Baan, TNO, Rijswijk), As a nondamagcd control, 
plasmid pHMI4 (3,7 kb) was used. Circular closed 
forms of both pJasmids were isolated and extensively 
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purified as described previously (Biggerstaff et al. 1991; 
van Vuuren et al. 1993). The reaction mixture contained 
250 ng each of damaged and nondamaged control 
plasmids, 45 m~1 HEPES/KOH (pH 7.8), 70 mM KCI, 
7.4 m!>! MgCl1 , 0.4 mM EDTA, 0.9 mMDTT, 201M ATP, 
40 mM phosphocreatine, 2.5 fIg creatine phosphoki-
nase, 3.5% glycerol, 18 fIg bovine serum albumin, 20 
/lM each of dCTP, dGTP, and TTP, 8 fIM dATP, 74 kBq 
of{a-np]dATP and 200 fIg of cell-free extract for the 
rodent extracts and 100 fIg for HeLa. After 3 hours 
incubation at 3D"C, plasmid ONAs were purified from 
the reaction mixture, linearized by restriction, and 
separated by electrophoresis on an 0.8% agarose gel. 
Results were quantified using an LKB Densitometer 
and a B&L Phospho-Imager. 
Atlli-p62 alltibody depletioll of a repair-proficient 
extracl. Protein A-Sepharose beads in PBS were incu-
bated with monoclonal antibodies against the p62 
subunit of BTF2 (Mab3C9; Fischer et al. 1992) or 
against p89 for 1 hour at O"c. The beads were washed 
with dialysis buffer and added to a repair-competent 
HeLa extract or a (partially) purified heparin or hy-
droxyapatite BTF2 fraction for 1 hour at DOC (van 
Vuuren et al. 1993). The bound proteins were removed 
by centrifugation and the supernatant was tested in the 
in vitro repair assay or for microneedle injection. West-
ern blot analysis following SOS-PAGE was carried out 
according to standard protocols (Sambrook et al. 1989). 
Mlcro;l/jectloll, Microinjection of XP hornopol),-
karyons was performed as described earlier (Ver-
meulen et al. 1994). Repair acth'ity was determined 
after UV irradiation (15 J/m 2 ), [3HJthymidine incuba-
tion (10 fIeUml; s.a.: 50 CilmMole), fixation, and 
autoradiography. Grains above the nuclei represent a 
quantitative measure for NER activity. RNA synthesis 
was detected after labeling with [3H]uridine (10 fICil 
ml; s.a.: 50 Ci/mMole), cDNAs were injected into one 
of the nuclei of the polykaryons: protein fractions and 
antibodies were injected into the cytoplasm of the cell. 
Antisera used for microinjection: polyclonal rabbit 
anti-ERCCl and anti-ERCC3 (van Vuuren et al. 1994) 
and polyclonal rabbit anti-ERCC2 (Schaeffer et al. 
1994). 
Complemelltatloll alia lysis by cell IIybridiza-
tiOIl. Fibroblasts of each fusion partner were labeled 
with latex beads (0.8 fIm or 2.0 ,um) 3 days prior to 
fusion by adding a suspension of beads to the culture 
medium. Cell fusion was performed with the ai~ of 
inactivated Sendai virus or, using polyethylene glycol, 
cells were seeded onto coverslips and assayed for UV+ 
induced unscheduled DNA synthesis (UDS) as dc-
scribed in detail elsewhere (Stefanini et al. 1993a; 
Vermeulen et al. 1993). 
OIlier procedures. Isolation of DNA, subcloning, 
and in vitro transcription and translation were done 
using established procedures (Sambrook ct al. 1989). 
RESULTS 
Idenliflcalion of Furlher Genelic Helerogeneily 
wilhln TID 
In an effort to assess the genetic heterogeneity within 
the class of repair·deficient TID patients, we have 
conducted a systematic complementation study of a 
large number of photosensitive TTD families by cell 
fusion and microneedle injection of cloned repair 
genes. This resulted recently in the identification of a 
second complementation group among NER-deficient 
TID patients (designated TID-A) (Stefanini el al. 
1993b). Figure 1 shows the results of an exhaustive 
complementation analysis of fibroblasts from one of 
two siblings (TID6VI and TID4VI) with relatively 
mild clinical features of TID and moderately impaired 
NER characteristics (detailed clinical description to be 
presented elsewhere). Full complementation of the 
repair defect was seen when fibroblasts of patient 
TID6yI were fused with representants of the known 
TTD complementation groups: XP group 0 (3 cell lines 
tested) and with TID-A fibroblasts (Fig. 1) (Stefanini 
et al. 1993a,b). This demonstrates that this family de-
fines a new TID complementation group. To see 
whether this group is genetically identical to one of the 
other XP groups not previously associated with TfD, 
further cell-hybridization experiments were carried out. 
No restoration of the deficient UV-induced UDS was 
found when TfD6VI cells were fused with an XP-B 
representant (XPCSlBA), whereas normal com-
plementation was observed with the other XP groups 
(Fig. I). This indicates that the repair defect in this 
family resides in the XPB!ERCC3 gene. Although 
1TD6VI cells appeared exceptionally sensitive to nu-
clear microneedle injection of DNA, still a few cells 
could be found corrected by ERCC3 eDNA, in agree· 
ment with the assignment by cell fusion. Defects in the 
TFIIH subunit ERCC3 thus extend to the disorder 
TID, increasing the already observed clinical hetero-
geneity among patients carrying mutations in ERCC3 
(Vermeulen et aL 1994). 
S),stcmatic Screening of TFIIH for NER Prolcins 
To examine whether besides XPB/ERCC3 (p89) 
additional NER factors are hidden in the TFIIH/BTF2 
complex, we ha\'e systematically screened the existing 
human and rodent NER mutants for complementation 
by BTF2. The final fractions ofTFIIH purification show 
at least five tightly associated proteins, including p89 
(XPB/ERCC3), p62, p44, p41, and p34 (Gerard et al. 
1991; Schaeffer et aL 1993). A purified BTF2·fraction 
(hydroxyapatite chromatography, gel pattern, and 
properties; see Gerard et al. 1991) was inserted by 
0fuslon partner CSJTT06VI lIil1hetero~eryon 
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Figure 1. Complementation anai}'sis of TTD6VI cells. Fibroblasts of TID6VI (labeled with Q.g·,um beads) wer.c fused with 
representatives of different XP and TID complementation groups (labeled with 2.0·,um beads). After performing the UV·inuuced 
UDS assay, the average number of autoradiographic grains above the nuclei was determined. DNA repair synthesis was expressed 
as the percentage of control UDS (vertical a: .. is) obsen'ed in normal fibroblasts a~saycd in parallel. The rdative standard errors of 
the mean are in all cases less than 5%. The different types of binuclear cells (homodikaryon~ of TID6VI and of the different fusion 
partners, and heterodikaryons) are recognized by their different bead content and indicated 3S such in the figllre. 
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microneedle injection into fibroblasts of all known 
excision-deficient XP, XP/CS, and TID complementa-
tion groups. The injected cultures were exposed to UV 
and incubated with [3H jthymidine to permit visualiza-
tion of the repair synthesis step of NER by in situ 
autoradiography (unscheduled DNA synthesis, UDS). 
The results, summarized in Table 1, show that 3 out of 8 
NER-deficient human complementation groups are 
corrected by the purified BTF2 transcription factor. 
Figure 2 presents micrographs of BTF2-injected mul-
tinucleated fibroblasts of XP-D, TID-A, and the new 
XP-B patient with TID symptoms. The repair activities 
in injected cells reach the levels of normal fibroblasts 
assayed in parallel, indicating full correction of the 
excision defect (see also Table 2). 
The restoration of NER could also be explained by 
correction of expression of one or more critical repair 
genes whose transcription is impaired by mutations in 
BTF2 subunits. Therefore, purified BTF2 was checked 
for its repair capacity in an in vitro repair assay (Wood 
el al. 1988; van VUUren et a!. 1993), where neither 
transcription nor translation can occur, because ribonu-
cleotides and amino acids are lacking. The results in 
Figure 3 and Table 1 show that the BTF2 fraction not 
only corrects the repair defect in rodent group 3 (the 
equivalent of XP-B), as reported earlier (\'an Vuuren et 
al. 1994), but also the rodent group equivalent 10 XP-D 
(CHO group 2, defective in ERCC2) (Flejter et ai, 
1992) and an extract from a SV40-transformcd 
1TD1BR cell line (TID-A). In contrast, no significant 
NER restoration is observed in extracts of UV-sensitive 
mutants from groups 1, 4, and 5 (defective in ERCC1, 
ERCC4, and XPG/ERCC5, respectively). These find-
ings extend the specificity of the repaiHorrecting ac-
tivity ofTFIlH and confirm the in vivo results obtained 
by microinjection. Furthermore, they demonstrate that 
besides XPB/ERCC3, XPD/ERCC2 and TTD-A must 
also have a direct involvement in NER. The in vitro and 
in vivo correction of ERCC2 mutants confirmed the in 
Tobie L Involvement of BTF2 in Different Human and 
Rodent NER-delkient Complementation Groups 
NER-deftcient 
complement. group, 
human mutants 
XP25RO 
XPCSlBA 
XP21RO 
XPlBR 
XP2RO 
XPl26LO 
XP2BI 
TID1BR 
lTDlBRSV 
XP-A 
XI'-B 
XP-C 
XP-D 
XP·E 
XP-F 
XP-G 
lTD-A 
TTIJ-A 
rodent mutants 
43.3B 
UV 5 
27.1 
UV 41 
UV 135 
136 
group I 
group 2 
group 3 
group 4 
group 5 
Correetion of NER defect 
by BTI'2 
mkroneedle injection 
+ 
+ 
+ 
in vitro repair assay 
+ 
+ 
+ 
vitro data of Drapkin et a!. (1994), who used a partially 
purified TFlIH preparation. However, the TFIIHI 
BTF2 purified fractions used in this study do not con-
tain a XPC-correcting activity, in contrast to the ob-
servations made by these authors. 
Relationship of XPD/ERCC2 and TID-A 
with 'he Core of TFIIH 
To further strengthen the link between NER and the 
TFIIH complex, the full elution profile of hydroxy-
apatite chromatography, the final purification step of 
BTF2 (Gerard et a!. 1991), was quantitatively screened 
for NER activity by microinjection as \vell as by in vitro 
complementation. The XP-D and TID-A correcting 
activities coelute with the activities of XP-B correction 
and transcription initiation (Fig. 4). Identical results 
were obtained after cosedimentation in glycerol gra-
dients (van Vuuren et al. 1994; \V. Vermeulen et aI., 
un pub!,). 
Independent evidence for a physical association of 
the XPD/ERCC2, XPB/ERCC3, and TIDA proteins 
with each other and with other components in the 
TFIIH complex can be obtained from antibody deple-
tion experiments. A crude repair-proficient HeLa ex-
tract was incubated with a monoclonal antibody against 
the p62 TFIIH subunit (Fischer et al. 1992), immobil-
ized on protein A-Sepharose beads, and after centrifu-
gation to remove bound proteins, the extract was tested 
for remaining repair capacity. Western blot analysis 
verified that the amount of p62 was strongly reduced 
(Fig. 5). In the in vitro correction assay, the p62deP1 et<d 
HeLa extract had lost most of its repair activity when 
compared with the repair level of mutant extracts alone 
and a mock-treated extract (see footnote to Table 2). 
To examine whether other NER factors were co-de-
pleted, the treated extract was tested for its comple-
menting capacity using both the in vitro assay and the 
microneedle injection. Previously, we have demonstrat-
ed that XPB/ERCC3, but not XPG/ERCC5, is simul-
taneously removed with p62 (van Vuuren et al. 1994). 
Table 2 shows that most XPD/ERCC2 and TIDA 
activities are also removed, whereas XPA, ERCCl, 
ERCC4, and XPG/ERCC5 are not significantly elimi-
nated (Table 2 and unpublished research). This is 
confirmed by the Western blot analysis revealing deple-
tion of XPB/ERCC3(p89) at the protein level (Fig. 5, 
lanes 5,6). The same co-depletion patterns were ob-
served with a monoclonal antibody against p89 (XPBI 
ERCC3) (Table 2). FUrthermore, depletion experi-
ments using monoclonal antibodies against two other 
components of TFIIH, p44 (the human homolog of 
yeast SSLl) and p34, revealed tight association with 
repair (Humbert et al. 1994; and results not shown). As 
with crude HeLa extracts, antibody depletion of 
purified BTF2 (hydroxyapatite and heparin purification 
fractions) using p62 monoclonal antibodies resulted in 
simultaneous removal of the XPB/ERCC3, XPDI 
ERCC2, and TI'DA factors ('rable 2). 111e depletion 
Figure 2. Microneedle injection of BlF2 in XP-
D (A), TTD-A (B), and XP-B (C) fibroblasts. 
Micrographs showi.ng thc effect of purified BTF2 
(HAP-fraction 12, containing the highest tran-
scriptional activity; Schaeffer et al. 1993) on 
NER-acti\·ity of injected XP-D (cell line 
XPlBR), TlD-A (TIDlBR), and XP-B 
(TTD6VI) fibrobla~ts, respectively. The injected 
cells (binnclear fibroblasts obtained by cell fu-
sion prior to injection) are indicated by arrows. 
As apparent from the number of silver grains 
above their nuclei, they exhibit a high (wild-
type) level of tN-induced UDS when compared 
to the noninjected surrounding celis, which ex-
prcs~ residuai UDS levels typical for these com-
piementation groups. The heavily labeled fibro-
blast in panel n is a cell performing S-phase 
replicative DNA s}llthesis at the moment of the 
UDS assay. 
B 
c 
and correction experiments provide strong evidence 
that three repair factors arc physically associated with 
three different TFJlH subunits and, thus, likely consti-
tute an integral part of transcription factor BTF2. 
Table 2 also shows that slllall amounts of correcting 
activities persist in the anti-p62-treated extract. 111is is 
largely due to incomplete removal of p62 (as shown by 
the Western blot analysis in Fig. 5). However, it is not 
I \ 
fully excluded that a small fraction of the ERCC2, 
ERCC3, and TTDA molecules exist dissociated from 
(the p62 part of) TFIIH, or reside in forms of TFIIH 
lacking p62. The same holds for the anti-p89 experi-
ments. A somewhat looser association between ERCC2 
and the p62-ERCC3 core of TFIIH is also derived from 
independent dissociation studies by Schaeffer and co-
workers (1994). Further indications for exchange of 
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Table 2, Effect of Immunodepletion of BTFl Components on NER Activity 
NER acthity (% of control) 
Tested cells/extracts 
Repair assay lmmunodepleted material (compl. group) protA depl anti p62 depl. anti p89 depl residual' 
Microncedle crude HeLa XP25RO (XP-A) 99 100 
" 
2 
injection lysate XI'CS2BA (XP-D) 103 39 33 13 
XP1BR (XP-D) 98 41 39 21 
TIDlBR (TID-A) 102 29 2J 8 
Microneedle D1F2 XPCS2BA (XP-B) 92 37 35 12 
injection (heparin 5PW, 'ITD6YI (XP-D) 100 42 44 44 
fraction 12) XPIBR (XP-D) 
" 
37 3S 2J 
TIDlBR (TID-A) 100 35 l5 8 
In vitro crude HeLa 27.1 (group 3) 100 35 n.d.< 34 
repair lysateb UV-5 (group 2) 100 32 n.d. 24 
TIDlBR (,ITO-A) 100 32 n.d. 27 
'Residual NER activit)': amount of repair exbibited by mutated cells/extracts. 
b p62.dcplctcd crude extract e~bibits a residual incorporation of 35% compared to a protA·treated control eMract, \\bicb is close 10 incorporation 
by most mutant extracts. 
< n,d,: Not detennined. 
various TFIIH subunits can be deduced from the in 
vitro complementation between ERCC2- and TID-A-
deficient extracts shown in Figure 3A (lanes 1-3), each 
of these extracts being defective in a different com-
ponent of the same complex. In Iinc with this, extracts 
defective in XPD/ERCCl and XPB/ERCC3 also ex-
hibit complementation in vitro (\'an Vuuren et al. 1993), 
and microinjection of free (recombinant) ERCC3 pro-
tein is able to induce a partial but clear correction of the 
repair defect of XP-B cells in vivo (van Vuuren et al. 
1994). We conclude thai a complex containing at least 
XPD/ERCC2, XPB/ERCC3, TfDA, and p62, and 
possibly also p44 (SSLl) and p34, is implicated in NER 
and that subunits of this complex can exchange in vivo 
and to some extent also in vitro. It is plausible that this 
1::::1 1'1 1 4 4 12 12 fraction 2 4 2 4 aID", 
+ m 
+ I. I 
."" A 2 3 4 5 8 7 
complex represents the entire multisubunit TFIIH tran-
scription factor. 
Is TIDA Identical to Any of the 
Cloned TFlIH SlIbunlls? 
A prediction of the findings reported above is that 
one of the components of BTF2 is responsible for the 
repair defect in TfO-A for which no repair gene has 
yet been isolated, Therefore, cDNAs encoding the 
cloned TFIIH subunits p62, p44, and p34 (Humbert et 
aL 1994), and XPDIERCC2(pSO) and XPBI 
ERCC3(p89) were inserted into a mammalian expres-
sion vector and injected into the nucleus of TfO-A 
fibroblasts. Prior to injection, the eDNA-containing 
Ia;::llli I ~ I: 1;1 fraction TIDog 
+ 
+ .. 
2 3 4 5 8 B 
Figure 3. In vitro correction of NER defect by purified BTFl. BTFl HAP-fraction 12 was added to an extract of rodent 
complementation group 2 (mutant UV5, equivalent to XP-D)(A), and to a human TID-A lysate (TfD1BRSY)(B), and tested for 
its capacity to restore the NER defect using an in vitro cell-free repair assay (Wood et al. 1988). The level of correction of NER 
activity using purified BTFl is of the same order (lanes 6,A and 8) as the level of complementation reached when the extract of 
group 2 is mixed \\lth a group 4 extract (lane 2A) or with the TID·A extract (lane 2B). No significant correction is obsen'cd when 
the purified BTF2-frae-tion is added to rodent complementation group 4 (mutant UV47) extract (lane 7A). The upper panel shows 
the ethidium·bromide-~tained DNA gel, the lower panel the autoradiogram of the dried gel. The presence of [~2P]dATP indicates 
repair synthesis. TIle positions of AAF-damaged and non·damaged DNA substrates, 250 ng each, are indicated by (+) and (-), 
respcctively. Lanes 1-3 contain in to!al2oo j1.g of cell-free extrae-t (in complementations, 100 j1.g of each extract was used); the 
other lanes contain 100 j1.g. The protein contribution by the BTFl frae-tion is negligible. 
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f1gure 4. Correlation between transcription activation and correction of the NER defect in XP-D/ERCC2 and TID·A mutant 
cells using different fractions from the HAP chromatography column. BTf2-derivcd in vivo NER-correcting activity was 
quantitatively detennined, after microinjc(tion, by counting the grains above the nuclei (UV.induced UDS) of injected cells and 
was expressed as the percentage of the lJDS·[evcl of repair-proficient contro! cells (C5RO) assayed in parallel (left black bar) 
(Vermeulen et a!. 1986). The hatched bars indicate the average UDS level (detennined by counting grains above 50 nuclei) of 
multikaryons injected \"ilh BTF2. The black bars represent UDS in noninjected neighboring cells. The in vivo NER activity 
profiles for, respectively, XP·B (XPCSIBA) (A), XP-D (XPlBR) (B), and TID-A (TfDlBR) (C) arc compared to the in vitro 
repair capacity for rodent complementation group 2 (ERCC2 mutant UV5) extracts (D) and to the transcription activity, as 
determined in a BTF2-dependenl in yitro transcription runoff assay using the adenovirus late promoter (E). Note that the UV5 
(group 2) extract in panel D (like the XP-D ceUs in panel B) has a considerable residual repair. The lower activity seen in the 
higher salt fractions (lanes /6-18) is attributed to an inhibition of repair incorporation by increased salt (Wood et a1. 1988). 
vectors were checked for their ability to specify pro· 
teins of the predicted size. None of these genes (p62, 
p44, p34), nor any of the cloned NER genes (ERCC1, 
XPDIERCC2, XPBIERCC3, CSBIERCC6, XPA, 
XPC, and the genes HHR23A and B; Masutani et al. 
1994), were able to exert correction of the repair defect, 
whereas microinjected ERCC2 and ERCC3 were able 
to restore UDS to XP-D and XP-B ceils, respectively, 
in the same experiments. It appears that the TIDA 
factor is yet another non·cloned component of TFIIH. 
E"idcncc for Dirccl Im'oh-ement of XPD/ERCC2 In 
Transcription In Vim 
The data described thus far tightly link the repair 
protein XPD/ERCC2 with transcription factor TFIIHI 
BTF2~ however, they do not demonstrate that the 
protein is directly imolved in transcription. Recently, 
Schaeffer and coworkers (1994) have shown that a p80 
protein associated with TFllH is identical to XPDI 
ERCC2 and that this protein stimulates the TFIIH-
dependent in vitro transcription reaction. In addition, 
Drapkin and coworkers (1994) have shown that an 
antibody directed against ERCC2 is able to inhibit the 
in vitro transcription reaction. To verify whether the in 
vitro results can be extrapolated to the in vivo situation, 
we have conducted antibody microinjection experi-
ments into Jiving normal cells. As shown in Figure 6A 
and quantitatively in Table 3, introduction of antibo-
dies against XPD/ERCC2 causes a strong inhibition of 
UV-induced UDS, consistent with the direct role of the 
protein in NER (Figs. 2 and 3) and similar to the effect 
observed using antibodies against another repair pro-
tein (ERCCl) that is not detectably associated with 
purified BTF2 (Table 3). In addition, a strong inhibi-
tion of general transcription (as measured by a I-hour 
[3 HJuridine labeling) is found (Fig. 6B), which is absent 
in the injections with ERCCt antiserum (Table 3). 
Similar, but less pronounced, effects on transcription 
and UDS are exerted by a less powerful serum against 
the XPB/ERCC3 component of TFIIH (Table 3) (see 
also van Vuuren et al. 1994). These results indicate that 
XPD/ERCC2, like XPB/ERCC3, is involved in tran-
scription in vivo. 
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Figure S. Western blot analysis of p62 and pS9 depiction of a 
repair-proficient HcLa extract. Monoclonal antibody 
(MAb3C9) against the p62 subunit of BTF2(TFIIH) coupled 
to protein-A-Sepharose beads was incubated with a repair-
proficient extract prepared from HeLa cells. To verify the 
removal of p62 and simultaneous removal of other compo-
nents of BTFl, the remaining cell-free extract and the bound 
fraction were analyzed by immunoblotting using monoclonal 
antibodies against p62 itself (lanes 1-4) and against the pS9 
(XPB/ERCC3) subunit of BTF2 (Janes 5 and 6). Lane 1 
contains the protein fraction bound to the anti-p62 beads, 
released by SDS {the strong bands at 55 kD and 25 kD 
represent the heavy and light chains of the antibodies released 
from the beads}. (Lanes 2 and 5) HcLa whole-cell extract 
treated with the anti-p62 beads. (Lanes 3 and 6) HcLa whole-
cell extract treated with protein-A beads alone (control). 
(Lane 4) Untreated HeLa whole-cell extract. In lanes 2-6, 
equal amounts of sample were loaded. 
DISCUSSION 
The findings reported here have implications in sev-
eral directions. At the molecular level, the identifica-
tion of at least three repair factors in TFIIH endows 
this complex with a dual functionality and extends the 
functional overlap between two quite different pro-
cesses, basal transcription and NER. At the clinical 
level, the identification of a link bctween TID and 
XPfCS group B cxtcnds thc association between TFIIH 
subunits and TID and supports the notion that CS, 
TfD, and some forms of XP represent different mani-
festations of one large clinical continuum. The con-
nection between TFIIH and TID provides new clues to 
understand the basis of the complex clinical features 
displayed by these disorders and, potentially, a number 
of other, strikingly related syndromes. 
Mechanistic Implicalions for Transcriplion 
and Repair 
A minimum of three NER factors is found to be 
associated with transcription factor TFIIH, In addition 
to XPBfERCC3 (Schaeffer et al. 1993), we demon-
strate that XPD/ERCC2 and TTDA reside in this 
complex. We provide evidence for thc involvement of 
the XPDfERCC2 helicase in transcription in vivo. 
Circumstantial data support the idca that the transcrip-
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don proteins p62, p44, and p34 are also implicated in 
NER (Humbert et al. 1994; van Vuuren et al. 1994; this 
paper). As previously anticipated (Bootsma and Hoeij-
makcrs 1993), the human homolog of SSLl, a yeast 
repair factor which was linked to translation previously 
(Yoon et al. 1992), was recently identified as the p44 
subunit of TFIIH (Humbert et al. 1994), Table 4 sum-
marizes the current evidence for the involvement of 
different human BTF2ITFIIH and yeast factor b 
subunits in repair. Tt is possible that the TI'DA protein 
is identical to the (non-cloned) p41 BTF2 subunit. 
Together, thcse data suggest that most, if not ali, com-
ponents of the transcription complex participate in 
cxcision repair, converting this complex into a func-
tional unit participating in at least two processes. 
It is still difficult to estimate how many polypeptides 
constitute TFIIH, Because of the absence of XPD/ 
ERCC2 as a major protein in the most pure BTF2 
preparation (Schacffer et al. 1994; Drapkin et al. 1994), 
it is likely that the five predominant bands present in 
the final stages of BTF2 purification (Gerard et al. 
1991) are derived from the mosl tightly associated 
protein fraction constituting the core of the complex. 
Protein profiles of the rat homolog (factor 8) suggest 
the presence of at least eight polypeptides (Conaway 
and Conaway 1989). Thus, BTF2 could well be con-
siderably larger in vivo and form a "supercomplex" of 
which Ihe more loosely bound factors have a tendcncy 
to (parlly) dissociate during purification. This could 
also explain the absence of a XPC-correcting activity in 
our TFIIH purifications, whereas others found associa-
tion of XPC with TFIIH, but not in the final purification 
fraction (Drapkin et al. 1994). Alternatively, it is pos-
sible that the XPC-corrccting activity represents a 
spurious copurification with TFllH. Association of 
XPC with TFIIH is somewhat unexpected, since XPC is 
thought to bc selectively involved in the global genome 
(transcription-independent) NER pathway (Venema et 
ai, 1990), 
BTF2 possesses a bidirectional unwinding activity 
involving XPB/ERCC3 and XPD!ERCC2 (Schaeffer 
et al. 1994), which may promote transition from a 
closed to an open initiation complex. It is likely that 
TFITH can bc utilized as an independent unit in the 
context of transcription and NER; e.g., for loading and! 
or translocation of the preinitiation complex or a NER 
scanning/incision complex or for the repair synthesis 
step. The TFIIH mutants XP-B, XP-D, and TTD-A 
display defects in both the "transcription-coupled" and 
the "global genome" NER subpathways, so the com-
plex is likely to playa role in the core of the NER 
reaction mechanism (Sweder and Hanawalt 1993). 
Clinical Heterogeneity and Pleiotropy Associated 
with Mulalions in TFIIH 
The spectrum of discases linked with TFIIH is 
heterogeneous and plciotropic, including seemingly 
unrelated symptoms such as photosensitivity, brittle 
hair and nails, neurodysmyelination, impaired sexual 
A 
Figure 6, Effect of injection of antibodies against XPD/ERCC2 on transcription and repair of normal cells. Micrograph A 
demonstrates the effect of injection ofERCC2 antibodies on UV-induced UDS of nonnal fibroblasts, assayed by a 2·hr incubation 
in [JHJthymirline immediately following UV·irradiation. Micrograph B shows the effect of injection oIXPD/ERCC2 anlisemffi on 
RNA synthesis of control (\\lld-type) fibroblasts assayed by a I-hr pulse-labeling with eHluridine. The UDS and RNA synthesis 
assays were performed 20 hr after injection of the antibodies. The strong reduction of autoradiographic grains above the nuclei of 
injected dikaIJ'ons (arroll's) compared to noninjectcd celh indicates a virtually complete inhibition of fu'l"A and repair synthesis. 
Thc heavily labeled nucleus in A is from a cell in S phasc at the time of incubation. Note that these preparations have a higher 
background labeling than the micrographs shown in Fig. 1. 
development, ichthyosis, and dental caries. Both the 
rare Xl' group B and the more common group D 
present pronounced clinical heterogeneity: classical XP 
(only in group D), atypical combination of XP and CS, 
and TfD (Johnson and Squires 1992; Vermeulen et al. 
11)94; this paper). The occurrence of patients displaying 
TID symptoms within XP-B extends the parallels be-
tween XP-B and XP-D and their respectivc gene prod-
ucts noted before (Weeda et al. 1990). Clinical vari-
ability in TID is even observed within families and also 
apparent from the close association with at least seven 
disorders (shown in Fig. 7) appearing in the On-line 
Mendelian Inheritance in Man (OMIM) database 
(McKusick 1992). The occurrencc of TID in three 
NER-deficient complementation groups argues against 
a chance association between genetic loci separately 
involved in NER and in brittle hair. Consistent with this 
notion, mutations in the XPDIERCC2 gene have been 
detected recently in TfD(XP-D) patients (Broughton 
ct al. 1994). 
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Table 3. Effect of Antibody Injection on Repair and 
Transcription 
Injected antiserum 
Rabbit anti ERCCt' 
Rabbit anti BRCC3' 
Rabbit anti ERCCl 
Preimmune rabbit serum 
% inhibition of % inhibition of 
NER' transcription~ 
97 0 
43 48 
87 8S 
2 7 
• Compared to UDS level observed in uninjected cells on the same 
slide. 
bCompared to transcription lc\·cl (assayed br I-hr pulse labeling 
v.ith eHluridine) observed in uninjeded cens on the same slide. 
'van Vuuren ct al. (199-1). 
How can we rationalize the pleiotropy and clinical 
heterogeneity in the above-mentioned conditions? The 
symptoms associated with a sole NER defect are dis-
played by the most common XP groups, A (totally 
deficient in NER) and C (defective in the "genome 
overall" repair subpathway). Patients in these groups 
present a relatively uniform clinical picture involving 
photosensitivity, pigmentation abnormalities, predispo-
sition to skin cancer and, in the case of XP-A, acceler-
ated neurodegeneration (which is not associated with 
neurodysmyelination), but no CS and lTD symptoms. 
The gene products affected in these groups are not vital 
and therefore do not appear to be essential for basal 
transcription. 
Obviously, the hallmarks of a pure NER deficiency 
do not include the salient features of CS and TID. It is 
tempting to link these \\ith the additional transcription-
related function. Indeed, it would be highly unlikely 
when all mutations in the three subunits of this bifunc-
tional complex would only affect the repair function 
and leave the inherent transcriptional role entirely 
intact. TIlis interpretation is supported by the haywire 
phenotype of the Drosophila ERCC3 mutant, involving 
UV sensitivity, central nervous system abnormalities, 
and impaired sexual development, as found in XP-B 
(Mounkes et al. 1992). Spermatogenesis in Drosophila 
is very sensitive to the level of ,81-tubulin (Kemphues et 
al. 1982). Mutations in the Drosophila ERCC3 gene 
seem to affect ,8-tubulin expression, causing male 
sterility (Mounkes et a1. 1992). In mammals, ,8-tubulin 
mRNA is selectively regulated by a unique cotransla-
tional degradation mechanism (Theodorakis and 
Cleveland 1992). It is possible that this renders ,8-
tubulin expression particularly sensitive to the level of 
transcription and thereby to subtle mutations in BT.F2, 
resulting in the immature sexual development found in 
TID and CS. Similarly, reduced transcription of genes 
encoding ultrahigh sulfur proteins of the hairshaft may 
account for the observed reduced cysteine content in 
the brittle hair of lTD patients (Hin and Pittelkow 
1990). Low expression of the myelin basic protein, 
whose transcription is known to be rate-limiting in the 
mouse (Readhead et al. 1987), may cause the charac-
teristic neurodysmrelination of CS and TID (Peserico 
et a1. 1992; Sasaki et al. 1992). A comparable explana-
tion is proposed for the poor enamelation of teeth in CS 
and TID (Nance and Berry 1992; McCuaiget al. 1993). 
The skin abnormalities typical of TID often involve 
ichthyosis. Various classes of ichthyoses show abnor-
malities in the production of filaggrin (Fleckman and 
Dale 1993). Thus, mutations in TFllH which subtly 
disturb its transcription function may affect a specific 
subset of genes whose functioning critically depends on 
the level or fine-tuning of transcription. Recent studies 
indicate that the requirement for basal transcription 
factors may vary from promoter to promoter depending 
on the sequence around the initiation site, the topo-
logical slate of the DNA, and the local chromatin 
structure (Parvin and Sharp 1993; Stanway 1993; Tim-
mers 1994). TIlCse mechanisms can easily explain the 
pronounced clinical heterogeneity even within families. 
On close inspection (Bootsma and Hoeijmakers 
1993), many parallels can be found between CS and 
TID. To a varying degree, CS patients exhibit features 
prominent in TID, such as thin, dry hair and scaly skin 
(Nance and Berry 1992). TID has recently been recog-
nized to include neurodysmyelination (Peserico et a1. 
1992), bird-like facies, dental caries, and cataract 
(McCuaig et al. 1993), hallmarks normally associated 
with CS. This suggests that CS and TID are mani-
festations of a broad clinical continuum, consistent with 
the notion that mutations in different subunits of the 
same (TFIIH) complex give rise to a similar set of 
Table 4. The NER connection of BTF2/TFIIH 
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NER protein, associated lIith 
BTF2 
XPBlERCC3 
XPDfERCC2 
TID·A 
p62' 
p44' 
'! , 
NER proteins \\ith 
yeast factor b 
RAD25/SSU b 
RAD3' 
? 
TFBl,i 
SSL1~ 
? 
7 
Pol~pepthles identified in 
SDS-PAGE 
p", 
p80 
? 
p62 
p44 
p .. w 
p34 
Factors for \\ !rich the iTlvolwment in NER is unequivocally demonstrated are in boldface . 
• NER (unction based on inference from (presumed) NER in\·oh"ement of Fast 
homologs 
b Rcfer<,nc<,s: Pdfk (1992); Feaver (1993). 
'Reference: Fearer (1993). 
d Some aUeks are UV sensitive. suggesting that ther are defidcnt in NER 
'The relationship between p.t! and lTD·A is not yet known. 
AFFECTED 
FUNCTION 
GENETIC 
SYNDROME 
CLINICAL 
SYMPTOMS 
8TF2 
other 
TFs? 
• non.photosensltlve varhmls 
XP/CS 
es 
PIBlDS 
es' 
(l)OIDS 
Polill T., 
Sabinas 
Netherton 
ONMR 
Hair bnln 
Mllrines~o 
.Sjogren 
.. otbers? 
lethal 
NER FEATURES: 
photosensitivity 
pigmentation 
abnormalities 
dry skin 
skin (Queer 
neurodegenerailon 
TRANSCR, FEATURES: 
dysrnyellnalioll 
gonadal dysgenesis 
brittle hair/nails 
ichthyosis 
denIal caries 
poor deHlopment 
heterogeneity 
Figure 7. Model for involvement of defects in transcription and repair in human disease (see text for explanation). 
phenotypic features. In this proposition, defects in the 
classical CS genes CSA and ERCC6/CSB (Troelslra et 
al. 1992), as well as XPGIERCC5 (Booisma and Hoeij-
makers 1993; Vermeulen ct at. 1993), are expected to 
somehow affect basal transcription as well. 
Model for Im'oh'ement of Transcription and Repair 
In CS and TID: Deduclion of the Existence of 
Transcription Syndromes 
A tentative model proposed for the etiology of the 
defects in the conglomerate of CS, TTD, and related 
disorders is shown in Figure 7. In this model, mutations 
in BTF2 factors inactivating only the NER function 
result in a XP phenotype as observed in the classic XP 
patients of XP-D. If, in addition, the transcription 
function is subtly affected, the photosensitive forms of 
combined XP/CS and TTD are found. Theoretically, 
mutations causing a (still viable) transcription problem 
without NER impairment are predicted. The notion 
that the new lTD XP-B members have only a mild 
repair defect (see Table 2) but nevertheless display 
lTD features not exhibited by the more repair-de-
ficient original XP·B cases fits perfectly into this 
reasoning. Indeed, a significant proportion of TfD 
patients, as well as clinically characteristic CS patients, 
is not noticeably photosensitive and has normal NER 
(Lehmann 1987; Nance and Berry 1992; Lehmann et al. 
1993). These findings extend the implications to non-
repair-defective disorders. Therefore, and in view of 
the pronounced heterogeneity inherent to the model, 
we propose that the Sjogren-Larsson (270200), RUD 
(308200), ICE (146720), OID (257960), [PAP 
(308205), CAM(F)AK (214550), Rothmund-lllOmp· 
son (268400), and KID (242150) syndromes (for refer-
ences, see Baden 1991; MeKusick 1992) also fall within 
this category. Interestingly, some of these diseases show 
occurrence of skin cancer. 
In conclusion, our findings provide evidence for the 
presence of a wide class of disorders that we propose to 
designate collectively as "transcription syndromes." A 
prediction from our model is that these patients carry 
mutations in transcription factors that do not affect the 
NER process. This proposition is testable, The explana· 
tion put forward here for this class of disorders would 
introduce a novel concept into human genetics. It can 
be envisaged that similar phenomena are associated 
with subtle defects in translation, implying the potential 
existence of "translation syndromes" (as suggested 
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earlier on completely different grounds; Fisher et al. 
1990). 
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